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Multidrug resistant (MDR) staphylococci are public health concern internationally. The 
treatment of these bacteria have become increasingly difficult due to their resistance to 
multiple antibiotics. In this thesis, multidrug resistant staphylococci have been recovered 
from high-frequency touched surfaces in public areas in the community and hospitals in 
East and West London. In total, 600 isolates collected of which 281 were MDR. In 
addition, 49 (8.17%) were mecA gene positive (mecA+). The most common species 
identified as multidrug resistant were S. epidermidis, S. haemolyticus and S. hominis, 
whereas penicillin, fusidic acid and erythromycin were the most frequent antibiotics the 
isolates were resistant to.  Whole genome sequencing (WGS) analysis for mecA+ isolates 
revealed that among the most frequent antibiotic resistance genes were blaZ, qacA/B and 
dfrC. Moreover, the mecA+ isolates had a diverse range of SCCmec types many of which 
were untypable due to carrying a novel combination of ccr genes or multiple ccr 
complexes. mecA+ S. epidermidis, S. haemolyticus and S. hominis isolates that have been 
whole genome sequenced were used in the "One Health" comparative genomics approach 
to compare them with isolates obtained from the ENA database that were recovered from 
clinical samples, healthy human body sites, livestock, companion animals and other 
environments. The mecA+ S. epidermidis and S. haemolyticus isolates in this study were 
genetically related and shared similar accessory gene profiles with ENA isolates that have 
been recovered from clinical samples. In addition, all three species mecA+ isolates 
recovered from public settings were genetically related to ENA isolates recovered from 
different source including healthy humans, livestock, and companion animals, plants and 
other environmental sources.  In conclusion, the high-frequency touched surfaces in 
public settings are reservoirs for staphylococci belonging to different lineages that are 
multidrug resistant and therefore pose a potential public health risk. 
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Chapter 1: Introduction 
Antimicrobial resistance (AMR) is a global problem (Ventola, 2015). Today many 
clinically important species have been identified to be multidrug resistant (MDR) (Alirol 
et al., 2017; Aloush et al., 2006; Gibson et al., 2010; Waters et al., 2011). This has been 
caused by the overuse of antibiotics (Michael et al., 2014). With the lack of development 
of new antibiotics, it is predicted there will be a post-antibiotic era where simple bacterial 
infection would lead to mortality as well as surgery no longer being plausible due to a 
risk of infections (Bragg et al., 2018). It has been predicted that by 2050, up to 10 million 
lives will be at risk (O’Neill, 2016). AMR bacteria are commonly found in clinical 
settings and animal agriculture due to the high amount of antibiotic used in these areas 
(Michael et al., 2014). From these areas, the AMR bacteria can disseminate into other 
niches (von Wintersdorff et al., 2016). One area in which AMR bacteria could spread and 
then further disseminate to other areas is in public settings. People can transmit AMR 
bacteria in these settings onto high-frequency hand touched surfaces (Bhatta et al., 2018; 
Roberts et al., 2013). The cycle can continue by further transmission from these surfaces 
onto people’s hands and then transmitted to other surfaces, spreading the AMR bacteria 
(Bhatta et al., 2018). One genus of bacteria that has already shown to spread AMR into 
public settings are staphylococci (Conceição et al., 2013; Lutz et al., 2014; Seng et al., 
2017b; Xu et al., 2015). Studies of MDR staphylococci from public settings are 
fragmentary with few reports mainly focusing on isolates recovered from buses, hotels, 
beaches and University campus (Conceição et al., 2013; Lutz et al., 2014, 2014; Seng et 
al., 2017a; Xu et al., 2015).  
1. Literature review 




Staphylococci are Gram-positive cocci with a diameter ranging from 0.5-1.0m. They 
are seen to grow in “grape-like” cluster but occasionally have occurred singly, in pairs, 
tetrads and short chains (Foster, 1996). These organisms are non-motile with some 
members of this genus having a capsule. On agar plates, they usually form dwarf colonies 
(Borderon and Horodniceanu, 1978). These colonies can appear smooth, glossy, butyrous 
or wet. For the majority of the time, colonies are opaque, but some can be pigmented, 
which are creamy-white in colour or yellow/orange in colour (Becker et al., 2014).  
1.1.2. Biochemical properties 
 
Staphylococci are catalase-positive facultative anaerobes that can grow at temperatures 
ranging from 30oC-37oC. (Conceição et al., 2013; Lutz et al., 2014; Soge et al., 2009; Xu 
et al., 2015). They are also oxidase-negative (though a few species are oxidase-positive), 
urease-variable, ornithine-decarboxylase-negative and halotolerant (Scybert et al., 2003; 
Tsoi and Tse, 2011; Vernozy-Rozand et al., 2000; Zhou et al., 2019). Staphylococci can 
be split into two groups; coagulase-positive (CoPS) and coagulase-negative staphylococci 
(CoNS). CoPS produce coagulase an enzyme which causes blood clotting, whereas CoNS 
lack this enzyme (Sasaki et al., 2010). Their chromosomal guanine-cytosine (GC) content 
range from 30-40% (Suzuki et al., 2012).  
1.1.3 Taxonomy 
 
Staphylococci belong to the Firmicutes phylum; bacilli class; Bacillales order and the 
Staphylococcaceae family (Becker et al., 2014). Staphylococcus consists of 47 species 
and 23 subspecies (Table 1.1 and Table 1.2) (Becker et al., 2014). Eight of these species 
are CoPS and 38 are CoNS. S. schleiferi can be both CoPS (S. schleiferi subsp. Coagulans) 
and CoNS (S. schleiferi subsp. Schleiferi) (Becker et al., 2014). Staphylococcus can be 
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Muscae Hyicus Intermedius Aureus Epidermidis Warneri Haemolyticus Lugdunensis 













   ssp. schleiferi 
  ssp. coagulans1 
S. aureus 
 Ssp. aureus1 





  spp. capitis 










 spp. hominis 






 spp. petasii 
 
S. lugdunensis 


























Species S. auricularis S. simulans 
S. carnosus 
spp. carnosus 










 spp. saprophy-  
ticus 
  spp. bovis 
S. equorum 
  spp. equorum 
  spp. linen 
S. gallinarum 
S. succinus 





  spp. sciuri 
  spp. carnaticus 





Table 1.2: Phylogenetic separation of Staphylococcus species part 2.Table from Becker et al., 2014
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1.1.4 Epidemiology and transmission 
 
Staphylococci have initially been described as either being human-associated or animal-
associated although studies have shown that members of these species can cross over to other 
species (Table 1.2) (Becker et al., 2014). They are found as part of the natural microbiota of 
the skin and mucous membrane of human and animals. Data shows that staphylococci can be 
found on axillar, the gluteal and inguinal regions, anterior nares, the umbilicus, the antecubital 
and popliteal spaces, the plantar foot regions, ocular surfaces and the conjunctiva (Costello et 
al., 2009; Graham et al., 2007; Grice et al., 2009; Wos-Oxley et al., 2010). As these organisms 
are found on the skin, they can be transmitted across from humans and animal and vice versa 
(Gómez-Sanz et al., 2019; Velasco et al., 2015). They can also be transmitted via an 
intermediate object that comes into contact with human or animal skin that contains these 
microorganisms (Conceição et al., 2013; Lutz et al., 2014; Seng et al., 2017b; Xu et al., 2015). 
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Species or subspecies Site or source of detection 
 
Environment 
and/or food Animals Humans 
S. arlettae 







Raw meat, public 
beaches, buses, 
housing and public 




sheep, dogs Skin, anterior nares 
S. auricularis − − 
External auditory canal (principle habitat), seldom on other skin 
regions 
S. capitis subsp. capitis − 
Cats, dogs, 
horses 
Predominantly on the scalp and arms, less frequently on other skin 
regions 
S. capitis subsp. urealyticus − − 
Predominantly on the skin (mostly from heads, primarily ears and 
foreheads) 
S. caprae − Goats Skin, anterior nares 
S. carnosussubsp. carnosus 
Fermented food 
(starter cultures, soy 
sauce mash) Cattle − 
S. carnosussubsp. utilis 
Fermented food 
(soy sauce mash, 
fermented fish)  − 
S. chromogenes − 
Cattle, pigs, 
horses, 
goats, sheep − 
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Species or subspecies Site or source of detection 











Fermented food and 
starter cultures − − 











Skin (preferentially axillae and the head; also arms and legs) and 
mucous membranes of the nasopharynx 







S. equorum subsp. linens 
Smear-ripened 
cheese (starter 
culture) − − 
S. felis − Cats, horses − 








Species or subspecies Site or source of detection 
S. haemolyticus 
Milk, fermented 






sheep Skin (preferentially legs and arms) 








Skin (preferentially axillae, arms, legs, and pubic and inguinal 
regions) 
S. hominis subsp. novobiosepticus − − − 
S. jettensis − − − 
S. kloosii − Goats − 
S. lentus 












guinea pigs Skin (preferentially lower abdomen and extremities) 
S. massiliensis − − Skin  
S. microti − Mice − 
S. muscae − 
Flies 
(trapped in 
cattle sheds) − 
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S. pasteuri Fermented sausages Pigs − 
S. petrasii subsp. croceilyticus − − Skin  
S. petrasii subsp. petrasii − − Skin  
S. pettenkoferi −Hotel room − Skin  












S. saccharolyticus −  Gorillas Skin, particularly on the forehead and arm 
S. saprophyticussubsp. bovis − Cattle − 
S. saprophyticus 







Species or subspecies Site or source of detection 
S. schleiferisubsp. schleiferi − Dogs, cats Skin (particularly preaxillary) 
S. sciuri subsp. carnaticus − 
Cattle, 
dolphins Skin 
S. sciuri subsp. rodentium − 
Rodents, 
whales Skin 














S. simiae − 
Squirrel 
monkeys − 
S. simulans − 
Cattle, 
horses, 
sheep Skin (legs, arms, and heads of children; occasionally in adults) 
S. stepanovicii − 
Insectivores
, rodents − 
S. succinussubsp. casei Fermented food 
Insectivores
, rodents − 
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Species or subspecies Site or source of detection 







songbirds Eye (single report) 

























sheep Skin (rare) 
Table 1.3: Sites or source of detection for different staphylococcal species. Table from Becker et al., 2014
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1.1.4.1 S. aureus 
The most well-known Staphylococcus spp.  is the CoPS S. aureus. This microorganism 
is a human commensal with 30% of the population being an asymptomatic carrier of it. 
However, it is also one of the most common causes of nosocomial infections. The 
majority of S. aureus carriage is within the anterior nares (Gorwitz et al., 2008). In 
humans, S. aureus can cause bacteraemia, endocarditis, osteoarticular, skin and soft tissue, 
pleuropulmonary and device-related infections (Tong et al., 2015). It has also been shown 
to infect pigs, cattle, horses, poultry, sheep, goats and dogs (Peton and Le Loir, 2014). 
Animal and human-associated isolates S. aureus are genetically different though there are 
cases of animal-associated Staphylococcus colonising farmers (Sung et al., 2008). 
Reports have detected S. aureus from environmental samples including beaches, seawater, 
public buses and built-up area (Conceição et al., 2013; Lutz et al., 2014; Roberts et al., 
2013). 
1.1.4.2 S. epidermidis  
S. epidermidis is the most common CoNS human skin-resident; however, rupture of first-
line surface barriers such as skin allows the bacteria to gain entry to the bloodstream and 
become one of the most frequent pathogens among CoNS. It has been evidenced that this 
bacterium is responsible for 22% of bloodstream infection found in intensive care unit 
patients in the USA (Otto, 2009). S. epidermidis is not exclusively recovered from 
humans and can be found on animals and plants. For livestock animals, S. epidermidis 
isolates have previously been recovered from cows, pigs and sheep (Argudín et al., 2015; 
Rahman et al., 2016). Some livestock-associated isolates were shown to be similar to that 
of hospital-associated isolates though some livestock-associated isolates were only 
specific to animals (Argudín et al., 2015). Isolates recovered from rice seeds were 
reported as being genetically different from known human commensal and clinical 
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isolates but was shown to be genetically similar to isolates recovered from wild mice 
(Chaudhry and Patil, 2016). MDR S. epidermidis has been isolated from non-healthcare 
settings like hotel rooms and university campuses, but no studies have shown if they are 
similar to that of hospital or animal associated S. epidermidis isolates (Seng et al., 2017b; 
Xu et al., 2015). 
1.1.4.3 S. haemolyticus  
S. haemolyticus is the second most common CoNS species that have been isolated from 
clinical cases (Czekaj et al., 2015). Similar to S. epidermidis, most infections are 
associated with immune-compromised patients and patients with implanted medical 
devices (Silva et al., 2013). S. haemolyticus has the highest level of antimicrobial 
resistance among the CoNS (Barros et al., 2012; Froggatt et al., 1989). Reports have 
shown that S. haemolyticus was found in 38.3% of the infant's nasal cavity from 429 
neonates admitted in a hospital in Brazil (Ternes et al., 2013). They have also been cases 
of AMR S. haemolyticus recovered from livestock, companion animals and public 
environments (Alirol et al., 2017; Ruzauskas et al., 2014; Seng et al., 2017b; Xu et al., 
2015). Unlike S. epidermidis little is known about genetic lineages of isolates recovered 
from a different source, but studies have reported on the transmission of isolates from 
companion and livestock animals to humans (Loncaric et al., 2016; Ruzauskas et al., 
2014). 
1.1.4.4 S. hominis  
S. hominis like S. epidermidis and S. haemolyticus is another CoNS human commensal, 
which has also been associated with nosocomial (Chaves et al., 2005; Ternes et al., 2013). 
Reports of S. hominis colonisation on animals is scarce, with only a few reports of them 
being isolated from dairy cattle and mosquitos (Hughes et al., 2016; Naushad et al., 2016). 
These reports do not show if these isolates could be transmitted to humans. From the 
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public settings, S. hominis has been previously isolated from hotel rooms as well as 
university campuses that were shown to be MDR (Seng et al., 2017b; Xu et al., 2015). 
No previous studies have looked into the genetic lineages of animal or environmental S. 
hominis before. 
1.2 Pathogenicity  
Staphylococci are capable of colonising and infecting many different hosts. These 
virulent factors can be species and/or strain-specific that are shown to have a function in 
adherence, aggression, invasion, persistence and evasion of the adaptive and innate 
immune system (Table 1.3) (Diep et al., 2006; Gill et al., 2005). Of the virulent factors 
previously characterised for this genus, the majority of them have only been identified in 
S. aureus (Gill et al., 2005). This includes a wide range of toxin genes which can cause 
diseases such as toxic shock syndrome (TSS), staphylococcal scalded skin syndrome 
(SSSS), necrotizing pneumonia, or deep-seated infections (Jarraud et al., 2002, 1999). In 
comparison, CoNS lack many of the virulent factors that have been identified in S. aureus. 
However, CoNS are still able to cause infections, although not to the degree to that of S. 
aureus.  CoNS infections are mainly caused by the implantation of medical devices 
(Christensen et al., 1985; Peters et al., 1982). Attachment to these devices normally 
requires the bacteria to produce a biofilm. Infections normally occur during the insertion 
of the device as a small number of cells attach to the implant from the patient's skin or 
mucosal layer. From here, the cells can disseminate via the bloodstream and colonise and 
infect other body sites, which can lead to sepsis, meningitis and endocarditis. Another 
important virulent factor that has been identified in S. haemolyticus, S. hominis, S. 
saprophyticus as well as S. aureus is the production of a polysaccharide capsule (Blake 
and Metcalfe, 2001; Flahaut et al., 2008; O’Riordan and Lee, 2004; Park et al., 2010).  





S. aureus S. epidermidis S. haemolyticus 




ebh P p A 
Clumping factor A clfA  P A A 
Clumping factor B clfB  P A A 
Collagen adhesion  cna P A A 




eap/map P A A 
Fibrinogen binding 
protein 
efb  P A A 
Fibronectin binding 
proteins 
fnbA P A A 
Fibronectin binding 
proteins 
fnbB P A A 
Intercellular adhesin icaA  P P A 
Intercellular adhesin icaB  P P A 
Intercellular adhesin icaC P P A 
Intercellular adhesin icaD P P A 
Intercellular adhesin icaR  P P A 
Ser-Asp rich fibrinogen-
binding proteins 
sdrC  P A A 
Ser-Asp rich fibrinogen-
binding proteins 
sdrD  P A A 
Ser-Asp rich fibrinogen-
binding proteins 
sdrE  P A A 
Ser-Asp rich fibrinogen-
binding proteins 
sdrF  A P A 
Ser-Asp rich fibrinogen-
binding proteins 
sdrG  A P A 
Ser-Asp rich fibrinogen-
binding proteins 
sdrH  A P A 
Staphylococcal protein A spa P A A 
Enzyme 
    
Cysteine protease  sspB  P P A 
Cysteine protease  sspC  P A A 
Hyaluronate lyase hysA  P A A 
Lipase  geh P P A 
Lipase  lip P P p 




S. aureus S. epidermidis S. haemolyticus 
Serine protease splA  P A A 
Serine protease splB  P A A 
Serine protease splC  P A A 
Serine protease splD P A A 
Serine protease splE  P A A 
Serine protease splF  P A A 
Staphylocoagulase  coa P A A 
Staphylokinase sak  P A A 
Thermonuclease nuc P P P 
Immune evasion 
    
Capsule  -- P A P 
Secretion system 
    
 esxA    
Type VII secretion 
system  
esaA  P A A 
Type VII secretion 
system  
essA P A A 
Type VII secretion 
system  
esaB  P A A 
Type VII secretion 
system  
essB P A A 
Type VII secretion 
system  
essC P A A 
Type VII secretion 
system  
esxB P A A 
Type VII secretion 
system 
esaD P A A 
Type VII secretion 
system  
esaE P A A 
Type VII secretion 
system  
esxD P A A 
Type VII secretion 
system 
esaD P A A 
Type VII secretion 
system 
esaG P A A 
Toxin 
    
Alpha hemolysin  hly/hla  P A A 
Beta hemolysin  hlb  P P A 
Delta hemolysin  hld  P P A 
Enterotoxin A sea  P A A 
Enterotoxin B seb  P A A 
Enterotoxin C sec  P A A 




S. aureus S. epidermidis S. haemolyticus 
Enterotoxin E see  P A A 
Enterotoxin G seg  P A A 
Enterotoxin H seh  P A A 
Enterotoxin I sei  P A A 
Enterotoxin J sej  P A A 
Enterotoxin Yent1 yent1  P A A 
Enterotoxin Yent2 yent2  P A A 
Enterotoxin-like K selk  P A A 
Enterotoxin-like L sell  P A A 
Enterotoxin-like M selm  P A A 
Enterotoxin-like N seln  P A A 
Enterotoxin-like O selo  P A A 
Enterotoxin-like P selp  P A A 
Enterotoxin-like Q selq  P A A 
Enterotoxin-like R selr  P A A 
Enterotoxin-like U selu  P A A 
Exfoliative toxin type A  eta  P A A 
Exfoliative toxin type B  etb  P A A 
Exfoliative toxin type C  etc P A A 
Exfoliative toxin type D  etd  P A A 
Exotoxin set10  P A A 
Exotoxin set11  P A A 
Exotoxin set12  P A A 
Exotoxin set13  P A A 
Exotoxin set14  P A A 
Exotoxin set15  P A A 
Exotoxin set16  P A A 
Exotoxin set17  P A A 
Exotoxin set18  P A A 
Exotoxin set19  P A A 
Exotoxin set1  P A A 
Exotoxin set20  P A A 
Exotoxin set21  P A A 
Exotoxin set22  P A A 
Exotoxin set23  P A A 
Exotoxin set24  P A A 
Exotoxin set25  P A A 
Exotoxin set26  P A A 
Exotoxin set2  P A A 




S. aureus S. epidermidis S. haemolyticus 
Exotoxin set31  P A A 
Exotoxin set32  P A A 
Exotoxin set33  P A A 
Exotoxin set34  P A A 
Exotoxin set35  P A A 
Exotoxin set36  P A A 
Exotoxin set37  P A A 
Exotoxin set38  P A A 
Exotoxin set39  P A A 
Exotoxin set3  P A A 
Exotoxin set40  P A A 
Exotoxin set4  P A A 
Exotoxin set5  P A A 
Exotoxin set6  P A A 
Exotoxin set7  P A A 
Exotoxin set8  P A A 
Exotoxin set9  P A A 
Gamma hemolysin  hlgA P A A 
Gamma hemolysin  hlgB P A A 
Gamma hemolysin  hlgC P A A 
Leukocidin M  lukF-like P A A 
Leukocidin M  lukM  P A A 
Leukotoxin D lukD P A A 
Leukotoxin E  lukE  P A A 
Panton-Valentine 
leukocidin 
lukF-PV P A A 
Panton-Valentine 
leukocidin 
lukS-PV P A A 
Toxic shock syndrome 
toxin 
tsst  P A A 
Table 1.4: Known virulent genes found in different staphylococcal species. Part of table data 
from http://www.mgc.ac.cn/cgi-bin/VFs/v5/main.cgi?func=VFanalyzer Staphylococcus 
pathogenomics accessed March 2018.P= present A= absent  
1.3 Speciation of staphylococci 
Speciation of staphylococci has developed from a long process of bacteria cultivation and 
biochemical tests for rapid identification. The improvement in speciation is important in 
clinical laboratories to help rapidly identify bacterial species cost-effectively to ensure 
that patients are given the right treatment quickly. 
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1.3.1 Traditional biochemical speciation methods 
A traditional method used in identifying staphylococci is to grow them on selective or 
differential media. A common media used in the identification of staphylococci is 
mannitol salt agar (Bautista-Trujillo et al., 2013). This agar is selective to staphylococci 
due to the high sodium chloride concentration (7.5%) and can differentiate between S. 
aureus and other staphylococci by the pH indicator which changes the media from red to 
yellow due to the fermentation of mannitol into an acid by-product by S. aureus (Bautista-
Trujillo et al., 2013). Although this might be a quick method to identify S. aureus there 
are instances of S. aureus that are mannitol-negative as well as some S. saprophyticus and  
S. haemolyticus being mannitol positive (dos Santos et al., 2015; Shittu et al., 2006).  This 
agar does not exclusively selective for staphylococci therefore further analyse would be 
required. To determine if these might be Staphylococcus and not bacteria from another 
genus; Gram staining would be performed followed by a series of biochemical tests 
(Figure 1.1). These would include a catalase test to determine if they might be 
staphylococci and a coagulase test which will determine if the bacteria are CoPS or CoNS 
(Figure 1.2). This method for speciating bacteria is time consuming and can normally 
take 24-48 hours to complete (Croxatto et al., 2012) .
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Figure 1.2: Catalase and coagulase test for staphylococcal identification. (A) Catalase test 
figure https://www.microbiologyinpictures.com/bacteria-photos/staphylococcus-




















1.3.2 16s ribosomal RNA gene sequencing 
A modern method used in t speciation of staphylococci is 16S ribosomal RNA (rRNA) 
gene sequencing (Janda and Abbott, 2007). 16S rRNA gene is a component of the 30S 
subunit of prokaryotic ribosomes. This gene is highly conserved between different 
species and can be amplified by PCR using universal primers to produce a 1,500bp 
sequence (Weisburg et al., 1991). Using bioinformatics tools, the isolates DNA sequence 
are then compared to known sequences on an open database to identify the bacterial 
species, and sometimes to strain level (Janda and Abbott, 2007). This method only works 
as long as that sequence has been identified before (Janda and Abbott, 2007). Compared 
to biochemical test this method is quicker and more accurate but still relatively time 
consuming. 
1.3.3 Speciation by matrix-assisted laser desorption ionization time-of-flight mass 
spectrometry  
Recently, matrix-assisted laser desorption ionization time-of-flight mass 
spectrometry (MALDI-TOF MS) has become widely used in clinical microbiology for 
rapid identification of bacteria to the species level (Croxatto et al., 2012) (Figure 1.3). 
This method is cheaper and faster of that used to in 16s rRNA but is not as efficient in 
identifying the different strains (Croxatto et al., 2012). This method only requires a single 
colony from an agar plate to be put onto a target plate. The cells on the target plate are 
then lysed with acid before a matrix solution is overlaid. They are then put into the 
MALDI-TOF MS instrument, and a laser is fired multiple times onto each spot, which 
leads to desorption of the analyte which are then vaporised and ionised.  These desorbed 
and ionised molecules are first accelerated through an electrostatic field then through a 
vacuum until they reach a detector, with small ions travelling quicker than larger ions. 
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This detector measures intensity and mass/charge (m/z) of each analyte fragment and 
plots them on a spectrum. The spectrum of these samples is then compared with a 
database of known bacterial species key mass ions to identify the bacterial species 
(Croxatto et al., 2012). A drawback with this method is that there are several 
manufacturers that produce MALDI-TOF MS each having their own database has 
restricted its commercial development, currently, to two major companies (Singhal et al., 
2015). Parallel studies with clinical isolates using Bruker’s Biotyper and the Shimadzu’s 
MALDI-MS using the SARAMIS system of bioMérieux has shown good concordance 
when reference spectra are present in the database (Cherkaoui et al., 2010). However, 
while the degree of confidence of a result mainly depends on the MALDI-MS and 
database, it is also influenced by sample preparation and even user dependent (Keys et 




Figure 1.3: Principal of MALDI-TOF identification of bacterial species. Figure from 
Lavigne et al., 2013 
 
1.4 Molecular typing of staphylococci 
Molecular typing is important for monitoring the staphylococci population as well as 
identifying if the infections are related to an outbreak (Miragaia et al., 2008). As bacteria 
species are constantly diversifying due to point mutation, recombination, acquiring or 
deleting of mobile genetic elements, it not always easy to find genetic markers that can 
be traced back to a common ancestor. Therefore genetic markers that are used for typing 
bacteria isolates need to be reproducible, stable; have high discriminatory power, 
epidemiological concordance versatile, easy to perform, easy to interpret; and should be 
cost-effective and time effective (Miragaia et al., 2008).  
 
1.4.1 Pulse field gel electrophoresis  
A traditional method used to group variants in many bacterial species is pulse field gel 
electrophoresis (PFGE) (Miragaia et al., 2008). This method uses nucleotide restriction 
enzymes to digest chromosomal DNA into short nucleotide fragments. The banding 
pattern of the fragments is then compared on an electrophoresis gel (Oliveira et al., 2002). 
1.4.2 Multilocus sequence typing 
 Some bacteria species can also be grouped by Multilocus sequence typing (MLST) 
(Figure 1.4). This requires amplifying fragments of seven housekeeping genes of 
individual species and sequencing them to identify polymorphism(s) in those genes 
(Miragaia et al., 2008). These strains are then grouped by their nucleotide polymorphisms 
into sequence type (ST). ST can be further grouped by their clonal complex (CC), which 
are ST distinguishable by a single nucleotide polymorphism in three or fewer loci 
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(Chambers and Deleo, 2009). MLST in S. aureus has been used to distinguish between 
hospital-associated and community-associated infection as well as to track the movement 
of different outbreaks across the world (Ghaznavi-Rad et al., 2010; Green et al., 2010; 
Wang et al., 2018).  
 
Figure 1.4: Schematic on how MLST is performed. Seven housekeeping genes are 
amplified from isolate and sequenced to determine their allele type. From the allelic 
profile the bacteria isolate ST can be determined. Figure from ( http://beta.mlst.net/) 
1.4.3 SCCmec typing 
Staphylococcal isolates can also be grouped by their Staphylococcus Chromosome 
Cassette mec (SCCmec) type a mobile genetic element that has the mecA gene which 
encodes for methicillin resistance (Miragaia et al., 2008).  This method helps determine 
the movement of these genes in different populations as well as to understand the SCCmec 
evolution (Miragaia et al., 2008). SCCmec typing can only be used in strains that have 
the genetic element where MLST uses genes that are ubiquitous in S. aureus and S. 
epidermidis.  
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1.4.4 Spa typing 
The Spa gene variable repeat region can also be used to differentiate between S. aureus 
isolates. Spa gene encodes protein A, which is an important virulence factor in S. aureus 
(Koreen et al., 2004). In Spa typing, they can discriminate between different S. aureus in 
outbreak settings by sequencing the polymorphic 24-bp variable-number tandem repeat 
(VNTR) within the 3′ coding region.  Genetic variations within the spa gene can occur 
rapidly and slowly by two independent mechanisms which can be used as a marker to 
track local and global transmission as well as long term epidemiologic and population 
studies (Koreen et al., 2004). 
1.4.5 Comparison of different molecular typing methods 
Different molecular typing techniques have their strengths and weaknesses. This was 
shown in two studies performed by Miragaia and co-workers, and Petersson and co-
workers (Miragaia et al. 2008; Petersson et al., 2010). These studies compared PFGE, 
MLST and SCCmec in S. epidermidis and Spa type to PFGE in S. aureus. The first study 
found that PFGE is most discriminative, followed by MLST and then SCCmec (Miragaia 
et al., 2008). The second study found that Spa was less discriminative in comparison to 
PFGE (Petersson et al., 2010). Although MLST might not be as discriminative as PFGE 
as shown by Miragaia and co-workers; MLST is used more today than PFGE as the 
techniques are standardised and results can be compared with other laboratories isolates 
submitted into the database, which is freely available (Miragaia et al. 2008; Nemoy et al., 
2005).  Spa typing might not be as discriminating as the other techniques but still can be 
useful in epidemiology cases in a low-prevalence setting (Petersson et al., 2010). 
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1.5 Whole genome sequencing  
The most discriminative method used today in determining the difference in genetics in 
a bacterial population is whole genome sequencing (WGS) (Bryant et al., 2012). This 
method generates a sequence of the whole bacterial chromosomes and plasmids for each 
species. WGS has helped aid in the understanding of the epidemiology, genetic evolution 
between strains and species and the frequency these genes occur in that species (Aanensen 
et al., 2016; Conlan et al., 2012; Gill et al., 2005). In the past WGS could not have been 
done on a large scale due to cost and time but advances in next-generation sequencing in 
the last 10 years has helped significantly by decreasing these limiting factors (Goodwin 
et al., 2016). This coincides with the advancement of computers ability to process a large 
amount of biological data quickly have shown an increase in studies using WGS and 
bioinformatics analyses in microbiology (Saeb, 2018). However, most of the literature 
still uses standard molecular typing for staphylococci as it still is considered quicker for 
routine surveillance and there is still some uncertainty on how to interpret the WGS data 
for epidemiology (Sabat et al., 2013).  
1.5.1 WGS to compare different species 
WGS can be used to compare many different bacteria species. An example of this for 
staphylococci is a study that compared S. aureus COL; one of the first methicillin-
resistant isolates and methicillin-resistant S. epidermidis RP62a (Gill et al., 2005). They 
found that these two species shared 1,681 core genes and the only variation most likely 
derives from genome islands found on the bacterial chromosome. Interestingly, the S. 
epidermidis strain they sequenced obtained a unique virulence gene for the species which 
encodes a polyglutamate capsule similar to that found in Bacillus anthracis (Gill et al., 
2005). This shows that WGS can be used to identify whether genes have been horizontally 
transferred from different bacterial species.  
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1.5.2 WGS to compare isolates from same species 
Most WGS studies are usually comparing populations of a single bacterial species. An 
example of this for staphylococci is a study which compared an environmental  S. 
epidermis G6_2 isolate recovered from a hotel room in London to previous WGS S. 
epidermidis isolates (Xu et al., 2018a). In this study, they identified this isolate to be a 
representative of MLST 59 (Xu et al., 2018a). They determined that this isolate was 
similar to that of other ST59 isolates phylogenetically and that the composition of the 
antibiotic resistance gene is partly preserved across this lineage (Xu et al., 2018a). 
Interestingly, the virulence delta-hemolysin gene was present in S. epidermis G6_2, 
which was absent in other ST59 samples (Xu et al., 2018a). 
WGS can be used to analyse the bacterial population structure. A common method of 
analysing bacterial population structure is by a pangenome analysis of bacterial species 
by considering which genes are considered core and which genes are accessory within a 
species (Conlan et al., 2012). Conlan and co-workers WGS to identify that S. epidermidis 
that are known as commensal and nosocomial (Conlan et al., 2012). They found that S. 
epidermidis species have a large core genome, but variable genes are constantly in flux 
due to transposable elements transcription factors and transporters (Conlan et al. 2012). 
From just WGS data, they could distinguish between commensal and nosocomial strains 
by the reduction of virulence markers and the presence of formate dehydrogenase gene 
(Conlan et al., 2012). They also found that nosocomial strains were shown to have more 
genetic rearrangement and single nucleotide polymorphism, than the commensal strains 
(Conlan et al., 2012). Additionally, they identified gene functions within the variable 
genome by assigning gene clusters of orthologous groups (COG) categories by aligning 
protein sequence against a BLAST database of COG sequences. This consists of 20 
groups, of which they found that there was high abundance of genes in the variable 
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genome which encodes for replication, recombination and repair; transcriptional 
regulators; and defense mechanisms (Conlan et al., 2012; Tatusov et al., 2003). The 
authors describe the reasoning for the high abundance of these COG groups in the variable 
genome was due high diversity of mobile genetic elements (recombinase and integrase 
genes), transcriptional regulators, and ABC-type multidrug transporters, respectively 
(Conlan et al., 2012). 
1.5.3 Detecting mobile genetic elements 
A key factor of the antibiotic resistance genes and virulence genes is that they can be 
found within mobile genetic elements. From WGS data, there are many approaches which 
have been implemented in trying to identifying if these genes are horizontally transferred 
across (Lu and Leong, 2016). These approaches including using NCBI BLAST for known 
mobile genetic elements found in phage insertion sequences or transposons and insertion 
sequences; genome assembling software that detect plasmids by comparing the read 
coverage to the overall medium coverage of the genome and software that can detect 
sequence composition biases to determine areas within the genome are genomic islands 
(Altschul et al., 1990; Antipov et al., 2016; Arndt et al., 2016; Bertelli et al., 2017). It is 
also possible to identify the donor’s organisms of the horizontal transfer genes by blasting 
proteins sequences against the NCBI reference database of proteins with known species 
(Pruitt et al., 2007; Zhu et al., 2014).  
Staphylococci WGS analyses other than S. aureus and S. epidermidis are very fragmented 
in the literature (Cavanagh et al., 2014; Conlan et al., 2012; Gill et al., 2005; Lilje et al., 
2017; Sabat et al., 2013; Xu et al., 2015). This may because other staphylococci are not 
common causes of infection. This might be the case but there has been an increasing 
number of S. haemolyticus and S. hominis infections that have been reported and it would 
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be interesting to find out more about their genetic lineages, especially the ones which are 
MDR (Czekaj et al., 2015; Voineagu et al., 2012). 
1.6 Antibiotic resistance variations in isolates recovered from different ecological 
niches 
 
MDR staphylococci have been found in many different ecological niches; ranging from 
healthcare, community, and environmental sources. The majority of the literature focuses 
on S. aureus isolates from the clinical setting (patients and environment) and the 
community (isolates from people not associated with healthcare facilities) but reports are 
more fragmented on the public environment especially for CoNS. 
1.6.1 MRSA population 
One of the most studied bacterial populations for staphylococci is methicillin-resistant S. 
aureus (MRSA). MRSA is interesting as it can be categorised into 3 subgroups, 
healthcare-associated MRSA (HA-MRSA); community-associated MRSA (CA-MRSA) 
and livestock-associated MRSA (LS-MRSA) (Naimi, 2003; Vanderhaeghen et al., 2010). 
All three groups have been shown to evolve separately from different clonal backgrounds 
(Naimi, 2003; Vanderhaeghen et al., 2010). HA-MRSA  isolates are transferred in 
healthcare facilities either from patients or healthcare workers; CA-MRSA is isolated 
from people who have a minimum to no contact with healthcare facilities whereas LA-
MRSA isolates only affect animals normally used in agriculture (Naimi, 2003; 
Vanderhaeghen et al., 2010). These groups were shown to have different phenotypes, for 
example, HA-MRSA was more resistant to antibiotics whereas CA-MRSA was more 
virulent due to them carrying the Panton-Valentine Leukocidin (PVL) toxin (Naimi, 
2003). It has also been shown that SCCmec type I, II and III are associated with HA-
MRSA whereas the other SCCmec types are associated with CA-MRSA and LA-MRSA 
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(Ahmad et al., 2009; Köck et al., 2013). A study in a hospital in Chicago found that HA-
MRSA (in epidemiological terms) isolates are more phenotypically related to what is 
consider community-associated based on their virulence and SCCmec element type 
(Maree et al., 2007). For LA-MRSA, there are few reports of human infections (Becker 
et al., 2017; Dorado-García et al., 2013) 
1.6.2 MRSA in public settings 
HA-MRSA isolates have been recently reported to be recovered from public settings not 
normally associated with healthcare facilities. These reports include isolates recovered 
from public beach sands, fresh and marine water; university campus and on public buses 
(Akanbi et al., 2017; Conceição et al., 2013; Lutz et al., 2014; Roberts et al., 2013; Soge 
et al., 2009). Studies on public buses in Portugal and the USA both reports that high-
frequency touched surfaces had a mixture of HA-MRSA and CA-MRSA isolate 
(Conceição et al., 2013; Lutz et al., 2014). The transfer of HA-MRSA onto public buses 
surfaces was due to bus routes going towards hospitals, therefore, were transmitted by 
patients and hospital workers. For public beaches reports from both the USA and South 
Africa were found to have CA-MRSA and HA-MRSA in beach sand and marine water 
(Akanbi et al., 2017; Roberts et al., 2013; Soge et al., 2009). The exact route of transfer 
of HA-MRSA is unknown, but it was discussed that higher prevalence of HA-MRSA in 
marine water than beach sand is due to higher exposure of contamination from 
pharmaceuticals, hospitals, and industrial waste as well as farmlands (Akanbi et al., 2017). 
From high-frequency touched surfaces in the public area on a university campus in the 
USA, there were MRSA clones that were similar to healthcare and community-associated 
origins (Roberts et al., 2013). In this study, the transmission of HA-MRSA to high-
frequency touched surfaces is unknown (Roberts et al., 2013). Interestingly, there are no 
reports in the literature on LA-MRSA isolates found in the public setting.  
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1.6.3 Healthcare and community-associated CoNS 
There are no reports on CoNS methicillin-resistant isolates distinction of their genotype 
and phenotype by isolation source but there is a study that identified the potential settings 
they are more likely to be spread. This study was published in 2010 in which they used 
long-range PCR to detect SCCmec element from nasal carriage CoNS isolates from 
patients who had no previous exposure to hospitals (Barbier et al., 2010). In this study, 
they tested 291 patients and found that 56 of them had methicillin resistance CoNS 
(Barbier et al., 2010).  The species found in this study were methicillin resistant was S. 
epidermidis, S. hominis, S. haemolyticus, S. pettenkoferi, S. cohnii (Barbier et al., 2010). 
This suggested that these species of staphylococci were more likely to spread in a 
community than the hospital, especially in patients who had no previous exposure to 
hospitals (Barbier et al., 2010).   
1.6.4 CoNS in public settings 
There are a few studies which have looked into the population of CoNS in public settings. 
Xu and co-workers reported that there were 71 isolates from 11 CoNS species from hotels 
rooms in London which were MDR as well as some of them showing the presence of 
mecA gene (Xu et al., 2015). In this study, the authors used PCR to identify the SCCmec 
and MLST (Xu et al., 2015). The most commonly detected species they found in this 
environment were S. haemolyticus, S. hominis, S. warneri, S. cohnii, and S. epidermidis 
(Xu et al., 2015).  Interestingly, they also reported new S. epidermidis MLST types (Xu 
et al., 2015). Some of the isolates which had the mecA gene had a lower level of 
methicillin resistance to that which was expected as we; as some of the isolates had 
SCCmec type that was undiscovered (Xu et al., 2015). This suggests that these 
environments could be reservoirs for MDR staphylococci (Xu et al., 2015). Seng and co-
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workers reportedly found that 41 out of 200 (20.5%) CoNS samples isolated from the 
university campus in Thailand were methicillin resistant (Seng et al., 2017b). These 
belonged to 6 different species, including S. haemolyticus, S. hominis, S. warneri, S. 
cohnii, S. epidermidis and S. saprophyticus (Seng et al., 2017b). In a similar manner to 
Xu and co-workers they used PCR to identify the SCCmec type and found that they 
belong to multiple types but the majority of these isolates SCCmec were untypable ( Xu 
et al., 2015, Seng et al., 2017b).  
1.6.5 Bacterial “resistomes" 
Bacterial "resistomes" is the study of all the genes that confer antibiotic resistance and 
their precursor in bacteria in a particular microbiome. As described by Wright  it includes 
antibiotic resistance genes from pathogens, antibiotic resistance genes in antibiotic-
producing bacteria (to protect themselves from antibiotics), cryptic resistance genes 
(genes found on the chromosome that would not obviously confer resistance due to low 
or lack of expression) and precursor genes (genes that do not directly confer resistances 
but may encode a protein that may have a level of activity against antibiotic molecule or 
have affinity to the molecule in which, depending on the right selective pressure, may 
evolve to a full resistant gene) (Wright, 2007). Resistome studies aims are to better 
understand the spread of antibiotic resistance genes from different environments as well 
as to understand the origins of antibiotic resistance genes. One resistome study that 
focused on staphylococci from 18  public restrooms from 4 buildings from non-healthcare 
settings over period of 24 weeks found that many of the staphylococcal species isolated 
were resistant to antibiotics have similar antibiograms to different species from the same 
restroom on different dates and others with isolates from restrooms in the same building 
(Mkrtchyan et al., 2013). They were able to identify the direct transfer of resistance 
determinants within restrooms and/or within buildings as they found that 11 
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staphylococcal isolates with the same antibiograms representing 5 different 
staphylococcal species and these were isolated from 5 different restrooms within the same 
building (Mkrtchyan et al., 2013). Additionally, they identified that from a single 
restroom there were 6 isolates from 3 species (S. haemolyticus (n=3), S. epidermidis (n=2) 
and S. aureus) from different sites that had the same antibiogram. These antibiograms 
were demonstrated to be also present in other staphylococcal species in 4 other restrooms 
within the same building on different days indicating widespread dissemination of 
resistance determinants in different Staphylococcus species and restrooms in the same 
building. They were able to demonstrate that public restrooms "resistome” and that these 
areas have a collection of pathogenic and non-pathogenic bacteria with antibiotic 
resistance determinants (Mkrtchyan et al., 2013). Other studies in “resistome" have 
focused on all bacterial species within a microbiome using metagenomic analyses in soil, 
hospitals wastewater, community sewage and gut microbiome then comparing a 
resistome within a single genus (Buelow et al., 2018; Mafiz et al., 2018; van Schaik, 
2015). 
More research is required to understand multidrug resistance staphylococcal isolates 
recovered from the environment as different reservoirs may have different antibiotic 
resistance profiles; SCCmec types, new species genotypes and virulent factors previously 
undiscovered in hospital-associated, community-associated and livestock-associated 
strains. The majority of work done on environmental isolates uses standard molecular 
typing but does not reveal the whole picture (Conceição et al., 2013; Lutz et al., 2014; 
Seng et al., 2017b, Xu et al., 2015). Using WGS will show if their genetic background is 
similar to that of hospital, community or animal associated staphylococcal isolates. It will 
also reveal whether any novel genes found in only these isolates are acquired from other 
bacteria or similar lineages. Using the “One Health” approach which is an ideology of 
 55 
comparing AMR bacteria in humans, animals and their environment, to determine 
staphylococcal isolates from public settings are a public health risk (Walsh, 2018).  
1.7 Antibiotic resistance  
The mass production of many types of antibiotics has revolutionised modern medicine; 
drastically reducing the mortality caused by bacterial infections. However, more and 
more bacterial infections are no longer treatable with modern antibiotics with a possibility 
of a future where mortality from bacterial infection will be high (Hau et al., 2018). AMR 
is not a modern phenomenon and precedes that of the first mass-produced antibiotics 
(D’Costa et al., 2011). This is due to the fact that antibiotics can be found naturally in 
fungus and bacteria as a defence mechanism (D’Costa et al., 2011). It only became a 
serious problem when antibiotics were overused in healthcare and agriculture (Shallcross 
and Davies, 2014). The development of AMR can arise through horizontal gene transfer 
by species to species; bacteriophages, plasmid or transposons pathogenicity islands, 
chromosomal cassettes as well as random mutations driven by selection when in the 
presence of antibiotics or other stress factors from its surrounding environment (Fajardo 
et al., 2008; Malachowa and DeLeo, 2010; Martinez and Baquero, 2000; Munita and 
Arias, 2016)  
Staphylococci have been found to harbour many different antibiotic resistance genes that 
give resistance to many types of drug classes which can be found in bacteria population 
associated with hospitals; community; animal and isolates that are found in the 
environment (Table 1.4) (Ahmad et al., 2009; Conceição et al., 2013; Soge et al., 2009; 
Xu et al., 2015). In the past hospital and agriculture isolates were shown to have resistance 
to many types of antibiotics compared to isolates from other sources due to the higher 
abundance of antibiotics. A recent study from Taiwan noticed little difference in the 
antibiotic resistance profile in isolates that cause keratitis from HA-MRSA and CA-
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MRSA whereas another study was shown to have a significantly higher portion of CA-
MRSA that were resistant to ciprofloxacin and clindamycin compared to HA-MRSA 
(Hsiao et al., 2015; Huang et al., 2006). In a study that looked at ST5 MRSA from human 
clinical samples and samples taken from swine in the USA were shown to be MDR, 
however, the two groups were distinct based on their phenotype and genotype (Hau et al., 
2018). There were no reports comparing the difference between antibiotic resistance 
profile between CoNS hospital-associated infection and community infection and 
livestock though studies have shown that both areas isolates showed resistance to multiple 
antibiotics with a rise of MDR isolates over time found in hospital and the community 
associated isolates (Bhargava and Zhang, 2012; May et al., 2014; Nanoukon et al., 2017) . 
Studies have found MDR resistance S. aureus and CoNS have been detected from the 
environment including within hospital environments, home environment, hotel rooms, 
university campuses and livestock environments (Schoenfelder et al., 2017; Seng et al., 
2017b; Shahbazian et al., 2017; Xu et al., 2015).
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Gene Resistant drug group and function S. aureus S. epidermidis 
AAC(6')-Ib7 
aminoglycoside antibiotic; antibiotic 
inactivation P A 
AAC(6')-Ie-APH(2'')-Ia 
aminoglycoside antibiotic; antibiotic 
inactivation P P 
AAC(6')-Ig 
aminoglycoside antibiotic; antibiotic 
inactivation P P 
aad(6) 
aminoglycoside antibiotic; antibiotic 
inactivation P P 
aadA 
aminoglycoside antibiotic; antibiotic 
inactivation P A 
acrB 
antibiotic efflux; cephalosporin; 
fluoroquinolone antibiotic; glycylcycline; 
penam; phenicol antibiotic; rifamycin 
antibiotic; tetracycline antibiotic; triclosan P A 
acrD aminoglycoside antibiotic; antibiotic efflux P P 
acrF 
antibiotic efflux; cephalosporin; 
cephamycin; fluoroquinolone antibiotic; 
penam P A 
acrS 
antibiotic efflux; cephalosporin; 
cephamycin; fluoroquinolone antibiotic; 
glycylcycline; penam; phenicol antibiotic; 
rifamycin antibiotic; tetracycline antibiotic; 
triclosan P A 
ADC-78 antibiotic inactivation; cephalosporin P A 
adeB 
antibiotic efflux; glycylcycline; tetracycline 
antibiotic P A 
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adeF 
antibiotic efflux; fluoroquinolone antibiotic; 
tetracycline antibiotic A A 
adeI 
antibiotic efflux; carbapenem; 
cephalosporin; diaminopyrimidine 
antibiotic; fluoroquinolone antibiotic; 
lincosamide antibiotic; macrolide antibiotic; 
penem; phenicol antibiotic; rifamycin 
antibiotic; tetracycline antibiotic P A 
adeJ 
antibiotic efflux; carbapenem; 
cephalosporin; diaminopyrimidine 
antibiotic; fluoroquinolone antibiotic; 
lincosamide antibiotic; macrolide antibiotic; 
penem; phenicol antibiotic; rifamycin 
antibiotic; tetracycline antibiotic P A 
adeK 
antibiotic efflux; carbapenem; 
cephalosporin; diaminopyrimidine 
antibiotic; fluoroquinolone antibiotic; 
lincosamide antibiotic; macrolide antibiotic; 
penem; phenicol antibiotic; rifamycin 
antibiotic; tetracycline antibiotic P A 
ANT(4')-Ib 
aminoglycoside antibiotic; antibiotic 
inactivation P P 
APH(3'')-Ib 
aminoglycoside antibiotic; antibiotic 
inactivation P P 
APH(3')-Ia 
aminoglycoside antibiotic; antibiotic 
inactivation P P 
APH(3')-IIa 
aminoglycoside antibiotic; antibiotic 
inactivation P P 
APH(3')-IIIa 
aminoglycoside antibiotic; antibiotic 
inactivation P P 
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APH(6)-Id 
aminoglycoside antibiotic; antibiotic 
inactivation P A 
apmA 
aminoglycoside antibiotic; antibiotic 
inactivation P A 
arnA 
antibiotic target alteration; peptide 
antibiotic P A 
bacA 
antibiotic target alteration; peptide 
antibiotic P A 
catB2 antibiotic inactivation; phenicol antibiotic P A 
cfrA 
antibiotic target alteration; lincosamide 
antibiotic; macrolide antibiotic; 
oxazolidinone antibiotic; phenicol 
antibiotic; pleuromutilin antibiotic; 
streptogramin antibiotic P P 
CRP 
antibiotic efflux; fluoroquinolone antibiotic; 
macrolide antibiotic; penam A P 
dfrC 
antibiotic target replacement; 
diaminopyrimidine antibiotic P P 
dfrG 
antibiotic target replacement; 
diaminopyrimidine antibiotic P P 
dfrK 
antibiotic target replacement; 
diaminopyrimidine antibiotic P A 
efmA 
antibiotic efflux; fluoroquinolone antibiotic; 
macrolide antibiotic P A 
emrB antibiotic efflux; fluoroquinolone antibiotic A P 
emrY antibiotic efflux; tetracycline antibiotic A P 
Enterococcus faecium chloramphenicol acetyltransferase antibiotic inactivation; phenicol antibiotic P P 
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erm(44) 
antibiotic target alteration; lincosamide 
antibiotic; macrolide antibiotic; 
streptogramin antibiotic A P 
ErmA 
antibiotic target alteration; lincosamide 
antibiotic; macrolide antibiotic; 
streptogramin antibiotic P P 
ErmB 
antibiotic target alteration; lincosamide 
antibiotic; macrolide antibiotic; 
streptogramin antibiotic P A 
ErmC 
antibiotic target alteration; lincosamide 
antibiotic; macrolide antibiotic; 
streptogramin antibiotic P P 
ErmT 
antibiotic target alteration; lincosamide 
antibiotic; macrolide antibiotic; 
streptogramin antibiotic P A 
Escherichia coli acrA 
antibiotic efflux; cephalosporin; 
fluoroquinolone antibiotic; glycylcycline; 
penam; phenicol antibiotic; rifamycin 
antibiotic; tetracycline antibiotic; triclosan P A 
Escherichia coli ampC 
antibiotic inactivation; cephalosporin; 
penam P P 
Escherichia coli mdfA 
antibiotic efflux; benzalkonium chloride; 
rhodamine; tetracycline antibiotic P A 
evgS 
antibiotic efflux; fluoroquinolone antibiotic; 
macrolide antibiotic; penam; tetracycline 
antibiotic P P 
fexA antibiotic efflux; phenicol antibiotic P P 
FosB3 antibiotic inactivation; fosfomycin P P 
fusB antibiotic inactivation; fusidic acid P P 
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Lactobacillus reuteri cat-TC antibiotic inactivation; phenicol antibiotic P A 
lmrP 
antibiotic efflux; lincosamide antibiotic; 
macrolide antibiotic; streptogramin 
antibiotic; tetracycline antibiotic P A 
lnuA 
antibiotic inactivation; lincosamide 
antibiotic P P 
lsaB 
antibiotic target protection; lincosamide 
antibiotic; pleuromutilin antibiotic; 
streptogramin antibiotic P A 
mdtB aminocoumarin antibiotic; antibiotic efflux A P 
mdtC aminocoumarin antibiotic; antibiotic efflux P P 
mdtN 
acridine dye; antibiotic efflux; nucleoside 
antibiotic P P 
mdtC 
acridine dye; antibiotic efflux; nucleoside 
antibiotic P P 
mdtO 
acridine dye; antibiotic efflux; nucleoside 
antibiotic A P 
mecA 
antibiotic target replacement; carbapenem; 
cephalosporin; cephamycin; monobactam; 
penam P P 
mecC 
antibiotic target replacement; carbapenem; 
cephalosporin; cephamycin; monobactam; 
penam P A 
mepA 
antibiotic efflux; glycylcycline; tetracycline 
antibiotic P P 
mepR 
antibiotic efflux; glycylcycline; tetracycline 
antibiotic P P 
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MexF 
antibiotic efflux; diaminopyrimidine 
antibiotic; fluoroquinolone antibiotic; 
phenicol antibiotic P A 
mgrA 
acridine dye; antibiotic efflux; 
cephalosporin; fluoroquinolone antibiotic; 
penam; peptide antibiotic; tetracycline 
antibiotic P P 
mphC antibiotic inactivation; macrolide antibiotic P P 
msbA antibiotic efflux; nitroimidazole antibiotic P P 
msrA 
antibiotic target protection; macrolide 
antibiotic; streptogramin antibiotic P P 
msrE 
antibiotic target protection; macrolide 
antibiotic; streptogramin antibiotic P A 
mupA antibiotic target alteration; mupirocin P P 
norA 
acridine dye; antibiotic efflux; 
fluoroquinolone antibiotic A P 
oqxB 
antibiotic efflux; diaminopyrimidine 
antibiotic; fluoroquinolone antibiotic; 
glycylcycline; nitrofuran antibiotic; 
tetracycline antibiotic P A 
OXA-214 
antibiotic inactivation; cephalosporin; 
penam A P 
OXA-72 
antibiotic inactivation; cephalosporin; 
penam P A 
blaZ antibiotic inactivation; penam P P 
qacA antibiotic efflux; fluoroquinolone antibiotic P P 
qacB antibiotic efflux; fluoroquinolone antibiotic P P 
QnrB10 
antibiotic target protection; fluoroquinolone 
antibiotic P A 
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salA 
antibiotic target protection; lincosamide 
antibiotic; pleuromutilin antibiotic; 
streptogramin antibiotic P A 
SAT-4 antibiotic inactivation; nucleoside antibiotic P P 
SHV-104 
antibiotic inactivation; carbapenem; 
cephalosporin; penam P A 
spd 
aminoglycoside antibiotic; antibiotic 
inactivation P A 
Staphylococcus intermedius chloramphenicol acetyltransferase antibiotic inactivation; phenicol antibiotic P A 
Streptococcus suis chloramphenicol acetyltransferase antibiotic inactivation; phenicol antibiotic P A 
TEM-116 
antibiotic inactivation; cephalosporin; 
monobactam; penam; penem P P 
TEM-149 
antibiotic inactivation; cephalosporin; 
monobactam; penam; penem P A 
TEM-162 
antibiotic inactivation; cephalosporin; 
monobactam; penam; penem P A 
TEM-171 
antibiotic inactivation; cephalosporin; 
monobactam; penam; penem P A 
TEM-193 
antibiotic inactivation; cephalosporin; 
monobactam; penam; penem P A 
TEM-201 
antibiotic inactivation; cephalosporin; 
monobactam; penam; penem P P 
TEM-207 
antibiotic inactivation; cephalosporin; 
monobactam; penam; penem P A 
TEM-220 
antibiotic inactivation; cephalosporin; 
monobactam; penam; penem P A 
TEM-40 
antibiotic inactivation; cephalosporin; 
monobactam; penam; penem P A 
tet(38) antibiotic efflux; tetracycline antibiotic P A 
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tet(C) antibiotic efflux; tetracycline antibiotic P P 
tet(K) antibiotic efflux; tetracycline antibiotic P P 
tet(L) antibiotic efflux; tetracycline antibiotic P A 
tet(W/N/W) 
antibiotic target protection; tetracycline 
antibiotic P P 
tetM 
antibiotic target protection; tetracycline 
antibiotic P A 
tetR 
antibiotic efflux; antibiotic target alteration; 
glycylcycline; tetracycline antibiotic P A 
tetS 
antibiotic target protection; tetracycline 
antibiotic P A 
tetT 
antibiotic target protection; tetracycline 
antibiotic P A 
tolC 
aminocoumarin antibiotic; antibiotic efflux; 
cephalosporin; cephamycin; 
fluoroquinolone antibiotic; glycylcycline; 
macrolide antibiotic; penam; phenicol 
antibiotic; rifamycin antibiotic; tetracycline 
antibiotic; triclosan A P 
vanA 
antibiotic target alteration; glycopeptide 
antibiotic P A 
vanHA 
antibiotic target alteration; glycopeptide 
antibiotic P A 
vanRA 
antibiotic target alteration; glycopeptide 
antibiotic P A 
vanSA 
antibiotic target alteration; glycopeptide 
antibiotic P A 
vanXA 
antibiotic target alteration; glycopeptide 
antibiotic P A 
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vanYA 
antibiotic target alteration; glycopeptide 
antibiotic P A 
vanZA 
antibiotic target alteration; glycopeptide 
antibiotic A A 
vatB 
antibiotic inactivation; streptogramin 
antibiotic A P 
vgaA 
antibiotic target protection; pleuromutilin 
antibiotic; streptogramin antibiotic P P 
vgaALC 
antibiotic target protection; pleuromutilin 
antibiotic; streptogramin antibiotic A P 
vgaB 
antibiotic target protection; pleuromutilin 
antibiotic; streptogramin antibiotic P P 
vgaE 
antibiotic target protection; pleuromutilin 
antibiotic; streptogramin antibiotic p A 
yojI antibiotic efflux; peptide antibiotic P A 
Table 1.5: List of antibiotic resistance genes and function that have been identified in S. aureus and S. epidermidis resistome. P=present, A=absent . 
This table only indicates if the antibiotic resistant genes were detected in staphylococci genome and plasmids from WGS data from the NCBI. 
This table does not indicate if the genes will encode antibiotic resistance for staphylococci. Data from https://card.mcmaster.ca/download 
updated 20 March 2019.
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1.7.1 Antibiotic resistance mechanisms 
Bacteria have developed sophisticated mechanisms to avoid being killed by antibiotics. 
These mechanisms are chemical alterations or destruction of the antibiotic using enzymes; 
decreased antibiotic penetration and efflux and the change of target site (Figure 1.5) 
(Munita and Arias, 2016).  These mechanisms have evolved over millions of years, of 
which resistance to a single antimicrobial class may be caused by multiple changes in 
biochemical pathways. For instance, fluoroquinolone resistance can accrue by either 
mutation in the genes that fluoroquinolone targets; over-expression of the efflux pump 
and protection of fluoroquinolone targets site with a protein called Qnr (Munita and Arias, 
2016).  
 
Figure 1.5: Mechanisms that have evolved in bacterial antimicrobial resistance. Figure from 
Dantas and Sommer, 2014 
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1.7.1.1 Penicillin resistance 
 
A common antibiotic-resistant mechanism feature found in staphylococci is penicillinase 
enzyme. This enzyme targets the beta-lactam rings found in penicillin, breaking down the 
molecular structure and therefore stopping the antibiotic binding to its target site. In 
staphylococci the blaZ gene is responsible for producing penicillinase enzyme. This gene 
is commonly identified in staphylococci from hospitals; community; animal and the 
environment. BlaZ has been identified to be encoded on the chromosome or plasmid in 
staphylococci. Penicillinase was identified as part of first epidemiology antibiotic 
resistance wave in hospital in S. aureus in the 1940s where it is believed to be encoded 
on a plasmid which can be horizontally transferred to other S. aureus or staphylococci 
sensitive penicillin (Chambers and Deleo, 2009).  
1.7.1.2 Broad spectrum resistance to beta-lactam antibiotics 
 
The second epidemic wave of antibiotic resistance in S. aureus came shortly after the 
mass use of methicillin in hospitals in the 1950s (Chambers and Deleo, 2009). Methicillin 
was a semisynthetic derivative of penicillin which was not affected by beta-lactamase. 
Instead S. aureus gains resistance to this antibiotic by replacing the drug target PBP2 
protein to the PBP2A protein. This new protein lowers the binding ability of drugs that 
have the β-lactam ring and give resistance to multiple drug classes, including carbapenem, 
cephalosporin, penam, cephamycin and monobactam (Chambers and Deleo, 2009). 
1.7.1.3 Staphylococcal Chromosomal Cassette mec 
 
The mecA gene in staphylococci can be located on a mobile genetic element known as 
Staphylococcal Chromosomal Cassette mec (SCCmec) (Oliveira et al., 2002). This 
mobile element is about 60kb in length and inserted itself next to the orfX gene (Boundy 
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et al., 2013; Oliveira et al., 2002). The SCCmec consist of two regions known as the mec 
complex and the chromosome cassette recombinase (ccr) complex. These regions can be 
genetically variable and normally used in classifying between different SCCmec types. 
To date, there are 11 (I-XI) different SCCmec types with further subtypes which are 
organised into a hierarchical system (Elements (IWG-SCC), 2009) (Figure 1.6). The 
different mec complexes are assigned A, B, C1, C2, D, E and the ccr complexes as A1/B1, 
A2B2, A3/B3, A4/B4, C1, A5/B3, A1/B6, A1 (Elements (IWG-SCC), 2009; Li et al., 
2011; Shore et al., 2011). These SCCmec types normally contain one mec complex and 
ccr complex though there are reports of unclassified SCCmec that have multiple 
complexes isolated from clinical and community sites (Chen et al., 2017). The third wave 
of antibiotic resistance epidemic in S. aureus in the 1970s was associated with SCCmec 
type II and SCCmec type III, whereas wave four happened in the mid-1990s and was 
marked by the spread of MRSA in the community with a smaller mobile element known 
as the SCCmec type IV (Chambers and Deleo, 2009). 
1.7.1.3.1 mec complex 
The mec complex normally carries the mecA gene along with its two regulatory genes 
mecR and mecI (Petinaki et al., 2001). These genes can be flanked by insertion sequences 
(IS) (Noto et al., 2008). MecR and mecI are not always present in the mec complex as it 
has been reported that only 60–95% of MRSA isolates have them (Petinaki et al., 2001). 
It has also been noted that the regulatory gene and IS have been identified as being 
truncated in some mec complexes (Shore et al., 2005).  
1.7.1.3.2 ccr complex 
The ccr genes are located in the ccr complex that is responsible for making the SCCmec 
element mobile (Ito et al., 2001). To date, three distinct ccr gene alleles have been 
discovered named ccrA, ccrB and ccrC of which ccrA and ccrB can be classified into four 
different allotypes (Elements (IWG-SCC), 2009). Ccr is grouped in the same allotypes 
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sharing 85% or more of the same nucleotides, whereas ccr in different allotypes normally 
share 60-82% of the same nucleotide (Elements (IWG-SCC), 2009). 
1.7.1.3.3 J-region 
Areas between mec and ccr complex are known as the joint region (j-region) (Elements 
(IWG-SCC), 2009). These regions are used for subtyping different SCCmec classes 
(Elements (IWG-SCC), 2009). In these regions, it has been reported to have known 
characteristic genes, pseudogenes, or noncoding regions as well as other mobile genetic 
elements (Ito et al., 2007). These areas have been shown to sometimes carry additional 
resistance genes including aminoglycosides, macrolides, fusidic acid and heavy metal 
ions (Lin et al., 2014; Monecke et al., 2011).  
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Figure 1. 6: SCCmec classification. The structural organization of SCCmec elements based 
on their mec complex (purple) and ccr complex (blue). In between these complexes are 
the J-region. Figure from Kaya et al., 2018. 
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1.7.1.3.4 mecC gene 
 
The mecA was long thought to be one conserved gene, however in 2011 a new emergent 
gene known as mecC was discovered which has 69% nucleotide and 63% amino acid 
homology to mecA (Kerschner et al., 2014). Originally this was a problem as this gene 
caused S. aureus infection to be misdiagnosed as methicillin-sensitive due to the fact they 
are more susceptibility to oxacillin and the  PCR  diagnosis for MRSA would not work 
due to new gene low homology toward mecA (Paterson et al., 2014). Interestingly, mecC 
isolates had increase susceptibility to cefoxitin.  
Little is known about the origin of the SCCmec element although there is some evidence 
that it might have originated in S. fleurettii (Tsubakishita et al., 2010). Interestingly they 
found that S. fleurettii had the mecA gene, but it did not contain the rest of the SCCmec 
element (Tsubakishita et al., 2010). This species is typically found as a commensal strain 
in animals, which has shown no clinical infection in humans (Tsubakishita et al., 2010). 
S. fleurettii cannot uptake the SCCmec element due to already having resistance to β-
lactam ring antibiotics. It is most likely that this species evolved resistance from the 
environment from an antibiotic produced by a fungus or by the medication/growth 
supplements given to livestock (Tsubakishita et al., 2010). 
1.7.1.4 Aminoglycoside-modifying enzymes 
 
Aminoglycoside-modifying enzymes are a large family of enzymes that have been 
previously identified in modifying the molecular structure of aminoglycoside antibiotics. 
This family of enzymes can be further split into three subclasses based on the type of 
modification they cause. These classes are aminoglycoside N-acetyltransferases (AACs); 
aminoglycoside O-nucleotidyltransferases (ANTs), and aminoglycoside O-
phosphotransferases (APHs). There are members of these families that are bifunctional 
AAC(6′)-Ie/APH(2″)-Ia from S. aureus  (Garneau-Tsodikova and Labby, 2016). 
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1.7.1.4 Vancomycin resistance  
 
Vancomycin resistance in Staphylococcus is caused by the decreased of antibiotic 
penetration. Reports in S. aureus show that resistance to vancomycin is due to increase 
peptidoglycan synthesis making the cell shape irregular, increase in cell wall thickness, a 
decrease in cross-linkage of peptidoglycan strands which revealed more D-Ala-D-Ala 
residues (Hanaki et al., 1998). The increase in D-Ala-D-Ala residues bind and trap 
vancomycin, preventing it from reaching its target in the cytoplasmic membrane (Hanaki 
et al., 1998).  The second form of resistance has also been described is the vanA operon, 
which is conjugal transfer on a plasmid from vancomycin-resistance Enterococcus 
faecalis. This alters D-Ala-D-Lac residues which reduces the binding affinity with 
vancomycin (González-Zorn and Courvalin, 2003).  
1.7.1.5 Efflux pumps 
 
Efflux pumps are an assembly of proteins involved in the removal of a single or multiple 
toxic molecules out of bacterial cells (Webber and Piddock, 2003). They are grouped into 
5 structural families; the resistance-nodulation-division (RND), the small multidrug 
resistance (SMR), the multi antimicrobial extrusion (MATE), the major facilitator 
superfamily (MFS), and the ATP-binding cassette (ABC) superfamilies (Hernando-
Amado et al., 2016.) In Gram-positives bacteria, some efflux pumps can work 
independently of any other protein whereas, in Gram-negative, they form tripartite 
complexes capable to traverse both bacterial membranes (Alcalde-Rico et al., 2016). 
Some of these efflux pumps can remove multiple types of antibiotics and are known as a 
multidrug efflux pump. A common efflux transporter in staphylococci that transports a 
single type of molecule is tet(K) which can actively transport tetracycline 
whereas norA is multidrug efflux transporter found in S. epidermidis that targets 
fluoroquinolone and acridine dye (Costa et al., 2019, Yamaguchi et al. 1995). 
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1.8 Aims 
This thesis aims were to recover and characterise environmental MDR staphylococci 
from high-frequency hand touched surfaces from general public settings and public areas 
in hospitals from East and West London and compare these isolates to other known 
clinical, animal, plant and environmental associated lineages by performing comparative 
whole genome sequencing analysis. These results will aid in the understanding of the 
evolution of antibiotic resistance and virulence in the environmental MDR staphylococci 
found. The project aims are to determine: 
1. the phenotypic and genetic background of environmental multidrug-resistant 
staphylococcal isolates, 
2. the factors distinguishing them from one another and any mutations which occur 
allowing environmental isolates to acquire the resistance and virulence genes,  
3. whole genome sequencing of environmental multidrug-resistant isolates which will be 
compared with well-characterised reference strains. 
These objectives will use a "One Health" approach which will allow us to determine if 
the genetic lineages of MDR staphylococci from public settings are genetically related to 
isolates from clinical, non-clinical, animal or environmental lineages. These results will 
help to determine/reveal if isolates from general public settings could pose a public health 
risk. In this study, two different geographical areas with similar features (shopping centre, 
train station and hospitals) were compared to identify differences in the abundance of 
MDR staphylococci in these areas.  
This thesis is comprised of 7 chapters. Chapter 1 is comprised of the introduction; which 
discusses previous research in relation to the research project; Chapter 2 is the material 
and methods used in performing experimental procedures. Chapter 3, 4, 5 and 6 are on 
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the results and how they relate to other studies and the implications of these finding and 
Chapter 7 has the overall conclusion from the thesis and ideas for future works. 
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Chapter 2: Material and methods 
2.1 Sample collection  
Staphylococcal isolates were recovered from high-frequency hand touched surfaces of 
inanimate objects (door handles, stair handrails, toilet flushers, toilet seats, taps, lift 
buttons, chair armrests) from four locations in general public settings, two locations from 
East London and two locations from West London between November 2016 to September 
2017 (figure 2.1). Public settings included shopping centres (concourses, escalators lifts, 
public washrooms) and train stations (entry gates, public washrooms, escalators). Isolates 
were also recovered from a hospital setting where the general public had easy access, 
without being a patient or visiting a patient (reception area, public washrooms, corridors, 
lifts). These sampling areas from East and West London were chosen as both have a large 
shopping centre, train station and hospital in close proximity to each other. From each 
location, 50 sites were randomly sampled using COPAN dry swabs (Copan Diagnostics 
Inc., USA). In total 600 isolates were recovered of which 224 were from East London 
and 376 from West London of which 182 of the isolates were from the community area 
and 418 from hospital areas; 97 from East London community area and 85 from West 




Figure 2.1: A map of sampling sites in East and West London.
/








2.2 Isolation of staphylococci 
All samples were directly inoculated onto mannitol salt agar (MSA, Oxoid Basingstoke, 
UK) within 1-3 hours of recovery and incubated aerobically for 24-72 hours at 37°C. 
MSA agar was prepared from powder and mixed into distilled water before being 
sterilised in an autoclave at 121oC for 15 minutes. Molten agar was poured into a 15mm 
x 100mm agar plate and was left to solidify. CoPS growth on MSA would produce yellow 
colonies with yellow halos where CoNS growth on MSA would produce pink colonies 
and no change to media colour (Figure 2.2). To prevent bias, up to 10 colonies from each 
plate were picked each having different colony morphology or if there are less than 10 
different colony morphologies an equal amount of different colony morphologies was 
selected. These isolates were screened for potential staphylococci characteristics, 
including performing catalase and coagulase tests. Prolex™ staph latex kits (ProLab 
Diagnostics, Neston, UK) was used to distinguish S. aureus and coagulase-negative 
staphylococci.  
 
Figure 2.2: Mannitol salt agar and colony morphology between CoPS and CoNS 
CoPS CoNS 
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2.3 Identification of staphylococci recovered from high-frequency hand touch areas 
Potential staphylococcal isolates were initially identified by conventional methods, 
including Gram staining and catalase testing. All the isolates were identified at species 
level using Matrix-assisted laser desorption ionisation-time of flight mass spectroscopy 
(MALDI-TOF-MS, Microflex LT, Bruker Daltonics, Coventry, UK) in a positive linear 
mode (2000–20,000 m/z range) (figure 2.3). Samples were prepared by growing bacterial 
cells on nutrient agar plates (prepared in the same manner as the MSA agar) at 37°C. A 
few colonies were picked from the agar plate and resuspended in a microcentrifuge tube 
containing 300 l of sterile distilled water, which was then mixed with 900 l of absolute 
ethanol. The microcentrifuge tube was then centrifuged for 2 minutes at max speed and 
the supernatant was removed by pipetting. The pellet was then resuspended in 50 l of 
70% formic acid (Sigma-Aldrich, UK) before 50 l of acetonitrile (Sigma-Aldrich, UK) 
was mixed into the solution. The solution was then centrifuged at max speed for 2 minutes 
and the 1 l of supernatant was placed onto an MSP 96 target polished steel plate (Bruker 
Daltonics, Coventry, UK) and left to air-dry. 1 μl α-cyano-4-hydroxycinnamic acid 
(HCCA) (Bruker Daltonics, Coventry, UK) used for matrix solution was overlaid. 
MALDI-TOF Biotyper 3.0 software (Bruker Daltonics, Coventry, UK) was used to 
analyse the spectra and to identify the bacterial species. Bacterial test standard 
Escherichia coli DH5α (Bruker Daltonics, Coventry, UK) was used for calibration and as 
a standard for quality control. Isolates that had higher confidence of identification had a 
score > 2.0 and low confidence of 1.7-1.90.
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Figure 2.3: Schematic on how staphylococcal species were identified by MALDI-TOF
4. The supernatant was 
removed by pipetting. 
The pelleted was then 
resuspended in 50 μl of 
70% formic acid before 
50 μl of acetonitrile was 
mixed into the solution. 
1. A few colonies were 
picked from the agar 
plate. 
2. Colonies resuspended 
in a microcentrifuge 
tube containing 300 l 
of sterile distilled water, 
which was then mixed 
with 900 l of absolute 
ethanol 
3. Microcentrifuge tube 
was then centrifuged for 
2 minutes at max speed 
5. Microcentrifuge tube 
was then centrifuged for 
2 minutes at max speed. cvcv
cvc 
6. 1 μl of supernatant 
was placed onto a steel 
target plate and left to 
air-dry. Dried samples 
was overlaid with 1 μl 
HCCA. 
7. Target plate analysed 
in MALDI-TOF MS. 
8. Spectra was compared with a database of known 
bacterial species mass ions to identify bacterial 
species 
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2.4 Comparative identification analysis of staphylococcal species using the Bruker 
Autoflex and ASTA Tinkerbell MALDI-TOF MS  
The accuracy and reproducibility of MALDI-TOF MS were tested by comparing 
identification data of the Brucker Autoflex (Biotyper 3.0 software) with the ASTA 
Tinkerbell (micro ID software) (Figure 2.4). A single colony was picked from a plate with 
a sterile toothpick and placed onto a well of 384 circles of the μFocus MALDI Plate 2000 
μm (ASTA, Manchester, UK). 1 μl of 70% formic acid was added on top of the colony 
on the target pate. The plate was left to air dry before the HCCA used for matrix solution 
was overlaid. The same target plate with the same spotted isolates was analysed by both 
the Bruker’s Autoflex and the ASTA’s Tinkerbell software. Bacterial test standard 
Escherichia coli DH5α (Bruker Daltonics, Coventry, UK) was used for calibration and as 
a standard for quality control. Both instrument parameters were operated at linear mode 
and both measured a mass range –m/z 200-20,000 Da. The Autoflex instrument ion 
extraction voltage is 19.5kV; fires 1,000 laser shots per spot and frequency of 200Hz 
whereas the Tinkerbell instrument sample voltage is 18kV; fires 1,200 laser shot per 
sample and has a delay time of 1.1 μs. For the Tinkerbell micro ID software, a score 
of >140 indicated high confidence identification and 110 to 139 low confidence of 
identification. Isolates were tested in triplicate. Spectra from both machines were 




Figure 2.4: Schematic on the comparative analysis of staphylococcal species identification using the Bruker Autoflex and ASTA Tinkerbell MALDI-
TOF MS
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2.5 Antimicrobial susceptibility testing 
All isolates were tested for their susceptibility against a panel of 11 antibiotics by using 
a disc diffusion method (Andrews and Howe, 2011). The antibiotics tested were the 
following: oxacillin (1µg), gentamicin (10 µg), mupirocin (20 µg), amoxicillin (10 µg), 
erythromycin (15 µg), tetracycline (10 µg), cefoxitin (30 µg), cefepime (30 µg), fusidic 
acid (10 µg), penicillin (1 unit) and chloramphenicol (30 µg) (Mast Group, Merseyside, 
UK). Antibiotic profiles of each isolate were determined according to the 
recommendation of the (CLSI) and British Society for Antimicrobial Chemotherapy 
(BSAC) (Andrews and Howe, 2011; CSLI, 2017). In addition, the minimum inhibitory 
concentrations (MIC) for oxacillin and cefoxitin were determined using E-tests 
(Biomerieux, Basingstoke) (Andrews and Howe, 2011; CSLI, 2017). Bacteria culture 
from MSA plates were streaked onto nutrient agar plates and grown aerobically for 16 to 
24 hours at 37 OC. Samples from the agar plates were then suspended into 500 l of 
nutrient broth (sterilised the same as MSA) and the turbidity was adjusted to the 0.5 
McFarland standard. 100 l of the adjusted inoculum was spread onto 15 ml Muller 
Hinton agar plates (prepared similarly to MSA) and then left to dry before aseptically 
placing the antibiotics discs or E-test strips onto agar plates. The inoculated Muller Hinton 
agar plates were then incubated for 24 hours at 37 OC. After incubation the zone of 
inhibition for disc diffusion and the minimum concentration that inhibits bacterial growth 
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2.6 Detection of the mecA gene by PCR 
The mecA gene was detected for all staphylococcal isolates using PCR. Freshly grown 
samples were suspended into 40 µl of sterile distilled water and boiled at 100 °C then 
cooled on ice for 5 minutes. The samples were then centrifuged at 13,000 × g for 1 minute 
and the supernatant was used for the PCR providing the DNA template. The PCR was 
performed using Met1 and Met2 primers (Eurofins, Germany) (Table 2.1). PCR reactions 
were performed in a 20 µl volume for each sample which consists of 10 µl of Phusion 
Master Mix;1 µl of met1, 1 µl of met2, 6 µl of sterile distilled water and 1 µl of isolates 
DNA template. The PCR condition can be found in Table 2.2. PCR product was loaded 
onto 1% agarose electrophoresis gel stained with SYBR safe (Thermofisher, UK) and ran 
at 120 V for 30 minutes. Electrophoresis gel was visualised using the ChemiDoc (Bio-






Table 2.1:  Primers sequence for amplifying the mecA gene 
Step Temperature (°C) Time Cycles 
Initial denaturing 93  5 minutes 1 
Denaturing 93  30 seconds  
Annealing 52 30 seconds  35 
Extension 72 1 minute  
Final Extension 72 10 min 1 
 
Table 2.2: PCR conditions for mecA gene 
 
 85 
2.6 WGS and bioinformatic analysis 
For a flow chart of all software used for genome assemble and bioinformatic analysis 
see figure 2.6. 
 






2.6.1 Genome sequencing 
49 staphylococci mecA positive (mecA+) isolates were whole genome sequenced using 
Illumina HiSeq platforms. 13 out of 49 isolates were whole genome sequenced by 
MicrobesNG (Birmingham, UK) and the remaining isolates were sequenced at Fudan 
University, Shanghai, China.   
Genomic DNA was extracted using TIANamp Bacteria DNA kit (Tiangen, China) and 
paired-end sequencing libraries were constructed using Nextera XT DNA Sample 
Preparation kits or TruSeq DNA HT Sample Prep Kit (Illumina, USA) following the 
manufacturer’s instruction.  The sequence coverage for each read was set for 30x.  
2.6.2 Genome assembly  
The raw reads quality was assessed using FASTQC software (Andrews, 2011). FASTQC 
measure per base sequence quality, per sequence quality scores, per base sequence 
content, per base GC content, per sequence GC content, per base N content, sequence 
length distribution, duplicate sequences, overrepresented sequences and overrepresented 
kmers (Andrews, 2011). From these measurements, the software can raise a warning if 
the reads are poor quality (Andrews, 2011). From the information given by FASTQC, the 
reads were trimmed using trimmomatic software (Version 0.35) set at Phred cutoff of 
Q20 to remove the miscalled bases from the end of the reads (Bolger et al., 2014). 
The trimmed reads were de novo assembly by SPAdes 3.11, a fast and flexible software 
which uses k-mers and De Bruijn graph to assemble draft genomes into contigs without 
a reference genome (Bankevich et al., 2012). From the assembled genomes; contigs that 
were ≤ 500bp were removed as these contigs are missed assembled due to composition 
of only unpaired reads, wrong paired-end orientation and abundance of abnormal insert 
sizes between paired reads. QUAST was used to asses contig assembly by measuring the 
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number of contigs per genome, size of the largest contig, size of genome GC content, 
N50 and L50 (Gurevich et al., 2013).  
2.6.3 Identifying antibiotic resistance and virulence genes from whole genome 
sequences 
Antibiotic resistance genes were detected using the Comprehensive Antibiotic Resistance 
Database (CARD) server (June 2019) due to having a comprehensive up to date database 
of antibiotic resistance genes (Jia et al., 2017). The cutoff for antibiotic resistance genes 
identification was set at ≥95% similarity of DNA sequence.  Virulence factors were 
detected by VFanalyzer server (June 2019) due to having the most comprehensive 
database of bacterial virulent factor genes and can avoid potential false positives due to 
paralog (Liu et al., 2019).  
2.6.4 SCCmec screening 
The diversity of SCCmec types were determined by searching against a database of 
known SCCmec molecular markers with NCBI BLAST with a cutoff e-value of 10-5 
 (Altschul et al., 1990; Monecke et al., 2016). NCBI BLAST is software that can find 
similarity between biological sequences accurately than other software (Altschul et al., 
1990). The SCCmec marker database was from Monecke and co-workers study (Monecke 
et al., 2016). 
2.6.5 Identification of mobile genetic elements  
 Plasmids were constructed from the trimmed read using PlasmidSPAdes (Antipov et al., 
2016). This software can identify plasmids by the read coverage of contigs is higher or 
lower than the chromosome coverage (Antipov et al., 2016). The advantage of this 
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software in predicting plasmids is that it requires no prior knowledge of plasmid elements 
(Antipov et al., 2016).  
Phage insertion and genomic island prediction were performed by PHASTER and 
Islandviewer4 (Arndt et al., 2016; Bertelli et al., 2017).  PHASTER uses the most up to 
date database of phage protein and can accurately predict the completeness of prophages 
within genomes by using NCBI BLAST to identify what phage proteins are found within 
a region of the genome (Arndt et al., 2016). Islandviewer 4 use multiple software to 
predict genomic island against reference strains. The reference strains used in this study 
were S. epidermidis ATTC 11228; S. haemolyticus JCSC 1435 and S. hominis K1. The 
software used by Islandviewer 4 is SIGI-HMM (sequence composition prediction method 
using Hidden Markov Model and measures codon usage) and IslandPath-DIMOB (can 
detect abnormal sequence composition by dinucleotide bias composition or the presence 
of genes that functionally relate to mobile elements) (Bertelli et al., 2017). 
Horizontally transferred genes and their predicted donor organism were predicted using 
HGTector pipeline (Zhu et al., 2014). This software uses the NCBI non-redundant protein 
database to BLAST sequences with cutoffs set at e-value=10-5 and percentage identity ≥ 
30%, and query coverage ≥ 50%. "Self" group was determined by their species taxonomy 
ID (S. epidermidis ID 1282; S. haemolyticus ID 1283 and S. hominis ID 1290): “Close” 
group been Staphylococcus genus (taxonomy ID 1279) and a distal group containing all 
other species (Pruitt et al., 2007). The cutoff was determined for each species using a 
Gaussian kernel smoothing with Silverman's rule-of-thumb bandwidth selector as this 
works best for an approximately normal density distribution (Zhu et al., 2014). This 
software is better compared to other software’s due to being insensitive to stochastic 
events such as gene loss, rate variation and database error  (Zhu et al., 2014). 
2.6.6 MLST S. epidermidis isolates 
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S. epidermidis isolates MLST sequence types were assigned using MLST2.0 online 
service (Thomas et al., 2007). This server has the most up to date MLST allele sequence 
and profile data and sequences found in PubMLST.org (Thomas et al., 2007). This 
software was only used to type S. epidermidis isolates as there is no standardised MLST 
for other CoNS. 
2.6.7 Core genome phylogenetic analysis 
A core SNP Maximal likelihood tree was constructed using isolates recovered from 
different sources (Table 2.3). SMALT (version 0.5.8) 
(https://www.sanger.ac.uk/science/tools/smalt-0) was used to generate a hash index of the 
reference genomes and to map the reads to the reference genomes. A hash index was set 
with word length to 11 and sampling step size to 1.  Reference genomes that were used 
to map each staphylococcal species were S. epidermidis ATTC 11228; S. haemolyticus 
JCSC 1435 and S. hominis K1. SMALT is preferred over other alignment software due 
to its flexibility and being more sensitive at detecting divergent hits (Caboche et al., 2014). 
SNP calling was done in parallel with all isolates of the same species using VarScan 
version 2.3.9. VarScan employs a robust heuristic/statistic approach to call variants 
compared with other software that  mainly uses a statistical approach. (Koboldt et al., 
2009). The VCF file was converted to multi-FASTA alignment file using a freely 
available  python script vcf2phylip (https://github.com/edgardomortiz/vcf2phylip). 
Recombination was detected and removed from the genome using the software Gubbins 
set at default parameters (Croucher et al., 2015) Gubbins can accurate reconstructions 
under realistic models of short-term bacterial evolution and can rapidly process data 
(Croucher et al., 2015). A maximal likelihood tree was constructed using RAxML version 
8 using the generalised time-reversible model (GTR) model with GAMMA method of 
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correction for site rate variation and 100 bootstrap replications (Stamatakis, 2014). 
RAxML is preferred over other software due to its handling of large datasets with its 
comparatively low memory consumption, advanced search algorithms and use of 
accelerated likelihood (Stamatakis, 2014). The phylogenetic tree was visualised and 









SE2.9 S. epidermidis JRVN01000000 Rice seed (Chaudhry and Patil, 2016) 
SE4.7 S. epidermidis JRVP01000000 Rice seed (Chaudhry and Patil, 2016) 
SE4.6 S. epidermidis JRVO01000000 Rice seed (Chaudhry and Patil, 2016) 
SE4.8 S. epidermidis JRVQ01000000 Rice seed (Chaudhry and Patil, 2016) 
UC7032 S. epidermidis ARWU01000000 cured meat (Gazzola et al., 2013) 
CIM40 S. epidermidis ATCW02000000 Mouse skin (Wang et al., 2014) 
APO27 S. epidermidis ATCU02000000 Mouse skin (Wang et al., 2014) 
CIM28 S. epidermidis ATDF02000000 Mouse skin (Wang et al., 2014) 
APO35 S. epidermidis ATCV02000000 Mouse (Wang et al., 2014) 
NIHLM057 S. epidermidis AKGO01000000 Human Occiput (Conlan et al., 2012) 
VCU128 S. epidermidis AHLI01000000 Clinical airways  
NW32 S. epidermidis LJIF01000000 Cow milk  
NIHLM015 S. epidermidis AKGZ01000000 Human (Conlan et al., 2012) 
NIHLM037 S. epidermidis AKGT01000000 Human (Conlan et al., 2012) 
14.1.R1 S. epidermidis CP018842 Human skin (Lassen et al., 2017) 
MRSE 52-2 S. epidermidis NTLC01000000 Human nasopharynx  
(Magaña-Lizárraga et al., 
2017) 
NIHLM023 S. epidermidis AKGU01000000 Human toe web (Conlan et al., 2012) 
S2 005 003 R3 50 S. epidermidis QFPG01000000 hospital surfaces and sink (Brooks et al., 2017) 
M01 S. epidermidis LYWE01000000 cowhouse  
ZSC S. epidermidis PHHR01000000 groundwater  
y24 S. epidermidis NRSY01000000 bovine mastitis milk  
PR246B0 S. epidermidis PCFD01000000 Pig rectum  
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M25 S. epidermidis LYWF01000000 cowhouse  
FDAARGOS-161 S. epidermidis CP014132 Clinical Peripheral blood  
1457 S. epidermidis CP020463 Central venous catheter (Lassen et al., 2017) 
AG42 S. epidermidis JNLI01000000 Animal Sheep rumen  
Scl25 S. epidermidis ATDC02000000 Mouse skin (Wang et al., 2014) 
CSF41498 S. epidermidis CP030246 Clinical cerebrospinal fluid (meningitis)  (Galac et al., 2019)  
SNUT S. epidermidis LQRB01000000 toluene treated bioreactor sludge (Kim et al., 2016) 
ATCC 12228 S. epidermidis CP022247 Human skin and mucosal 
(MacLea and Trachtenberg, 
2017) 
PM221 S. epidermidis HG813242 Cow (Savijoki et al., 2014) 
SNUC 5038 S. epidermidis PYYR01000000 Cow (Naushad et al., 2016) 
SNUC 75 S. epidermidis PYZF01000000 Cow (Naushad et al., 2016) 
FDAARGOS_83 S. epidermidis JTAY02000000 Clinical (urine)  
RP62A S. epidermidis CP000029 Clinical (intravascular catheter-associated sepsis)  (Gill et al., 2005) 
SRR1182420 S. epidermidis SRR1182420 Clinical blood  
ET-024 S. epidermidis JGVL01000000 
endotracheal tube biofilm of a mechanically ventilated 
patient 
(Vandecandelaere et al., 
2014) 
SRR1182422 S. epidermidis SRR1182422 Clinical blood  
SRR1182424 S. epidermidis SRR1182424 Clinical blood  
SRR1182423 S. epidermidis SRR1182423 Clinical blood  
SRR1182419 S. epidermidis SRR1182419 Clinical blood  
SRR1182413 S. epidermidis SRR1182413 Clinical blood  
VCU037 S. epidermidis AFTY01000000 Clinical human airways  
M0881 S. epidermidis AOAJ01000000 Human Skin  
VCU045 S. epidermidis AFEI01000000 Clinical (human airways)  
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FDAARGOS 153 S. epidermidis CP014119 Clinical (peripheral blood)  
764 SEPI S. epidermidis JUTX01000000 Clinical  
M0026 S. epidermidis JBVX01000000 Clinical (blood)  
NIH06004 S. epidermidis AKHH01000000 Clinical(blood) (Conlan et al., 2012) 
NIH08001 S. epidermidis AKHG01000000 Clinical (blood) (Conlan et al., 2012) 
SRR1182399 S. epidermidis SRR1182399 Clinical blood  
SRR1182398 S. epidermidis SRR1182398 Clinical blood  
SRR1182400 S. epidermidis SRR1182400 Clinical blood  
SRR1182371 S. epidermidis SRR1182371 Clinical blood  
SRR1182410 S. epidermidis SRR1182410 Clinical blood  
SRR1182401 S. epidermidis SRR1182401 Clinical blood  
SRR1182412 S. epidermidis SRR1182412 Clinical blood  
SRR1182418 S. epidermidis SRR1182418 Clinical blood  
SRR1182416 S. epidermidis SRR1182416 Clinical blood  
BPH0662 S. epidermidis LT571449 Clinical  
DAR1907 S. epidermidis CP013943 Clinical (Blood)  
ENVH131 S. epidermidis LYVR01000000 Hospital environment   
ENVH150 S. epidermidis LYVW01000000 Hospital environment  
LRKNS114 S. epidermidis LZEO01000000 Hospital environment  
LRKNS116 S. epidermidis LZEQ01000000 Hospital environment  
LRKNS117 S. epidermidis LZER01000000 Hospital environment  
SH06 17 S. epidermidis PHKN01000000 Clinical blood  
SH03_17 S. epidermidis PHKH01000000 Clinical (blood)  
SH07 17 S. epidermidis PHKM01000000 Clinical (blood)  
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760 SEPI S. epidermidis JUUB01000000 Clinical  
SNUC 3608 S. epidermidis QXSP01000000 Cow (Naushad et al., 2016) 
SNUC 901.1 S. epidermidis PYYQ01000000 Cow (Naushad et al., 2016) 
B45679-10 S. epidermidis MVFV01000000 Clinical(blood)  
FDAARGOS 148 S. haemolyticus LORN02000000 Clinical (blood)  
DNF00585 S. haemolyticus JRNK01000000 Clinical (vagina)  
Z52 S. haemolyticus PHHQ01000000 groundwater  
SW007 S. haemolyticus MTIZ01000000 Dog (Bean et al., 2017) 
SNUC 128 S. haemolyticus PZIV01000000 Cow (Naushad et al., 2016) 
SNUC 1317 S. haemolyticus PZIP01000000 Cow (Naushad et al., 2016) 
SNUC 1450 S. haemolyticus PZIL01000000 Cow (Naushad et al., 2016) 
C10F S. haemolyticus JQHA01000000 Clinical sputum  
SNUC 1408 S. haemolyticus PZIM01000000 Cow (Naushad et al., 2016) 
2263-3461 S. haemolyticus CUEO01000000 Clinical (teat) (Cavanagh et al., 2014) 
SNUC 4966 S. haemolyticus PZIC01000000 Cow (Naushad et al., 2016) 
SNUC 1584 S. haemolyticus PZIK01000000 Cow (Naushad et al., 2016) 
IPK TSA25 S. haemolyticus NDWY01000000 surface area of a building with less than 200 occupants  
M-176 S. haemolyticus CUEQ01000000 Clinical blood (Cavanagh et al., 2014) 
OG2 S. haemolyticus NCXH01000000 Kefir seed  
RIT283 S. haemolyticus JFOJ01000000 willow  
S167 S. haemolyticus CP013911 Leaf vegetable (Hong et al., 2016) 
MTCC 3383 S. haemolyticus LILF01000000 Human  
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IIF2SW-P5 S. haemolyticus MIZW01000000 
waste and hygiene compartment of International Space 
Station 
(Checinska Sielaff et al., 
2016) 
R1P1 S. haemolyticus AJVA01000000 copper alloy coin  
SH1752 S. haemolyticus LRHN01000000 Clinical infected eye (Panda and Singh, 2016) 
95671 S. haemolyticus CUFA01000000 Central venous catheter (Cavanagh et al., 2014) 
SGAir0252 S. haemolyticus CP025031 tropical air samples collected in Singapore (Premkrishnan et al., 2018) 
SHN36 S. haemolyticus LRBN01000000 Healthy eye (Panda and Singh, 2016) 
BC05211 S. haemolyticus MRUZ01000000 bovine milk  
8074328 S. haemolyticus CUFG01000000 Clinical blood (Cavanagh et al., 2014) 
1HT3 S. haemolyticus LAKG01000000 Clinical Colon  
115601 S. haemolyticus CUHH01000000 Central venous catheter (Cavanagh et al., 2014) 
ERR085179 S. haemolyticus ERR085179 Clinical (Cavanagh et al., 2014) 
SRR1182430 S. haemolyticus SRR1182430 Clinical  
SRR1182429 S. haemolyticus SRR1182429 Clinical  
SRR1182428 S. haemolyticus SRR1182428 Clinical  
SRR1182432 S. haemolyticus SRR1182432 Clinical  
SRR1182431 S. haemolyticus SRR1182431 Clinical  
ERR085182 S. haemolyticus ERR085182 Clinical (Cavanagh et al., 2014) 
JCSC1435 S. haemolyticus NC_007168 Human (Takeuchi et al., 2005) 
51-30 S. haemolyticus CUDO01000000 Clinical blood  
ERR085171 S. haemolyticus ERR085171 Clinical (Cavanagh et al., 2014) 
25-12 S. haemolyticus CUCI01000000 Clinical blood  
ERR085165 S. haemolyticus ERR085165 Clinical (Cavanagh et al., 2014) 
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ERR085166 S. haemolyticus ERR085166 Clinical (Cavanagh et al., 2014) 
ERR085174 S. haemolyticus ERR085174 Clinical (Cavanagh et al., 2014) 
ERR085170 S. haemolyticus ERR085170 Clinical (Cavanagh et al., 2014) 
ERR085168 S. haemolyticus E RR085168 Clinical (Cavanagh et al., 2014) 
ERR085173 S. haemolyticus ERR085173 Clinical (Cavanagh et al., 2014) 
ERR085169 S. haemolyticus ERR085169 Clinical (Cavanagh et al., 2014) 
ERR085172 S. haemolyticus ERR085172 Clinical (Cavanagh et al., 2014) 
SH1574 S. haemolyticus LRBM01000000 Clinical eye (Panda and Singh, 2016) 
NW19 S. haemolyticus MRUY01000000 bovine milk  
SH747 S. haemolyticus LRHM01000000 Clinical eye (Panda and Singh, 2016) 
105731 S. haemolyticus CUHI01000000 Catheter (Cavanagh et al., 2014) 
0894-2001-2009 S. haemolyticus QVPX01000000 Umbilical wound  
G811N2B1 S. haemolyticus PGWX01000000 Human nares  
285 SHAE S. haemolyticus JVMX01000000 Clinical  
FDAARGOS_130 S. haemolyticus LOSE02000000 Clinical  
ERR085180 S. haemolyticus ERR085180 Clinical (Cavanagh et al., 2014) 
708075 S. haemolyticus CUFF01000000 Clinical  
AB S. haemolyticus CUEN01000000 Human nares (Cavanagh et al., 2014) 
6682 S. haemolyticus CUGF01000000 Clinical blood (Cavanagh et al., 2014) 
C10A S. haemolyticus JPRW01000000 Clinical sputum (Chan et al., 2015) 
A109N1B1 S. haemolyticus PGWY01000000 Human nares  
83131B S. haemolyticus CP025396 Clinical  
83131A S. haemolyticus CP024809 Clinical  
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ERR085175 S. haemolyticus ERR085175 Clinical (Cavanagh et al., 2014) 
ERR085178 S. haemolyticus ERR085178 Clinical (Cavanagh et al., 2014) 
51-06 S. haemolyticus CUCU01000000 Clinical blood (Cavanagh et al., 2014) 
ERR085183 S. haemolyticus ERR085183 Clinical (Cavanagh et al., 2014) 
51-07 S. haemolyticus CUCV01000000 Clinical blood (Cavanagh et al., 2014) 
ERR085177 S. haemolyticus ERR085177 Clinical (Cavanagh et al., 2014) 
ERR085176 S. haemolyticus ERR085176 Clinical (Cavanagh et al., 2014) 
ERR085181 S. haemolyticus ERR085181 Clinical (Cavanagh et al., 2014) 
6035 S. haemolyticus CUFD01000000 Clinical blood (Cavanagh et al., 2014) 
6249 S. haemolyticus CUFE01000000 Clinical blood (Cavanagh et al., 2014) 
SNUC 3870 S. hominis QXVR01000000 Cow (Naushad et al., 2016) 
SNUC 5336 S. hominis PZHX01000000 Cow (Naushad et al., 2016) 
SNUC 4474 S. hominis QXVP01000000 Cow (Naushad et al., 2016) 
SNUC 2620 S. hominis PZIA01000000 Cow (Naushad et al., 2016) 
SNUC 5852 S. hominis PZHV01000000 Cow (Naushad et al., 2016) 
SNUC 3404 S. hominis PZHY01000000 Cow (Naushad et al., 2016) 
SNUC 2444 S. hominis PZIB01000000 Cow (Naushad et al., 2016) 
SNUC 5746 S. hominis PZHW01000000 Cow (Naushad et al., 2016) 
K1 S. hominis MWPJ01000000 bovine milk  
BHG17 S. hominis MPNR01000000 goose droppings (Wang et al., 2017) 
SNUC 2694 S. hominis PZHZ01000000 Cow (Naushad et al., 2016) 
H69 S. hominis LVVO01000000 Air from residential area 
(Lymperopoulou et al., 
2017) 
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Hudgins S. hominis MAYR01000000 Human skin (Calkins et al., 2016) 
J11 S. hominis FBVJ01000000 Human  
C80 S. hominis ACRM01000000 Human  
NCTC_11320 S. hominis PPQE01000000 Human (Cole et al., 2019) 
RE2.10 S. hominis LWJR01000000 rice seed  
UMB0272 S. hominis PKIP01000000 Human  
MMP2 S. hominis LNTW01000000 Ancient permafrost (Kashuba et al., 2017) 
KR S. hominis NGVM01000000 Kefir seed  
As2 S. hominis LFKR01000000 whole mosquito body (Hughes et al., 2016) 
As3 S. hominis LFKS01000000 whole mosquito body (Hughes et al., 2016) 
As1 S. hominis LFKQ01000000 whole mosquito body (Hughes et al., 2016) 
ZBW5 S. hominis AKGC01000000 Human skin (Jiang et al., 2012) 
CCUG 42399 S. hominis PPQX01000000 Clinical blood (Cole et al., 2019) 
SH04_17 S. hominis PHKJ01000000 Clinical blood  
SH08_17 S. hominis PHKL01000000 Clinical blood  
LRKNS031 S. hominis LXRS01000000 Clinical  
SRR5482196 S. hominis SRR5482196 Clinical blood  
SRR5482200 S. hominis SRR5482200 Clinical blood  
SRR5482295 S. hominis SRR5482295 Clinical blood  
SRR5482291 S. hominis SRR5482291 Clinical blood  
SRR5482198 S. hominis SRR5482198 Clinical blood  
SRR5482201 S. hominis SRR5482201 Clinical blood  
SRR5482203 S. hominis SRR5482203 Clinical blood  
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Table 2.3: Accession numbers of isolates used in phylogenetic and pangenome analyses 
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2.6.8 Accessory genome phylogenetic analysis  
The distance of the accessory genome for each sample was determined using the 
POPpunk pipeline. This software uses variable-length k-mer comparisons to distinguish 
isolates’ divergence in shared sequence (Lees et al., 2019). Firstly, a database is created 
of all the core and accessory distances between each pair of isolates. Secondly, the 
database is fitted to a mixture of up to three 2D Gaussians to the distribution of core and 
accessory distances. The number of mixture components is adjusted for each species to 
get results that have a low-density score (proportion of edges in the network), high 
transitivity score and high overall score (Network score based on density and transitivity) 
(Lees et al., 2019). Accessory genome distance was then plotted on a t-SNE graph with 
the perplexity (number of close neighbours each point has) adjusted for each species to 
give the clearest picture of clustering. T-SNE plot was visualised using Microreact, which 
is free and easily used software on the internet (Argimón et al., 2016).  
2.6.9 Pangenome analysis  
Pangenome analysis was performed using the high-speed stand-alone pangenome 
pipeline Roary (version 3.4.2) using the same isolates used in phylogenetic analyses (Page 
et al., 2015). This tool determines what genes are found in the core genome and what is 
found in the accessory genome. The Roary pipeline parameter was set to minimum 
BLASTP percentage identity of 95. The online tool WebMGA was used to assign genes 
found in the pangenome into their Cluster of Orthologous Groups (COG) family by 
RPSBLAST which uses a query sequence to search a database of pre-calculated position-
specific scoring matrix and reports significant hits in a single pass (Wu et al., 2011). This 
method is good at identifying protein domains and gene functions within query sequences 
(Wu et al., 2011).  
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2.7 Statistical analysis 
A Chi-squared test was performed to identify any significant difference in the proportion 
of multidrug resistant staphylococci and mecA gene in isolates recovered from general 
public settings and public areas in hospitals in East and West London (Campbell, 2007).  
All percentages were rounded to the nearest tenth. The Chi-squared test was also used to 
determine the difference in the portion of genes of the COG family that are unique in 
isolates from general public settings when compared to public areas in hospitals and 
isolates from East London when compared to isolates from West London. A P value 
of >0.05 was considered to be significant. The Barnard exact test was performed to 
identify significance in the proportion of antibiotic resistance genes from WGS sample 
recovered from general public settings and public areas in hospitals in East and West 
London (Barnard, 1945). A two-sided P value of >0.05 was considered to be significant.  
2.7.1 Hierarchy clustering analysis 
Hierarchy clustering of a heatmap for resistance/sensitivity for phenotype and presence 
absences of genes were created using the R computer language package ‘Heatmap.plus’ 
(https://cran.r-project.org/web/packages/heatmap.plus/index.html).  
2.7.2 correlation matrix analysis 
 Pearson correlation was performed on isolates of antibiotic resistant phenotype and 
genotype data using ‘cor' test function in R computer language and plotted using the R 




Chapter 3: Sample collection, species identification of multidrug resistant 
staphylococci and antibiotic genotype and SCCmec element. 
3.1 Introduction 
Methicillin-resistant Staphylococcus aureus (MRSA) and coagulase-negative 
staphylococci (CoNS) can spread in healthcare and community-associated areas by skin 
to skin and skin to contaminated surfaces contacts (Conceição et al., 2013; David and 
Daum, 2010; Xu et al., 2015). Previous studies have shown those non-healthcare 
associated environments, including recreational beaches, public buses, residential 
(student) and built-up areas harbour multidrug resistant S. aureus (Conceição et al., 2013; 
Lutz et al., 2014; Roberts et al., 2013). However, studies reporting similar findings for 
CoNS are fragmentary (Conceição et al., 2013; Mkrtchyan et al., 2013; Roberts et al., 
2013; Seng et al., 2017b; Soge et al., 2009; Stepanović et al., 2008; Xu et al., 2015). 
The methicillin resistance gene mecA is located on a mobile genetic element 
‘staphylococcal cassette chromosome mec (SCCmec)’(Oliveira et al., 2002). The mecA 
gene encodes the penicillin-binding protein 2a (PBP2a) that has a low binding affinity to 
all beta-lactam antibiotics (Stapleton and Taylor, 2002). The SCCmec is diverse in its 
genetic structure and to date, 11 different SCCmec types have been characterised. 
SCCmec is determined by the combination of mec (A, B, C1, C2, D, E) and the 
chromosome cassette recombinase (ccr) (A1/B1, A2/B2, A3/B3, A4/B4, C1, A5/B3, 
A1/B6, A1/B3) complexes (Elements (IWG-SCC), 2009; Li et al., 2011; Shore et al., 
2011).  Different SCCmec types have evolved from two different genetic lineages, 
including hospital-associated and community-associated clones, however, currently,  
these different lineages can be found both in hospital and community environments 
(Maree et al., 2007). However, community-associated SCCmec types are generally 
smaller in size compared to their  hospital-associated counterparts (2009). 
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 3.2 Method 
This chapter describes the overall collection of multidrug-resistance (MDR) 
staphylococci from high-frequency touched surfaces in public settings in East and West 
London. These isolates were collected from two sites from East London and West London. 
One site was from public settings from the community and the other was public areas 
from Hospitals. The isolates were speciated using Brucker MALDI-TOF MS and 
validated with the ASTA Tinkerbell MS.  Staphylococci antibiotic resistance profile was 
determined against a panel of 11 different antibiotics as well as the MIC for oxacillin and 
cefoxitin. From their resistance profile, the proportion of MDR staphylococci from East 
and West London, public areas in the community and public areas in hospitals can be 
determined. All isolates that were shown to have mecA gene from PCR were whole 
genome sequenced (WGS). From WGS data the antibiotic resistance genes, SCCmec type, 
the difference between the areas genotype and if the genotype matched with the bacteria 
phenotype can be determined.  
3.3 Results 
3.3.1 Sample collection 
600 samples collected from November 2016 to September 2017 were screened for 
multidrug resistance from the general public settings and public areas in hospitals from 
East and West London (Table 3.1). 224 of these isolates were recovered from East 
London and 376 from West London. 182 were from general public settings and 418 from 
public areas in hospitals. 97 samples were recovered from public settings from East 
London, 85 from public areas in West London. 127 samples were recovered from public 




Table 3.1: Summary of the environmental sites in hospital and community general public areas. ELC= East London Community; WLC=West London 
Community; ELH=East London Hospital, WLH=West London Hospital. Table in Cave et al., 2019
 Area 
 ELC WLC ELH WLH 
Specific site washroom door handles washroom door handles washroom door handles washroom door handles 
 Washroom taps Washroom taps Washroom taps Washroom taps 
 Toilet flusher Toilet Flusher Toilet Flusher Toilet flusher 
 Toilet seat Toilet Seat Toilet seat Toilet seat 
 Soap dispensers Soap dispensers Soap dispensers Soap dispensers 
 Door handles Door handles Door handles Door handles 
 Elevator button Elevator Button Elevator button Elevator button 
 Bench armrest Bench armrest seat armrest seat armrest 
 Escalator rail Escalator rail Stair hand rail Stair hand rail 
 Stair rail Stair rail  Baby changing area 
 ATM machines ATM machines   
 Ticket machine Ticket machine   
 Pedestrian crossing buttons Touch screen TV   
  Public phone   
  
Pedestrian crossing 
buttons   
Number of isolates 97 85 127 291 
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3.3.2 Multidrug resistant species of staphylococci isolates 
281 of the 600 (46.8%) isolates were multidrug resistant staphylococci belonging to 11 
species. These included: S. epidermidis (n=75); S. haemolyticus (n=61); S. hominis 
(n=56); S. saprophyticus (n=24);  S. warneri (n=16);  S. capitas ( n=15);  S. cohnii (n=15); 
S. sciuri (n=9), S. aureus (n=5), S. pasteuri (n=4) and  S. equorum (n=1). There was a 
significantly higher proportion of multidrug resistant staphylococci (P=0.0002) recovered 
from East London (56.7%) compared to those recovered from West London (50.0%) 
(Table 3.2). 
There was a marginally significant difference (P=0.0458) of the proportion of multidrug 
resistant staphylococcal isolates from public areas in the hospitals to general public 
settings (49.5% and 40.7% respectively) (Table 3.3). 
The most commonly found antibiotic that the staphylococcal isolates were resistant to 
was penicillin (n=226/80.4%); followed by fusidic acid (n=203/72.2%) erythromycin 
(n=153/54.5%), amoxicillin (n=78/27.8%); tetracycline (n=74/26.3%); oxacillin 
(n=70/24.9%); cefoxitin (n=63/22.4%); mupirocin (n=41/14.6%); gentamycin 
(n=27/9.6%); cefepime (n=20/7.1%), and chloramphenicol (n=11/4.0%). 
A hierarchy clustering within a heatmap showed there was no correlation in the species 
and area they were isolated from to their antibiotic resistance profile (Figure. 3.1). The 
Chi-square analyses demonstrated that there was a significantly higher proportion of 
multidrug resistant staphylococci with erythromycin resistance (P= ≤0.0001) and 
chloramphenicol resistance (P=0.0143) from West London (62.3% and 6.5% respectively) 
compared to East London (37.0% and 0.8% respectively) (Table 3.1). The opposite was 
observed for mupirocin where intermediate resistance with a significantly higher 
 106 
proportion of multidrug resistant staphylococci (P=≤0.0001) was found in East London 
(19.7%) compared to West London (2.6%) (Table 3.2).  
In the general public settings, there was a significantly higher proportion of isolates that 
had resistance to gentamycin (P=0.00162) and tetracycline (P=0.0211) (16.2% and 36.5% 
respectively) compared to public areas in hospitals (36.5% and 22.7% respectively) 
(Table 3.2). In contrast, a significantly higher proportion of multidrug resistant 
staphylococci (P=0.0143) found in public areas in hospitals (26.1%) were resistant to 
cefoxitin compared to general public settings (12.2%). 
 107 
 Figure 3.1: Hierarchical clustering heatmap showing there was no clustering of the antibiotic resistance profile of isolates in comparison with the 
species and area they were isolated from. Red tile indicates resistance, black tiles represent intermediate resistance and green represent sensitive. 
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East London West London Chi-Square test  
Total number of isolates screened (N = 224) Total number of isolates screened (N=376) 
  N % of total number of isolates 
screened 





X2 P value 
Multidrug resistant 
staphylococci 
127 56.7 154 41.0 15.7 13.944 0.0002 
mecA positive 24 10.7 27 7.18 3.5 2.246 0.134 
  N % MR staphylococci N % of MR staphylococci % 
Differen
ce 
X2 P value 
Oxacillin 38 29.9 32 20.8 9.1 3.097 0.0784 
Gentamicin R 13 10.2 13 8.4 1.8 0.268 0.6049 
Gentamicin I 1 0.8 0 0 0.8 1.217 0.27 
Mupirocin R 4 3.2 8 5.2 2.1 0.706 0.4006 
Mupirocin I 25 19.7 4 2.6 17.1 21.87 <0.001 
Amoxicillin 33 26.0 45 29.2 3.3 0.363 0.5468 
Erythromycin R 47 37.0 96 62.3 25.3 17.80 <0.001 
Erythromycin I 1 0.8 5 3.3 2.5 2.006 0.1567 
Tetracycline 36 28.4 38 24.7 3.7 0.481 0.4878 
Cefoxitin 29 22.8 34 22.1 0.8 0.022 0.8809 
Cefepime R 7 5.5 10 6.5 1.0 0.117 0.7321 
Cefepime I 2 1.6 1 0.7 0.9 0.557 0.4556 
Fusidic acid 97 76.4 106 68.8 7.6 1.971 0.1603 
Penicillin 102 80.3 124 80.5 0.2 0.002 0.9648 
Chloramphenicol R 1 0.8 10 6.5 5.7 5.992 0.0144 
Chloramphenicol I 1 0.8 2 1.3 0.5 0.17 0.6997 
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Table 3.2: The proportion of multidrug resistant staphylococci and mecA+ isolates compared with the number of isolates screened in East and West 
London and the proportion of antibiotics they were resistant compared with the number of multidrug resistant staphylococci from East and West 
London. All chi-squared test was performed with 1 degree of freedom. R= resistance; I= intermediate resistance; MR= multidrug resistant. Table 
in Cave et al., 2019
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Table 3.3: The proportion of multidrug resistant staphylococci and mecA+ isolates compared with the number of isolates screened in general public 
settings and hospitals; the proportion of antibiotics that were resistant compared to the number of multidrug resistant staphylococci from general 
 General public settings 
Total number of isolates 
screened (n=182) 
Public areas in hospitals 
Total number of isolates screened 
(n=418) 
Chi-Square test 
 n % of the total number of 
isolates screened 




X2 P value 
Multidrug resistant 
staphylococci 
74 40.7 207 49.5 8.9 3.991 0.0458 
mecA positive 14 7.7 33 7.9 0.2 0.007 0.9332 
Antibiotic resistance N % MR staphylococci N % MR staphylococci % 
Difference 
X2 P value 
Oxacillin 24 32.4 46 22.2 10.2 3.097 0.0784 
Gentamicin R 12 16.2 14 6.8 9.5 5.79 0.0161 
Gentamicin I 0 0.0 1 0.5 0.5 0.355 0.5512 
Mupirocin R 2 2.7 10 4.8 2.1 0.603 0.603 
Mupirocin I 6 8.1 23 11.1 3.0 0.528 0.4674 
Amoxicillin 18 24.3 60 29.0 4.7 0.591 0.4421 
Erythromycin R 33 44.6 110 53.1 8.6 1.589 0.2075 
Erythromycin I 1 1.4 5 2.4 1.1 0.297 0.5856 
Tetracycline 27 36.5 47 22.7 13.8 5.316 0.0211 
Cefoxitin 9 12.2 54 26.1 13.9 6.06 0.0138 
Cefepime R 7 9.5 10 4.8 4.6 2.049 0.1523 
Cefepime I 2 2.7 1 0.5 2.2 2.542 0.1109 
Fusidic acid 54 73.0 149 72.0 1. 0.027 0.8706 
Penicillin 56 75.7 170 82.1 6.5 1.436 0.2308 
Chloramphenicol R 1 1.4 10 4.8 3.5 1.749 0.186 
Chloramphenicol I 0 0.00 3 1.5 1.5 1.081 0.2985 
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public settings and hospitals. All chi-squared test was performed with 1 degree of freedom. R= resistance; I= intermediate resistance; MR= 
multidrug resistant  . Table in Cave et al. 2019. 
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3.3.3 MALDI-TOF validation 
The accuracy of these results was checked with Brucker instruments by testing 89 MDR 
isolates from 10 different species. This includes  S. aureus (n=5); S. capitis (n=10); S. 
cohnii (n=10); S. epidermidis (n=11);  S. haemolyticus (n=11);  S. hominis (n=11) ;  S. 
pasteuri (n=2); S. sciuri (n=6); S. saprophyticus (n=12) and  S. warneri (n=11) (Table 
3.4). Brucker’s Autoflex was able to predict 7 species correctly 100% of the time whereas 
ASTA’s Tinkerbell predicted 6 species correctly 100% of the time. Of the species, they 
predicted correctly 100% of the time only 3 species for each instrument was predicted at 
high confidence 100% of the time. These were S. epidermidis and S. saprophyticus for 
both instruments; S. saprophyticus for Brucker’s Autoflex and S. capitis for ASTA’s 
Tinkerbell. Only S. cohnii (3.3%) for Brucker Autoflex and S. aureus (37.5%) and S. 











































































Table 3.4: Percentage of 92 environmental staphylococci isolates which were correctly 
identified by two MALDI-TOF instruments. 
The two instruments’ mass spectrum was compared with all isolates from the 
environment. There were comparable mass ions peaks for the same isolates on both 
instruments. These also included the S. cohnii isolates which were predicted correctly at 
high confidence by the ASTA Tinkerbell instrument but were misidentified or identified 
at low confidence on Bruker's Autoflex and vice versa with the S. aureus and S. sciuri 
isolates (Figure 3.2). The only species which had 100% correct ID to high confidence for 



































































Figure 3.2: Spectra of the species that had low confidence or incorrect identification on one instrument but had high confidence or correct identification  
on the other MS platform which had similar mass ion peaks.  
A= S. cohnii; B= S. aureus, C= S. sciuri. Blueline Brucker Autoflex, Redline Asta Tinkerbell  
C 
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3.3.4 Detection of mecA gene 
The mecA gene was identified in 49 (8.2%) isolates. There was no significant difference 
in the proportion of the mecA gene determined in isolates recovered from East London 
(10.7%) compared to those recovered from West London (7.2%) (P=0.1340), the general 
public settings (7.7%) and public areas in hospitals (7.2%) (P = 0.9332). Of the isolates 
that were mecA+, 44 (62.9%) were oxacillin resistant, whereas 43 (68.3%) isolates were 
cefoxitin resistant. Five isolates that were mecA+ were sensitive to oxacillin and 6 mecA+ 
isolates (all belonging to the S. sciuri species) were sensitive to cefoxitin.  
3.3.5 Determination of MICs for oxacillin and cefoxitin 
The MICs for oxacillin and cefoxitin were determined for 49 isolates that carried the 
mecA gene (Table 3.5). Although all isolates were mecA+, only 44 CoNS isolates had 
MIC above the resistance breakpoints, according to CSLI, 2017. Five isolates, including 
S. hominis 372, 385, 387; S. epidermidis 465 and S. haemolyticus 361 that were mecA+, 
were phenotypically oxacillin sensitive. However, all five isolates were resistant to 
cefoxitin by zone diffusion assay. These isolates were recovered from public areas in 
hospitals. Neither CLSI nor BSAC recommend MIC standards for recoding cefoxitin 
resistance. Nevertheless, 42 out of 43 isolates in this study had MIC values of 1.5 μg/ml 
and were resistant to cefoxitin as shown by a disc diffusion assay. 
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Isolate  species 
 
Areas in 





1 S. haemolyticus ELC R R S R S R R R S R S 3 4 
27 S. sciuri ELC R S S S S S S S R R S 0.5 0.75 
33 S. sciuri ELC R S S S S S S S R R S 0.5 1 
59 S. sciuri ELC R S S S S S S S R S S 0.75 1 
74 S. sciuri ELC R S S S S S S S R S S 0.5 1 
75 S. sciuri ELC R R I S S S S S R S S 0.75 1 
93 S. haemolyticus ELC R R I R S S R I S R S 2 4 
99 S. haemolyticus ELC R R S R S R R S S R S 3 4 
105 S. haemolyticus ELC R R S R S R R R R R S 2 4 
109 S. sciuri ELC R S S S S S S S R R S 1 1 
207 S. hominis WLC R S S S R S R S R R S 0.5 6 
208 S. hominis WLC R S S R R R R S R R S 2 6 
209 S. hominis WLC R S S R R S R S R R S 1.5 6 
211 S. cohnii WLC R S S S R S R R S R S 4 4 
321 S. epidermidis ELH R S S R R S R S R R S 0.75 3 
327 S. epidermidis ELH R I S R S S R S R R S 0.75 2 
329 S. epidermidis ELH R S S R R R R S R R S 0.75 8 
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Isolate  species 
 
Areas in 





343 S. cohnii ELH R S S R R R R S R R S 1.5 12 
349 S. cohnii ELH R S S R R S R S R R S 1.5 12 
355 S. epidermidis ELH R S S R R S R S R R S 0.5 3 
361 S. haemolyticus ELH S S S R S S R S R R S 0.38 4 
372 S. hominis ELH S S S S S S R S S R S 0.25 6 
373 S. haemolyticus ELH R S S R S S R S S R S 1 8 
385 S. hominis ELH S S S S S S R S S R S 0.125 1.5 
386 S. hominis ELH R S S R R S R S R R S 4 0.38 
387 S. hominis ELH S S R R R S R S R R S 0.064 16 
407 S. epidermidis ELH R S S R S S R S R R S 0.5 4 
435 S. epidermidis WLH R R S R S S R R R R S 1 6 
436 S. epidermidis WLH R S S R R R R S S R S 1.5 8 
445 S. haemolyticus WLH R S I R R S R S S R R 4 4 
465 S. epidermidis WLH S S S R R R R R R R R 0.38 2 
475 S. epidermidis WLH R S R S R S R R R R S 2 12 
479 S. hominis WLH R S S R R R R S R R S 1.5 16 
492 S. haemolyticus WLH R S S S S S R S S R S 0.75 8 
506 S. haemolyticus WLH R S S R R R R R S R S 4 12 
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Isolate  species 
 
Areas in 





538 S. haemolyticus WLH R S S R I S R R R R R 0.5 6 
620 S. hominis WLH R S S R S S R S S R S 3 16 
623 S. hominis WLH R S S R S S R S S R S 2 24 
631 S. epidermidis WLH R R S R R S R I R R S 3 16 
664 S. epidermidis WLH R S S R S S R S S R S 2 6 
673 S. epidermidis WLH R R S R R R R S R R S 4 3 
699 S. warneri WLH R S S R S S R S S R S 3 8 
700 S. warneri WLH R S S R R S R S S R S 4 6 
702 S. warneri WLH R S S R R S R S S R S 2 12 
711 S. epidermidis WLH R R S R R R R S S R R 12 24 
712 S. epidermidis WLH R R S R R R R S S R R 12 24 
713 S. epidermidis WLH R R S R R R R S S R R 256 12 
715 S. epidermidis WLH R S R R R R R S S R R 256 12 
716 S. epidermidis WLH R S R R R R R S S R R 256 12 
Table 3.5: The antibiotic resistance profile of 49 mecA+ isolates recovered from public areas in hospitals and general public settings.  
R = resistant; I = intermediate resistance, S = sensitive; Oxa = oxacillin; Gen = gentamycin; Mup = mupirocin; Amx = amoxicillin; Erm = 
erythromycin; Tet = tetracycline; Fox= cefoxitin; Fep = cefepime; Fua= fusidic acid; Pen= penicillin; Chl= chloramphenicol ELC= East London 
Community; WLC= West London Community; ELH= East London Hospital; WLH= West London hospital.  Table in Cave et al. 2019 
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3.3.6 De novo assembly statistics of whole genome sequencing data 
The sequenced reads were assembled for the 49 mecA+ staphylococcal isolates that were 
WGS to produce a draft genome (Table 3.6). Contigs less then 500bp were filtered out. 
The assembly ranged from 14-99 contigs; N50 of 67,338-1,568,201and L50 1-14. 
Genome size and GC content for S. epidermidis range from 2,423,410 to 2,632,209 with 
a GC content 31.3 to 32.1%. For S. haemolyticus 2,377,188 to 2,597,964bp with a GC 
content of 32.6 to 32.7%. For S. hominis 2,114,977 to 2,243,945bp with a GC content of 
31.27 to 31.4%. For S. cohnii 2,672,915 to 2,710,971bp with a GC content of 32.37 to 
32.5%. S. warneri 2,408,240 to 2,408,986bp with GC content 32.6%; and S. sciuri 
2,780,223 to 2,784,151bp with a GC content of 32.5 to 32.6%. The number of contigs in 
S.  epidermidis ranged 34 to 99 with a  mean of 47.6% of the contigs larger than 10,000bp 
and 24.0% of the contigs bigger than 50,000bp. For S. haemolyticus the number of contigs 
ranged from 65 to 96 with a mean of 61.5% of the contigs larger than 10,000bp and 24.1% 
of the contigs larger than 50,000bp. S. hominis isolates have a number of contig range 
from 13 to  81  with a mean of 64.4% of isolates contig larger than  10,000bp and  34.8% 
of the contigs larger than 50,000bp. S. cohnii number of contigs range from 32 and 48 
with a mean of  51.6% of the isolates contig larger than 10,000bp and  31.8% of isolates 
contig is larger than 500,000bp.  S. warneri number of contigs range from 17 to 18 with 
a mean of 50% of the contigs larger than 10,000bp and 30.8% of the isolates contig is 
larger than 50,000bp. S.  sciuri number of contigs range from 14 to 22 with a mean of 
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25000 bp) 





length N50 L50 
GC 
(%) 
1 S. haemolyticus 71 44 28 21 198,215 2,426,191 76,937 11 32.7 
27 S. sciuri 22 10 8 7 1,460,882 2,781,043 1,460,882 1 32.5 
33 S. sciuri 20 9 8 6 1,462,178 2,784,151 1,462,178 1 32.5 
59 S. sciuri 17 8 7 5 1,567,438 2,780,228 1,567,438 1 32.5 
74 S. sciuri 16 9 8 6 1,462,149 2,780,223 1,462,149 1 32.5 
75 S. sciuri 14 8 7 5 1,568,201 2,779,680 1,568,201 1 32.5 
93 S. haemolyticus 65 37 25 13 391,966 2,435,134 87,864 7 32.7 
99 S. haemolyticus 80 47 31 22 139,290 2,597,964 88,243 12 32.7 
105 S. haemolyticus 76 45 30 20 198,215 2,429,313 76,937 11 32.7 
109 S. sciuri 21 8 7 5 1,567,274 2,783,685 1,567,274 1 32.6 
207 S. hominis 45 31 23 15 309,626 2,243,945 107,022 7 31.4 
208 S. hominis 39 23 18 17 326,099 2,250,725 122,411 6 31.3 
209 S. hominis 48 32 23 15 307,785 2,225,890 106,764 7 31.4 
211 S. cohnii 32 24 23 16 375,488 2,710,971 194,587 5 32.4 
321 S. epidermidis 41 26 19 15 296,717 2,573,368 145,078 6 32.0 
327 S. epidermidis 39 24 18 14 365,826 2,573,135 168,921 6 32.0 
329 S. epidermidis 44 28 22 16 253,615 2,570,296 141,020 7 32.0 
343 S. cohnii 48 21 18 12 519,772 2,689,027 274,787 4 32.4 
349 S. cohnii 46 20 16 12 526,250 2,672,915 296,280 4 32.5 
355 S. epidermidis 40 24 20 13 434,249 2,499,607 159,061 5 31.9 
361 S.  haemolyticus 96 55 29 14 243,763 2,444,366 52,518 12 32.7 
372 S. hominis 34 21 15 12 466,679 2,171,866 159,266 4 31.4 
373 S. haemolyticus 69 42 28 18 251332 2,377,188 78,596 11 32.7 
385 S. hominis 13 10 8 7 1016183 2,170,655 522,044 2 31.4 
386 S. hominis 81 31 18 9 466504 2,214,036 133,680 5 31.3 
387 S. hominis 41 25 18 15 317973 2,231,903 135,176 5 31.3 
 123 
407 S. epidermidis 34 23 20 15 356468 2,423,410 143,743 6 32.1 
435 S. epidermidis 52 29 24 17 254787 2,632,209 120,838 7 31.8 
436 S. epidermidis 51 29 24 18 285291 2,463,964 105,346 8 32.0 
445 S.  haemolyticus 70 50 31 14 211088 2,496,057 65,245 11 33.0 
465 S. epidermidis 39 22 18 13 517090 2,485,514 226,829 4 32.0 
475 S. epidermidis 45 29 20 15 518475 2,506,454 120,888 6 32.0 
479 S. hominis 41 23 16 14 312950 2,248,765 154,197 5 31.3 
492 S. haemolyticus 38 23 19 14 257061 2,339,728 158,248 6 32.7 
506 S. haemolyticus 69 43 26 16 286475 2,457,490 87,637 10 32.6 
538 S. haemolyticus 67 45 27 17 228797 2,484,453 77,667 10 32.6 
620 S. hominis 43 24 18 14 411659 2,114,977 140,509 5 31.4 
623 S. hominis 32 21 15 12 466681 2,172,479 159,266 4 31.4 
631 S. epidermidis 60 36 24 16 326412 2,461,843 103,579 8 32.0 
664 S. epidermidis 42 24 20 15 518823 2,522,035 180,767 5 32.0 
673 S. epidermidis 63 39 30 16 209796 2,483,246 95,655 9 32.0 
699 S. warneri 17 8 8 6 1271043 2,408,986 1,271,043 1 32.6 
700 S. warneri 18 10 9 5 1194182 2,408,574 611,334 2 32.6 
702 S. warneri 17 8 7 5 1270917 2,408,240 1,270,917 1 32.6 
711 S. epidermidis 61 34 28 20 204104 2,594,970 93,620 9 31.8 
712 S. epidermidis 61 34 28 20 204104 2,594,586 93,620 9 31.8 
713 S. epidermidis 62 34 28 20 204104 2,594,914 93,620 9 31.8 
715 S. epidermidis 67 34 28 20 204104 2,569,288 93,539 9 31.8 
716 S. epidermidis 99 48 34 18 177708 25,99,974 67,338 14 31.7 
Table 3.6: Genome assembly statistics of isolates recovered from general public settings in East and West London. 
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3.3.7 Prevalence of antibiotic genes from WGS data 
The mecA gene was found in 43 out of the 49 isolates that were whole genome sequenced. 
Of these all S. sciuri isolates did not carry the mecA gene. Instead, they carried the mecA1 
gene, which had only 84.4% homology to mecA gene.  
Apart from mecA, 24 other antibiotic resistance genes were detected in 43 isolates. BlaZ 
was most commonly found resistance gene with 39 isolates (90.7%) followed by qacA/B 
with 22 (51.2%); dfrC  with 18 (41.9%), norA and ant(4')-lb with 17 (39.5%); AAC(6')-
Ie-APH(2'')-Ia with 15 (34.9%), fusB with 14 (32.6%), msrA with 13 (30.2%), ermC with 
12 (27.9%), mphC with 9 (27.6%), tetK 8 (18.6%), mupA with 7 (16.3%), cat with 6 
(14.0%), dfrG with 5 (11.63%), mgrA with 5 (9%), lnuA with 4 (9.3%), fusC  and aph3-
IIIa with 3 (7.0%) and sat4A, vgaA, vatB which were all found in 1 isolate (2.3%).  
From these 43 isolates, 3 (7.0%) isolates had two antibiotic resistance genes; 3 (7.0%) 
had three antibiotic resistance genes; 7 (16.9%) had four antibiotic resistance genes , 2 
(4.7%) had five antibiotic resistance genes, 7 (16.3%) had six antibiotic resistance genes, 
2 (4.7%) had seven antibiotic resistance genes, 3 (7.0%) had eight antibiotic resistance 
genes, 6 (14.0%) had nine antibiotic resistance genes and 5 (11.6%) had ten antibiotic 
resistance genes.  
A hierarchy clustering within a heatmap of the mecA+ isolates resistance gene profile has 
shown a clustering of S. epidermidis isolates except for sample 407 and 465 as well as all 
S. warneri isolates and S. haemolyticus from East London community (Figure 3.3). 
Interestingly, all S. epidermidis isolates had the norA and dfrC genes. 
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Red tile indicates the presence of antibiotic resistance genes; green tile absence of resistance gene. Figure in Cave et al., 2019
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Barnard’s Exact test analysis showed there was a significantly higher proportion of 
isolates with the dfrG gene (P=0.0054) in East London (29.4%) compared to West 
London (0%) (Table 3.7). There was a significantly higher proportion of isolates with the 
cat (P=0.0419) and mup gene (P=0.0238) in West London (23.1% and 26.9% respectively) 
and compared to East London (both 0%).  
For general public settings there was significantly higher proportion of antibiotics aph2-
IIIa (P=0.0024), lnuA (P= 0.0116) and dfrG (P=0.0031) (25%, 37.5% and 50% 
respectively) compared to public areas in hospitals (0%, 0% and 2.86% respectively) 
(Table 3.8). The opposite was observed with isolates carrying the dfrC (P=0.0238), and 
norA gene (P=0.0238) with a significantly higher proportion found in public areas in 
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Table 3.7: The proportion of antibiotic resistance genes in isolates recovered from East and 
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Table 3.8:The proportion of antibiotic resistance genes in isolates recovered general public 




3.3.8 Correlation of antibiotic resistance phenotype and genotype using WGS 
analysis 
Antibiotic resistance phenotype and genotype were compared to determine whether the 
phenotype of the isolates correlates with the genes responsible for resistance to particular 
antibiotics to which they were resistant (Table 3.9). The data showed that not all 
phenotypes correlated with the predicted genotype. For better visualisation a Pearson 
correlation was performed on all isolates that were WGS sequenced that were shown to 
have known antibiotic resistance genes (Figure 3.4). MecA gene, cefoxitin and penicillin 
resistant phenotypes were removed from the Pearson correlation analysis as all isolates 
were shown to have these traits. There was a strong correlation (p=>0.05) for gentamicin 
and aminoglycoside resistance gene aac(6’)-le-aph(2”)-la (r=0.73); amoxicillin and the 
beta-lactam resistant blaZ gene (r=0.56), tetracycline and tetK (r=0.62), fusidic acid fusB 
gene (r=0.51) and chloramphenicol and cat gene (r=0.67). mupirocin had a weak 
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Figure 3.4: Parson correlation matrix of antibiotic resistance phenotype compared with 
antibiotic resistance genotype. White spaces not significantly correlated (<p=05). Blue 
circles indicated significant positive correlation and red show significant negative 

















3.3.9 Determination of SCCmec types using WGS data 
The SCCmec types were determined in 49 isolates that were mecA+ by mapping for 
genetic markers from whole genome sequencing data (Table 3.10). 17 (34.7%) of 49 
isolates which harboured the previously reported SCCmec types. These included SCCmec 
type IV (n=11) which was exclusively found in S. epidermidis isolates from public areas 
in hospitals; followed by type V (n=5) found in S. haemolyticus and S warneri and type 
VIII (n=1) found in an S. hominis isolate. The SCCmec element was absent in the genome 
of 10 (18.4%) isolates. 2 (4.1%) isolates harboured pseudo-SCCmec as they had mec 
complex but lacked the ccr complex. The remaining 19 (38.8%) isolates SCCmec types 
were untypable as they either have a novel combination of mec and ccr complex (n=4), 
or had multiple ccr complexes (n=13) or had novel ccr complexes (n=2). A select few of 


































































































































































No SCCmec element 
No SCCmec element 
No SCCmec element 
No SCCmec element 










































































































































Table 3.10: The diversity of SCCmec types of the 49 coagulase negative staphylococcal 




Figure 3.5: A select sample of SCCmec structure from staphylococcal isolates from high-frequency touched sites. A= Isolate 1: S. haemolyticus 
SCCmec type V; B= Isolate 475: S. epidermidis SCCmec type IV, C=479 S. hominis SCCmec type VIII; D=99 S. haemolyticus with mec C2 
complex and ccrC, ccrA1/B1 complex E= 208 S. hominis with a ccrA1/B1, ccrB4/A4 complex and F= 211 S. cohnii with a mec A complex and a 
ccrB3/A1 complex.  Figure in Cave et al. 2019
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3.4 Discussion 
3.4.1 Multidrug resistant staphylococcal species 
281 multidrug resistant staphylococcal isolates belonging to 11 species were identified in 
this study. The most prevalent species were S. epidermidis (n=74) and S. haemolyticus 
(n=61). S. epidermidis and S. haemolyticus have previously been reported as the most 
common CoNS isolated from surfaces in public settings and hospitals surfaces (Seng et 
al., 2017b, 2017a; Xu et al., 2015). Interestingly, it has been demonstrated that S. aureus 
(n=5) was less prevalent on high-frequency hand touched surfaces, even though 30% of 
the human population are S. aureus carriers (Sollid et al., 2014). This may be because S. 
aureus is more commonly carried in the nasal passages than on hands (Tammelin et al., 
2003).  S. aureus is the most virulent species of staphylococci and the most common 
cause of infection in hospitalised patients (Liu, 2009). However, S. epidermidis, S. 
hominis and S. haemolyticus are amongst the most frequent nosocomial pathogens 
responsible for minor skin infections to life-threatening diseases (Basaglia et al., 2003; 
Huebner and Goldmann, 1999). In addition, community-associated CoNS have also been 
reported to cause infections (Chu et al., 2008).  
3.3.2 MALDI-TOF MS validation 
MALDI-TOF MS is the clinical standard for rapidly identifying bacteria to a species level 
(Schubert and Kostrzewa, 2017). Multiple companies which develop similar instruments, 
each building their preassembled database of microbial mass spectral profiles, however, 
the research conducting an experiment requires correct prediction at the species level to 
high confidence (Veloo et al., 2017). With few exceptions, there was excellent 
congruence between data derived using ASTA's Tinkerbell LT and Bruker's Autoflex at 
species level using the exact same isolates spotted on the target plate. When the two 
instruments mass spectrum were compared, the same key mass ions was observed even 
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in isolates which were identified as different species or their level of confidence in 
identification between the two instruments were different, suggesting the absence of a 
reference spectrum. These instruments are mainly used in clinical laboratories; therefore, 
their databased are assembled from clinically relevant isolates where environmental 
isolates were not considered a priority (Seuylemezian et al., 2018). However, the 
boundaries between isolates which are considered to be clinical or environmental isolates 
are becoming more blurred and gradually more environmental isolates will be 
incorporated in databases for taxa such as mycobacteria, staphylococci, streptococci  
(Clark et al., 2013).   
3.4.3 Resistance phenotype 
Amongst the staphylococcal isolates, there was an increased susceptibility toward 
penicillin (80.4%), fusidic acid (72.4%), and erythromycin (54.5%). Xu and co-workers 
reported increased susceptibilities toward penicillin, fusidic acid, erythromycin, and 
cefepime among staphylococcal isolates recovered from surfaces of inanimate objects in 
London hotel rooms (Xu et al., 2015). It has been reported that in primary care in England, 
48.8% of antibiotics prescribed were penicillin and 13.4% were macrolides, lincosamides 
and streptogramins (Dolk et al., 2018). This potentially suggests why penicillin and 
erythromycin, a macrolide class antibiotic as two of the three most common antibiotic 
resistant phenotype from general public settings. 
3.4.4 Comparison of the proportion of antibiotic resistant bacteria from East and 
West London 
Areas in East and West London harboured high levels of antibiotic resistant staphylococci 
in proportion to the number of isolates that were examined. Significantly higher 
proportion (P=0.0002) of multidrug resistant staphylococci was observed from East 
London (56.7%) compared to West London (50.0%). This may be due to East London 
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having a higher population density (9.7x103 per km2; 2017 estimate) compared to West 
London (8.9x103 per km2; 2017 estimate) (Park, 2017). Previous studies have shown that 
there is a linkage in population density to the development of antibiotic resistant 
(Bruinsma et al., 2003).  
There was no difference in distribution of these multidrug resistant isolates in two 
geographical areas at species level, apart from the observation that S. warneri isolates 
were exclusively recovered from West London, but not from East London, whereas S. 
sciuri and S. equorum were recovered from East London. 
3.4.5 Comparison of the proportion of antibiotic resistant bacteria from public 
settings and public areas in hospitals 
There was a high level of multidrug resistant staphylococci isolated in public areas in 
hospitals and general public settings. This was demonstrated by the number of isolates 
that were recovered. Statistically, there was a significantly higher proportion (P=0.0458) 
of multidrug resistant staphylococci in public areas in hospitals (49.5%) compared to that 
in general public settings (40.7%) which was expected due to the increased use of 
antibiotics in hospitals than in the community (Cantón and Morosini, 2011). However, 
the proportions of multidrug resistant bacteria isolated from general public settings in this 
study (46.8%) were less than that reported in similar studies from a university campus in 
Thailand (61%) and hotel rooms in London (86%) (Seng et al., 2017b; Xu et al., 2015). 
In this study, isolates were recovered from areas in hospitals that are accessible to the 
general public and not just to the hospital staff or patients. These areas included reception 
areas, public washrooms, corridors and lifts. The high levels of multidrug resistant 
staphylococci recovered from these areas in hospitals suggest a cross-contamination 
between community-associated and hospital-associated staphylococci.  
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3.4.6 Proportion of mecA gene by PCR from different areas 
There was no significant difference in the carriage of the mecA gene in isolates recovered 
from East (10.71%) and West London (7.2%) and general public settings (7.7%) and 
public areas in a hospital (7.2%). The prevalence of the mecA gene in general public 
settings was less than that reported from the university campus in Thailand (20.5%) and 
hotel rooms in London (29.6%) (Seng et al., 2017b; Xu et al., 2015). In this study, the 
prevalence of the mecA gene in hospitals was also less than reported from a hospital in 
Thailand (70.1%). For the latter, it was expected as the isolates were recovered from 
medical ward surfaces and one would expect to find a high level of methicillin-resistance 
due to the frequent use of multiple antibiotics (Seng et al., 2017a).  
Interestingly, 6 S. sciuri isolates that were mecA+ by PCR and were resistant to oxacillin 
had a homolog of mecA known as mecA1 (table 3.3). mecA1 is considered to be the 
ancestry gene of mecA, which normally does not have resistance towards oxacillin. A 
recent study has shown that S. sciuri has developed oxacillin resistance using a variety of 
mechanisms from diversification of the non-binding domain of native PBPs, change in 
the mecA promoter, acquiring the SCCmec element and the adaptation of the bacterial 
genetic background (Clark et al., 2013) 
3.4.7 Assembly statistics 
The overall assembly of all the isolates that were WGS was too a high standard as they 
were similar in size and GC % to that of known reference isolates. The genome size and 
GC content of the assembly is similar to reference genomes S. epidermidis ATCC1228 
(length 2,570,371bp, GC 32.1%), S. haemolyticus JCSC1435 (length 2,685,015 bp, GC 
32.8%) S. hominis K1 (2,253,412, GC 31.4); S. cohnii FDAARGOS_334 (length 
2,557,319, GC 32.7%) , S. warneri SG1 (length 2,486,042 GC 32.7%) and S. sciuri 285 
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(length 2,764,040; GC 32.6%) (Cheng et al., 2013; MacLea and Trachtenberg, 2017; 
“Staphylococcus cohnii (ID 24233) - Genome - NCBI,” n.d.; “Staphylococcus hominis 
subsp. hominis (ID 2014) - Genome - NCBI,” n.d.; “Staphylococcus sciuri (ID 10782) - 
Genome - NCBI,” n.d.; Takeuchi et al., 2005) 
3.4.8 Resistance genes 
There was a large diversity of antibiotic resistance genes which encodes resistance to 
different types of antibiotics. Of these genes blaZ (90.7%) and qacA/B (51.2%) were the 
most common. Previous studies on the prevalence of antimicrobial resistance genes in 
CoNS from clinical and environmental is limited, but some reports have shown that blaZ 
is of one the most common antibiotic resistance genes found in staphylococci (Klibi et 
al., 2018; Pedroso et al., 2018). QacA/B has been previously reported to high prevalence 
from the University campus in Thailand (60.4%). This gene may have an important role 
for the survival of the bacteria within the environment as they encode multidrug efflux 
pump which has shown cross resistance-towards antiseptic and disinfectant compounds 
used to reduce bacterial contamination from surfaces (Wang et al., 2008).  
Although S. epidermidis isolates were recovered from different areas, they possessed 
relatively similar antibiotic resistance profiles when compared by hierarchy clustering 
analysis. This may be due to the observation that all isolates had the fluoroquinolone 
efflux transporter gene norA and trimethoprim resistance dihydrofolate reductase gene 
dfrC (Costa et al., 2019; Totake et al., 1998). These genes may be essential for S. 
epidermidis survival, especially as norA like qacA/B has shown reduce susceptibility to 
antiseptic and disinfectant substances (Costa et al., 2019). 
3.4.9 Correlation of antibiotic phenotype and genotype  
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For the isolates that had the mecA gene (WGS analysis), there were a few discrepancies 
with antibiotic phenotype to the predicted antibiotic resistance genotype. Seven antibiotic 
resistance genotypes correlated to the predicted genotype. Oxacillin, cefoxitin and 
penicillin correlation was not measured for the known resistance gene mecA due to all the 
isolates having the gene, therefore automatically have a strong correlation. It is possible 
that these resistance phenotypes that did not match with the genotype were derived from 
unknown SNP or genes which have not previously been described. 
3.4.10 SCCmec classification 
SCCmec was detected in 36 out of the 49 isolates that were whole genome sequenced; 
however, SCCmec types were assigned only to 17 isolates. The most common type was 
SCCmec type IV (n= 11), followed by SCCmec type V (n=5). These results are consistent 
with previously reported studies of clinical and from environmental isolates (Seng et al., 
2017b). In this study, SCCmec type IV was exclusively found in S. epidermidis isolates. 
This is in keeping with others reporting a high association between SCCmec type IV and 
S. epidermidis (Chen et al., 2017). SCCmec type V was associated with S. haemolyticus 
and S. warneri isolates but is mainly reported to be associated with S. haemolyticus in 
clinical isolates (Zong et al., 2011). SCCmec type VIII was the only other typeable 
SCCmec from this study. 
The remaining SCCmec types were untypeable as they harboured a novel ccr complex or 
multiple ccr complexes. Multiple ccr complexes have previously been described in 
clinical and community-associated isolates but currently, this is the first report of these 
SCCmec types determined in the isolates recovered from the general public environments 
(Chen et al., 2017). It has been reported that multiple ccr complexes have been shown to 
produce more stable mecA mRNA transcription compared to single elements as well as 
having a better cell wall integrity (Chen et al., 2017).  This suggests that isolates with 
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multiple ccr complexes may have increased susceptibilities to oxacillin or cefoxitin, 
however, they do not always correlate with their phenotypic data. This adaptation may 
help the bacteria to survive more extended periods under persistent antibiotic pressure. 
The remaining SCCmec types were untypeable as they harboured a novel ccr complex or 
multiple ccr complexes. Multiple ccr complexes have previously been described in 
clinical and community-associated isolates but currently, this is the first report of these 
SCCmec types determined in the isolates recovered from the general public environments 
(Chen et al., 2017). It has been reported that multiple ccr complexes have been shown to 
produce more stable mecA mRNA transcription compared to single elements as well as 
having a better cell wall integrity (Chen et al., 2017).  This suggests that isolates with 
multiple ccr complexes may have increased susceptibilities to oxacillin or cefoxitin, 
however, they do not always correlate with their phenotypic data. This adaptation may 
help the bacteria to survive more extended periods under persistent antibiotic pressure. 
3.5 Conclusion 
In this chapter, multidrug resistant staphylococcal isolates were collected from high-
frequency hand touched surface from public settings from East and West London and 
compared with each other. Their antibiotic resistance genes and SCCmec type were 
identified using WGS which have not been previously done on isolates from public 
settings. From these analyses, there were novel findings. These findings were: 
1. General public areas and common public areas in hospitals in London can be 
reservoirs for MDR staphylococci. These MDR bacteria can be found at high 
levels on high-frequency touched surfaces.  
2. Penicillin, erythromycin and fusidic acid the most common antibiotic 
staphylococci were resistant to in public settings. 
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1. There was a higher proportion of MDR staphylococci from East London 
compared to West London. This may be because East London has a larger 
population than West London. 
2. Public areas in hospitals have a higher portion of MDR staphylococci compared 
to general public settings. This is due to there being a higher abundance of 
antibiotic used in hospitals compared with public settings in the community. 
3. MALDI-TOF species identification for the majority of staphylococcal species was 
accurate except for few species that were not clinically related. 
4. There was a strong correlation between resistance phenotype and known 
resistance genes in WGS isolates recovered in this study. Those that have shown 
a weak correlation had unknown genes or SNPs that confer resistance, which has 
not been previously described. 
5. A diverse range of SCCmec types was determined from general public settings 
and public areas in hospitals of which many were untypeable due to having either 
a novel ccr or an extra ccr complex. These SCCmec structures have not been 
previously reported in isolates recovered from environmental surfaces in general 
public settings.  
Overall, these findings show that these isolates have the potential to spread antibiotic 
resistant staphylococci to different people via general public settings and have the 
potential to cause infections which are untreatable with antibiotics that are currently 
available. 
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Chapter 4: Comparative genomics of mecA positive S. epidermidis isolates 
recovered from public settings using the One Health approach; determining 
horizontal gene transfer in these isolates 
4.1 Introduction 
Staphylococcus epidermidis is the most common skin commensal and is the prominent 
cause of nosocomial and device-associated infections (Otto, 2009). In general coagulase-
negative staphylococci (CoNS) lack virulence determinants, which generally are 
responsible for aggression. Nevertheless, they have factors which support adherence and 
colonisation. For S. epidermidis, one of its crucial virulence properties is the ability to 
attach to medical devices, and implants. This requires the bacteria to have the ability to 
produce biofilm (Trampuz and Zimmerli, 2005; Ziebuhr et al., 2006). For this to happen, 
the bacteria cells adhere to a surface, in which the bacterial cells then accumulate, forming 
a three-dimensional multi-layer, multi-cellular structure (Büttner et al., 2015). This step 
is critical for S. epidermidis pathogenesis as well as its internalisation and persistence in 
the host cells. Finally, the biofilm structure is dissembled (Büttner et al., 2015). From the 
dissembled biofilm, a single cell can disseminate through the bloodstream to colonise and 
form new biofilms at different sites in the body (Otto, 2008). This can lead to sepsis, 
meningitis and endocarditis (Becker et al., 2014). S. epidermidis is an important reservoir 
of mobile genetic elements (MGE) including antibiotic resistance and virulence genes 
(Conlan et al., 2012; Hung et al., 2015; Miragaia et al., 2009). Reports have shown that 
the arginine catabolic mobile element (ACME), which is important to S. aureus USA300 
fitness, originated in S. epidermidis and has been horizontally transferred across (Planet 
et al., 2013). Extensive studies have been performed on the genetic lineages of S. 
epidermidis but little is known about the genetic lineages of isolates recovered from high-
frequency touched surfaces in general public areas within hospitals and horizontal gene 
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transfer (HGT) of antibiotic resistance and virulence determents (Chaudhry and Patil, 
2016; Conlan et al., 2012).  
4.2 Method 
Horizontal gene transfer can occur in S. epidermidis via bacteriophages, plasmid, 
transposons pathogenicity island and chromosomal cassettes. Multiple software has been 
developed to identify these genetic elements which can be split into two methods, 
parametric and phylogenetic (Malachowa and DeLeo, 2010; Ravenhall et al., 2015). 
Parametric methods search the genome for sections that are significantly different from 
that of the genome average, for example, the guanine-cytosine content or codon-usage 
(Ravenhall et al., 2015). The phylogenetic methods examine evolutionary histories of 
genes and identify conflicting phylogenies (Ravenhall et al., 2015). The benefits of the 
parametric methods are that it does not require a closely related isolate to be used for 
comparisons. Drawbacks to this method are that it relies on the host genome to be uniform 
in its genetic makeup without accounting for intragenomic variability, which can lead to 
overprediction (Ravenhall et al., 2015).  Phylogenetic methods are better at characterising 
the HGT event as they can identify the donor species (Ravenhall et al., 2015). A drawback 
to this method is that there could be conflicts in the phylogenies due to events not 
considered by the mode; heavily relying on reliable reference species trees which are not 
always available, and the computational time to process and reconstruct many genes and 
species trees (Ravenhall et al., 2015). Therefore, in this study, multiple software 
(HGTector and Islandviewer 4) was used that can utilise both methods to detect HGT. 
Whole genome sequencing phylogenetic studies and pangenome studies are used to infer 
relationship and evolution history between isolates from the same species (Caputo et al., 
2019; McNally et al., 2016). WGS phylogenetic analyses can infer the evolutionary 
difference in bacterial genomes between isolates by looking for SNPs. Whereas in 
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pangenome analysis the genes from all isolates are clustered based on their genetic 
relativeness and then further grouped into core genes (found in all the isolates) or 
accessory genes (not always present in) within a bacterial species. Pangenome analysis 
can be used to characterise strains by a particular group of genes, for example, antibiotic 
resistance genes or virulent genes as well as determine the function of genes found in the 
core or accessory genome (Manara et al., 2018; Page et al., 2015). Additionally, the 
accessory genome distance can be interpreted in all isolates of a bacterial collection with 
a k-mer approach (Lees et al., 2019). This method is quick and can infer the difference in 
the accessory genome to a higher degree compared to pangenome due to the ability to use 
variable-length k-mers to accurately resolve genetic divergence (Lees et al., 2019). 
In this study, bioinformatic analysis was used to determine Multilocus sequence types 
(MLST) and predict virulence, and antibiotic resistance genes in mecA positive (mecA+) 
S. epidermidis isolates recovered from public settings from East and West London. It was 
also identified HGT events within the genome and the potential donor organisms of 
horizontally transferred antibiotic resistance and virulence genes. Additionally, it was 
investigated if these genes were transferred via plasmids or by phages or by other mobile 
genetic elements.  
A core SNP maximum likelihood phylogenetic tree was constructed using mecA+ S. 
epidermidis isolates from public settings from East and West London and other  S. 
epidermidis  isolates reference and draft genomes from the European Nucleotide Archive 
(ENA) database recovered from clinical samples (blood, cerebrospinal fluid, urine); 
healthy humans skin, nares and nasopharynx; livestock (cows, pigs and sheep); rodents 
(rats), plants, hospital environment from wards and catheters, animal housing and natural 
environment; to identify the genetic lineages of isolates from public settings. It was 
measured the distance of the accessory genome of isolates recovered from public setting 
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with the same isolates from the ENA database used in the core SNP maximum likelihood 
phylogenetic tree to determine if isolates recovered from the same source share the same 
accessory genes and the accessory genome using a k-mer approach (Poppunk) (Lees et 
al., 2019). A pangenome was also constructed to identify core and accessory genes in the 
genome. As part of the pangenome analyses, the absence and presence of antibiotic 
resistance and virulence genes across all S. epidermidis were identified as well as the 
Clusters of Orthologous Groups (COG) function family of the unique genes found in 
isolates collected from public settings in East and West London.  
 Results 
4.3.1 MLST of WGS Staphylococcus epidermidis 
The MLST sequence types (ST) of the mecA+ S. epidermidis from public settings in East 
and West London sequence were determined from whole genome sequencing data. 10 
different sequence types (ST) were assigned to 17 S. epidermidis isolates (Table 4.1). ST2 
was the most common (n=5) sequence type, followed by ST66 (n=3) and ST87 (n=2). 
Two new sequence types were identified which have been assigned ST771 and ST779 






Area Sequence type (ST) 
321 ELH 66 
327 ELH 66 
329 ELH 66 
355 ELH 558 
407 ELH 59 
435 WLH 188 
436 WLH 771 
465 WLH 54 
475 WLH 5 
631 WLH 87 
664 WLH 779 
673 WLH 87 
711 WLH 2 
712 WLH 2 
713 WLH 2 
715 WLH 2 
716 WLH 2 
Table 4.1: MLST types of S. epidermidis isolates recovered from public settings in East and 
West London. East London Hospital= ELH; West London Hospital = WLH 
4.3.2 Virulence genes identified in mecA+ S. epidermidis recovered from public 
settings in East and West London  
28 virulence genes were identified in 17 of the mecA+ S. epidermidis isolates recovered 
from East and West London, of which 10 were identified in all isolates from public 
settings (Table 4.2). All isolates harboured the nuc gene (encoding thermonuclease an 
enzyme that can hydrolyse the host cell DNA and RNA), sspA gene (encoding serine V8 
protease enzyme which is involved detaches bacterial cells from colonised sites); sspB 
gene (encoding cystine protease enzyme which breakdown elastin, fibronectin and 
kininogen), lip and geh genes (encoding lipase enzyme which breakdown fatty acid); 
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sdrG gene (encoding Ser- Asp rich fibrinogen-binding proteins which is involved in 
bacterial adhesion); atl (encoding autolysin involved in bacterial adhesion), ebp 
(encoding elastin binding protein involved in bacterial adhesion), hlb gene (encoding beta 
hemolysin toxin) and capB and capC gene (encoding polyglutamic acid capsule for 
immune invasion). sdrH, sdrF, sdrG and sdrE genes (encoding Ser-Asp rich fibrinogen-
binding proteins which are involved in bacterial adhesion) were found in 76.2%, 64.7% 
(for sdrF and sdrG) and 11.8% respectively. Ebh gene (encoding cell wall-associated 
fibronectin-binding protein involved in bacterial adhesion) was found in 94.1% isolates. 
IcaA, icaB, icaC, icaD and icaR genes (Intercellular adhesion proteins involved in biofilm 
formation) were found in 47.1% of the isolates. EsaA, essA, essB, essC, esxA and esaB 
genes (encoding for the Type VII secretion system involved in bacterial survival and 
long-term persistence) were found in 23.6% (for EsaA, essA, essB, essC) and 5.9% (for 
esaB) of the isolates. Interestingly, 29.4% and 23.5% of isolates had the gtaB gene 
(encoding polysaccharide capsule) and cylR2 (encoding cytolysin which is involved in 
lysing erythrocytes, polymorphonuclear leukocytes and macrophages) respectively which 
are virulent factors normally associated with Bacillus and Enterococcus respectively. 
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Virulence gene Function 
Percentage (%) 
of the mecA 
isolates from 
public areas in 
East and West 
London 
nuc Thermonuclease 100 
sspA  Serine V8 protease enzyme  100 
lip Lipase enzyme 100 
geh Lipase enzyme 100 
sdrG Ser- Asp rich fibrinogen-binding proteins 100 
atl Autolysin  100 
ebp Elastin binding protein  100 
hlb  Beta hemolysin toxin 100 
capB Polyglutamic acid capsule  100 
capC Polyglutamic acid capsule  100 
sdrH Ser-Asp rich fibrinogen-binding proteins  11.8 
sdrF Ser-Asp rich fibrinogen-binding proteins  76.2 
sdrG  Ser-Asp rich fibrinogen-binding proteins  64.7 
sdrE  Ser-Asp rich fibrinogen-binding proteins  11.8 
Ebh  Cell wall-associated fibronectin-binding protein  94.1 
IcaA Intercellular adhesion proteins  47.1 
icaB Intercellular adhesion proteins  47.1 
icaC Intercellular adhesion proteins  47.1 
icaD  Intercellular adhesion proteins  47.1 
icaR  Intercellular adhesion proteins  47.1 
esaA Type VII secretion system  23.6 
essA Type VII secretion system  23.6 
essB Type VII secretion system  23.6 
essC Type VII secretion system  23.6 
esaB Type VII secretion system  5.9 
gtaB  polysaccharide capsule 29.4 
cylR2 Cytolysin 23.5 
Table 4.2: Percentage of Virulence genes found in the 17 mecA+ S. epidermidis recovered 
from East and West London 
A hierarchy clustering heatmap was used to group the virulence genes if they were 
isolated from public areas in hospitals in East or West London (Figure 4.1). Interestingly, 
isolates that had the icaA, icaB, icaC, icaD and icaR were from West London hospital 















Figure 4.1: Hierarchy clustering heatmap of isolates virulence gene profiles in comparison to the area they were recovered from. (A)Hierarchy 


















































































4.3.3 Horizontal gene transfer in isolates recovered from public settings in East and 
West London 
Horizontally transferred genes were determined in 17 mecA+ S. epidermidis isolates from 
public setting using the HGTector pipeline. 8.6% to 10.1% of the S. epidermidis isolates 
from public setting genes are considered to be horizontally transferred based on BLAST 
hit distribution patterns from NCBI non-redundant protein sequences database (Pruitt et 
al., 2007; Zhu et al., 2014) (Table 4.3). In comparison, reference isolate S. epidermidis 
ATCC 1228 recovered from human skin and mucosa was shown to have 8.6% of its gene 
to be horizontally transferred. 118 genera were predicted to be donors of HGT from the 
17  mecA+ S. epidermidis isolate recovered from public settings in London based on best 
hit of the non-redundant protein sequences database and NCBI taxonomy database of 
which Bacillus (mean n=34), Macrococcus (mean n=20) and Salinicoccus (mean n=19) 









Percentage (%) of 
HGT derived 
genes 
ATCC 12228 2416 208 8.6 
321 2420 233 9.6 
327 2419 231 9.6 
329 2417 228 9.5 
355 2308 208 9.0 
407 2257 176 7.8 
435 2453 248 10.1 
436 2264 200 8.8 
465 2267 194 8.6 
475 2276 209 9.2 
631 2250 216 9.6 
664 2330 230 9.9 
673 2276 208 9.1 
711 2423 231 9.5 
712 2422 230 9.5 
713 2421 231 9.5 
715 2388 219 9.2 
716 2417 230 9.5 
Table 4.3: Number of HGT genes predicted from the HGTector pipeline in mecA+ S. 
epidermidis from East and West London and reference genome S. epidermidis ATCC 122
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 S. epidermidis ID 
Predicted donor 
genus ATCC 11228 321 327 329 355 407 435 436 465 475 631 664 673 711 712 713 715 716 
Acidithrix 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 
Actinomyces 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
Aerococcus 1 1 2 2 2 0 2 1 1 1 3 0 2 1 1 1 1 0 
Aeromicrobium 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
Aeromonas 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Amphibacillus 0 0 0 0 3 0 0 0 0 2 0 0 0 0 0 0 0 0 
Amycolatopsis 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
Andreesenia 1 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 
Andreprevotia 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
Aneurinibacillus 0 0 0 0 0 0 1 1 0 0 0 0 1 0 0 0 0 0 
Anthococcus 1 0 0 0 0 0 1 0 1 0 0 1 0 1 1 1 1 1 
Aquibacillus 1 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 
Arachidicoccus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Arcobacter 0 1 1 1 1 0 1 0 0 0 0 1 0 1 1 1 1 1 
Atopostipes 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 
Auricoccucs 4 7 7 6 2 2 5 3 6 5 6 6 6 6 5 5 6 5 
Bacillus 29 33 34 33 29 27 37 29 32 31 30 29 32 40 39 37 40 39 
Beduini 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 
Bhargavaea 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Blautia 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
Brevibacillus 0 1 1 1 1 0 0 2 2 2 0 0 0 0 0 0 0 0 
Caenibacillus 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 
Carnobacterium 2 4 3 3 4 2 4 6 2 2 2 2 2 3 3 2 2 2 
Caryophanon 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
Clostridium 4 3 3 3 4 3 6 3 5 4 4 5 5 3 3 3 3 3 
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 S. epidermidis ID 
Predicted donor 
genus ATCC 11228 321 327 329 355 407 435 436 465 475 631 664 673 711 712 713 715 716 
Collinsella 0 0 0 0 0 0 0 0 0 1 0 2 0 0 0 0 0 0 
Coprobacillus 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 1 
Corynebacterium 0 3 3 3 1 1 1 1 2 1 1 2 2 0 0 0 0 0 
Curtobacterium 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
Cutibacterium 0 1 1 1 2 2 1 0 2 1 1 3 1 3 3 3 3 3 
Deferribacter 0 0 0 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 
Desmospora 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
Desulfosporosinus 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Desulfotomaculum 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 
Dickeya 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
Domibacillus 1 1 1 1 1 1 0 0 0 0 0 1 0 0 0 0 0 0 
Drancourtella 1 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 
Edaphobacillus 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Eikenella 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
Enterobacter 1 7 7 7 6 1 2 2 1 2 3 1 3 2 2 2 2 2 
Enterococcus 16 10 10 10 10 2 11 11 6 11 13 7 13 9 8 8 8 8 
Eremococcus 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
Eubacterium 0 0 0 1 0 0 1 0 0 0 0 1 0 1 1 1 1 1 
Exiguobacterium 0 0 0 0 1 2 1 1 4 0 1 1 0 1 1 1 1 1 
Fictibacillus 2 0 0 0 0 2 2 1 2 2 1 2 1 2 2 2 2 2 
Gallibacterium 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 2 0 1 
Gemella 0 0 0 0 0 0 2 0 0 0 0 0 0 2 2 2 2 2 
Geobacillus 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 
Gracilibacillus 5 1 1 1 0 1 3 1 0 1 1 1 2 1 1 1 2 1 
Halalkalibacillus 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
Halanaerobium 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
Halobacillus 0 0 0 0 1 0 1 0 0 0 0 0 0 1 1 1 1 1 
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 S. epidermidis ID 
Predicted donor 
genus ATCC 11228 321 327 329 355 407 435 436 465 475 631 664 673 711 712 713 715 716 
Halolactibacillus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
Helcococcus 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
Jeotgalibacillus 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
Jeotgalicoccus 8 10 9 10 14 7 8 9 2 9 6 11 6 6 7 7 6 6 
Kurthia 0 0 0 0 0 1 1 0 0 0 0 1 0 1 1 1 1 1 
Kyrpidia 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
Lachnoanaerobaculum 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 
Lachnoclostridium 0 0 0 0 0 1 1 0 1 0 0 0 0 1 1 1 1 1 
Lactobacillus 8 11 11 11 11 8 10 9 8 10 8 10 7 9 10 9 8 10 
Lactococcus 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 
Lentibacillus 0 2 2 2 0 0 1 3 3 0 0 0 0 0 0 0 0 1 
Leptotrichia 0 2 2 2 1 0 0 2 0 0 0 0 0 0 0 0 0 0 
Listeria 2 1 1 1 3 1 3 2 1 0 0 2 2 1 1 2 2 1 
Lysinibacillus 2 6 6 6 3 2 3 2 4 2 2 3 2 1 1 2 2 2 
Macrococcus 19 23 23 23 19 17 21 21 16 18 16 18 16 20 20 20 20 20 
Mannheimia 1 1 1 1 0 0 0 0 0 1 1 1 1 0 0 0 0 0 
Marinilactibacillus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Marinococcus 0 0 0 0 0 0 0 0 1 2 1 0 1 1 1 1 0 0 
Massilibacterium 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 1 0 
Massilioclostridium 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 
Methanobrevibacter 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
Methylocaldum 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
Microvirga 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 
Moraxella 0 0 0 0 0 1 1 0 1 0 0 0 0 1 1 1 1 1 
Neisseria 0 1 1 0 0 0 0 1 0 0 0 0 0 1 1 1 0 1 
Nocardia 2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
Nosocomiicoccus 4 5 5 4 2 2 8 4 4 4 5 3 6 4 3 4 2 4 
 167 
 S. epidermidis ID 
Predicted donor 
genus ATCC 11228 321 327 329 355 407 435 436 465 475 631 664 673 711 712 713 715 716 
Novibacillus 1 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 0 
Numidum 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 1 
Oceanobacillus 4 3 3 3 3 2 8 6 5 5 8 4 7 5 5 5 4 5 
Oenococcus 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 
Oleispira 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
Ornithinibacillus 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Paenibacillus 12 9 9 9 8 11 11 8 10 11 11 14 11 11 12 10 10 10 
Parageobacillus 1 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 
Parvimonas 1 1 1 1 0 0 0 0 0 0 0 0 1 1 0 1 1 1 
Planococcus 5 4 4 4 4 5 3 4 4 5 4 5 5 4 4 4 4 5 
Planomicrobium 0 0 0 1 0 0 1 0 1 0 1 0 0 1 1 1 1 0 
Pontibacillus 2 2 2 2 0 0 2 0 2 2 3 2 2 2 2 2 2 2 
Pseudomonas 5 8 8 8 5 3 3 6 2 5 5 2 5 3 4 4 3 1 
Psychrobacter 1 0 0 0 0 1 0 1 0 0 0 1 0 0 0 0 0 0 
Rhizobium 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 
Rodentibacter 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 
Ruminococcus 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
Rummeliibacillus 1 0 0 0 0 1 1 1 1 2 2 0 2 1 1 1 1 1 
Saccharibacillus 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
Salinicoccus 18 24 24 23 15 20 21 15 13 19 17 20 15 20 19 21 18 18 
Salipaludibacillus 1 0 0 0 0 0 1 0 1 1 1 1 1 1 1 1 1 1 
Sedimentibacter 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
Segetibacter 0 0 0 0 0 1 1 1 1 1 1 1 1 0 0 0 0 0 
Sporolactobacillus 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
Sporosarcina 0 1 1 1 2 2 2 0 2 0 2 0 1 0 0 0 0 0 
Streptococcus 9 14 14 12 11 11 16 11 10 10 9 15 10 21 21 21 19 22 
Streptomyces 1 1 0 1 1 1 3 3 2 3 2 3 4 2 1 2 1 4 
 168 
 S. epidermidis ID 
Predicted donor 
genus ATCC 11228 321 327 329 355 407 435 436 465 475 631 664 673 711 712 713 715 716 
Terribacillus 1 1 1 1 1 0 1 0 0 0 0 0 0 0 1 0 1 1 
Tetragenococcus 1 2 2 2 3 1 4 1 2 1 3 1 3 1 1 1 1 1 
Thalassobacillus 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
Thermoactinomyces 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Thiorhodovibrio 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
Trichococcus 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Tuberibacillus 0 1 1 0 1 0 0 0 0 0 0 0 0 1 1 1 0 1 
Tumebacillus 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 
Vagococcus 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 
Veillonella 8 2 2 2 4 6 3 1 3 1 1 5 2 3 2 2 4 5 
Virgibacillus 2 2 2 2 2 2 2 3 3 3 2 2 3 5 4 5 4 5 
Weissella 1 2 2 2 1 1 1 1 1 1 1 1 1 2 2 2 2 2 
Youngiibacter 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Table 4.4: MecA+ S. epidermidis and reference ATCC 11228 HGT-derived from by the best match putative donor genus as indicated by the best distal 
match.
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13 out of 17 antibiotic resistance genes from the 17 mecA+ S. epidermidis isolates were 
predicted to be horizontally transferred from another bacteria (Table 4.5). The mecA gene 
was predicted in all isolates to be horizontally transferred. The donor species was 
predicted as Macrococcus canis. Interestingly, ermC, AAC(6')-Ie-APH(2'')-Ia, and mupA 
are the only horizontally transferred genes that were predicted to be donated from two 
different species from different organisms. ErmC was found to be transferred from 
Neisseria meningitidis MC58 except for isolate 475 in which it was predicted to be 
donated from Actinomyces spp. S6-Spd3. AAC(6')-Ie-APH(2'')-Ia was predicted to be 
transferred from Enterococcus faecalis V583 except for isolates 631 and 673 which was 
donated from Streptococcus mitis B6. MupA was predicted to be donated by Bacillus 
halmapalus except for isolate 435, 475 and 715 which was donated by Bacillus spp. V-
88. 
S. epidermidis ID. 
Antibiotic resistance 
gene 
Closest predicted donor 
species 
321 mecA Macrococcus canis 
 ermC Neisseria meningitidis MC58 
  ANT(4')-IB Arcobacter thereius 
 qacA/B Bacillus ndiopicus 
 fusB Enterococcus thailandicus 
327 mecA Macrococcus canis 
 qacA/B Bacillus ndiopicus 
 ermC Neisseria meningitidis MC58 
 ANT(4')-IB Arcobacter thereius 
 fusB Enterococcus thailandicus 
329 mecA Macrococcus canis 
 ermC Neisseria meningitidis MC58 
 ANT(4')-IB Arcobacter thereius 
 qacA/B Bacillus ndiopicus 
 fusB Enterococcus thailandicus 
355 mecA Macrococcus canis 
 ANT(4')-IB Arcobacter thereius 
 msrA Veillonella atypica 
 qacA/B Bacillus ndiopicus 
 fusB Enterococcus thailandicus 
407 mecA Macrococcus canis 
 mphC Veillonella atypica 
 msrA Veillonella atypica 
 qacA/B Bacillus ndiopicus 
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S. epidermidis ID. 
Antibiotic resistance 
gene 
Closest predicted donor 
species 
435 mecA Macrococcus canis 
 mupA Bacillus spp. V-88 
 ant(4')-IB Arcobacter thereius 
 AAC(6')-Ie-APH(2'')-Ia Enterococcus faecalis V583 
 fusB Enterococcus thailandicus 
436 mecA Macrococcus canis 
 tet(k) Streptomyces cinnamoneus 
 ermC Neisseria meningitidis MC58 
465 mecA Macrococcus canis 
 mphC Veillonella atypica 
 mrsA Veillonella atypica 
 tet(k) Lactobacillus kimchicus 
 fusB Enterococcus thailandicus 
475 mecA Macrococcus canis 
 ErmC Actinomyces spp. S6-Spd3 
 mupA Bacillus spp. V-88 




 mecA Macrococcus canis 
 qacA/B Bacillus ndiopicus 
 fusB Enterococcus thailandicus 
 vatB Bacillus gottheilii 
 AAC(6')-Ie-APH(2'')-Ia Streptococcus mitis B6 
664 mecA Macrococcus canis 
 ANT(4')-IB Arcobacter thereius 
 qacA/B Bacillus ndiopicus 
673 vgaB Bacillus tuaregi 
 mecA Macrococcus canis 
 qacA/B Bacillus ndiopicus 




 fusB Enterococcus thailandicus 
 vatB Bacillus gottheilii 
 AAC(6')-Ie-APH(2'')-Ia Streptococcus mitis B6 
711 mupA Bacillus halmapalus 
 mecA Macrococcus canis 
 ANT(4')-IB Arcobacter thereius 




 AAC(6')-Ie-APH(2'')-Ia Enterococcus faecalis V583 
712 mupA Bacillus halmapalus 
 mecA Macrococcus canis 
 ANT(4')-IB Arcobacter thereius 
 ermC Neisseria meningitidis MC58 
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S. epidermidis ID. 
Antibiotic resistance 
gene 





 AAC(6')-Ie-APH(2'')-Ia Enterococcus faecalis 
713 mupA Bacillus halmapalus 
 mecA Macrococcus canis 
 ermC Neisseria meningitidis MC58 




 AAC(6')-Ie-APH(2'')-Ia Enterococcus faecalis 
715 ANT(4')-IB Arcobacter thereius 
 mupA Bacillus spp. V-88 




 AAC(6')-Ie-APH(2'')-Ia Enterococcus faecalis 
716 ANT(4')-IB Arcobacter thereius 
 ErmC Neisseria meningitidis MC58 
 mecA Macrococcus canis 




 AAC(6')-Ie-APH(2'')-Ia Enterococcus faecalis 
Table 4.5: HGT antibiotic resistance genes and the predicted donor organism from mecA+ 
S. epidermidis isolates from public areas from East and West London. 
6 out of 28 virulence genes were predicted to be horizontally transferred (Table 4.6). The 
hlb which was ubiquitous in all the mecA+ S. epidermidis isolates from East and West 
London was predicted to be horizontally transferred from Thermoactinomyces spp. In 
isolates 321, 327 and 329 the predicted donor of hlb gene was Thermoactinomyces spp. 
wherein the other isolates the predicted donor was Virgibacillus alimentarius. 
Interestingly, it was predicted the icaA and icaR genes which encode for the intercellular 
adhesion and the essC and the esxA gene which encodes for type VII secretion system to 
be horizontal transferred. The icaR gene was predicted to be donated by 3 species. In 
isolates 435, 711, 713 and 716 icaR were predicted to be donated from Lachnospiraceae 
bacterium C6A11; isolates 436 and 465 were predicted to be donated from Lentibacillus 
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jeotgali and in isolates 712 and 715 were predicted to be donated from Desulfotomaculum 
acetoxidans DSM 771.   
 
S. epidermidis ID gene Closest predicted donor species 
321 essC Listeria booriae 
 esxA Bacillus spp. UNC41MFS5 
 hlb Thermoactinomyces spp. 
 cylR2 Clostridium spp. W14A 
327 essC Listeria booriae 
 esxA Bacillus spp. UNC41MFS5 
 hlb Thermoactinomyces spp. 
 cylR2 Clostridium spp. 
329 essC Listeria booriae 
 esxA Bacillus spp. UNC41MFS5 
 hlb Thermoactinomyces spp. 
 cylR2 Clostridium spp. 
355 essC Listeria booriae 
 esxA Bacillus spp. UNC41MFS5 
 hlb Virgibacillus alimentarius 
 cylR2 Weissella hellenica 
407 hlb Virgibacillus alimentarius 
435 icaA Macrococcus caseolyticus JCSC5402 
 icaR Lachnospiraceae bacterium C6A11 
 hlb Virgibacillus alimentarius 
436 icaA Macrococcus caseolyticus JCSC5402 
 icaR Lentibacillus jeotgali 
 hlb Virgibacillus alimentarius 
465 icaA Macrococcus caseolyticus JCSC5402 
 icaR Lentibacillus jeotgali 
 hlb Virgibacillus alimentarius 
475 hlb Virgibacillus alimentarius 
631 hlb Virgibacillus alimentarius 
664 hlb Virgibacillus alimentarius 
673 hlb Virgibacillus alimentarius 
711 icaA Macrococcus caseolyticus JCSC5402 
 icaR Lachnospiraceae bacterium C6A11 
 hlb Virgibacillus alimentarius 
712 icaA Macrococcus caseolyticus JCSC5402 
 icaR Desulfotomaculum acetoxidans DSM 771 
 hlb Virgibacillus alimentarius 
713 icaA Macrococcus caseolyticus JCSC5402 
 icaR Lachnospiraceae bacterium C6A11 
 hlb Virgibacillus alimentarius 
715 icaA Macrococcus caseolyticus 
 icaR Desulfotomaculum acetoxidans DSM 771 
 hlb Virgibacillus alimentarius 
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716 icaA Macrococcus caseolyticus JCSC5402 
 icaR Lachnospiraceae bacterium C6A11 
 hlb Virgibacillus alimentarius 
Table 4.6: MecA+ S. epidermidis isolates from public areas from East and West London HGT 
virulence genes and the predicted donor organism. 
4.3.4 Antibiotic resistance and virulence genes carried within a genomic island  
All mecA+ S. epidermidis isolates recovered from East and West London were predicted 
to have multiple genomic islands based on Islandviewer 4 methods (Bertelli et al., 2017) 
(Table 4.7). Interestingly, the mecA gene was predicted to be found on a genomic island 
in 4 of the isolates. For the other isolates, the mecA gene was near a genomic island. 
Antibiotic resistance genes were detected in all isolates except for isolate 407. From these 
17 mecA+ S. epidermidis isolates 2 (11.8%)  had 7  antibiotic resistance genes; 1 (5.9%) 
had 6 antibiotic resistance genes; 4 (23.53%) had 5 antibiotic resistance genes; 1 (5.9%)  
had 4 antibiotic resistance gene; 2 (11.8%) had 3 antibiotic resistance gene;  2  (11.8% ) 
had 4 antibiotic resistance genes, and 1 (5.9%) had 1 antibiotic resistance gene which was 
predicted to be encoded within a genomic island regions. The most common antibiotic 
resistance gene detected within genomic island regions were blaZ (n=10); qacA/B and 
AAC(6')-Ie-APH(2")-Ia (n=7); ANT(4")-Ib (n=6); ermC (n=5); mupA (n=4); vatB, vgaA, 
ANT(4")-Ib (n=2) and then fusB and tet(K) (n=1). The cylR2 gene in isolate 321, 327 and 










S. epidermidis ID 
No. of Predicted 
genomic island 
regions Antibiotic genes 
Virulence 
genes 
321 8 qacA/B cylR2 
  ANT(4")-Ib  
327 11 ermC cylR2 
  qacA/B  
329 10 qacA/B cylR2 
355 5 fusB cylR2 
  qacAB  
  ANT(4")-Ib  
407 4   
435 7 blaZ  
436  ErmC  
  tetK  
  blaZ  
465 5 blaZ  
475 4 blaZ  
  mecA  
  mupA  
  blaZ  




  qacA/B  
  ANT(4')-Ib  
  ermA  
  blaZ  
664 5 qacA/B  
  ANT(4')-Ib  
673 7 AAC(6')-Ie-APH(2")-Ia  
  vgaB  
  ermA  
  vatB  
  tet(k)  
  qacA/B  
  blaZ  
711 10 cat  
  AAC(6')-Ie-APH(2")-Ia  
  blaZ  
  mupA  
  ermC  
712 8 mecA  
  AAC(6')-Ie-APH(2")-Ia  
  cat  
  ermC  
  mupA  
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S. epidermidis ID 
No. of Predicted 
genomic island 




713 7 cat  
  blaZ  
  ermC  
  AAC(6')-Ie-APH(2")-Ia  
  mecA  
715 7 AAC(6')-Ie-APH(2")-Ia  
  mupA  
  ANT(4')-Ib  
  mecA  
  blaZ  
716 8 cat  
  AAC(6')-Ie-APH(2")-Ia  
  blaZ  
  ermC  
  ANT(4')-Ib  
Table 4.7: Genomic islands of 17 mecA+ S. epidermidis isolates from East and West London 
4.3.5 Antibiotic and virulence resistance genes carried on plasmids  
All mecA+ S. epidermidis (n=17) isolates recovered from East and West London 
possessed plasmids (ranging from 1 to 4) (Table 4.8). 15 of the 17 isolates carried one 
resistance gene. Three isolates (17.7%) had 5 antibiotic resistance genes carried on their 
plasmids; 3 isolates (17.7%) had 4 antibiotic resistance gene; 6 isolate (35.3%) had 3 
antibiotic resistance genes, 2 isolates had 2 antibiotic resistance gene, 1 isolate had 1 
antibiotic resistance gene and 2 isolates had 2 antibiotic resistance genes carried on their 
plasmids. Two isolates had more antibiotic resistance genes encoded on their plasmids 
than their chromosome (isolates 321 and 435).  Up to 4 antibiotic resistance genes were 
carried on a single plasmid. ErmC and ant(4’)-Ib (n=10) was the most common resistance 
genes to be carried on a plasmid followed by qacA/B, cat, and fusB (n=5); then blaZ (n=4); 
mupA (n=3); AAC(6’)-le—APH(2”)-la, mphC and msrA (n=1). No virulence genes were 
identified to be carried on the plasmids. Interestingly, blaZ was not predicted to be 
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donated from a different organism but was identified to be encoded on some of the 







Antibiotic resistance genes (and 
plasmid they are found on) 
321 3 4:5 ermC (plasmid 1) 
blaZ (plasmid 2) 
fusB (plasmid 2) 
ant(4')-Ib (plasmid 2) 
qacA/B (plasmid 2) 
327 2 5:4 blaZ (plasmid 1) 
fusB (plasmid 1) 
ant(4')-Ib (plasmid 1) 
qacA/B (plasmid 1) 
329 2 5:4 blaZ (plasmid 1) 
fusB (plasmid 1) 
ant(4')-Ib (plasmid 1) 
qacA/B (plasmid 1) 
355 4 4:4 fusB (plasmid 1) 
blaZ (plasmid 1) 
qacA/B (plasmid 1) 
ant(4')-Ib (plasmid 1) 
407 2 3:3 mphC (plasmid 1) 
qacA/B (plasmid 1) 
msrA (plasmid 1) 
435 3 3:5 ermC (plasmid 1) 
fusB (plasmid 2) 
AAC(6’)-le—APH(2”)-la (plasmid 2) 
ANT(4’)-Ib (plasmid 2) 
mupA (plasmid 2) 
436 3 8:1 ermC (plasmid 1) 
465 1 7:0 No genes 
475 5 4:2 mupA (plasmid 1) 
ermC (plasmid 2) 
631 3 8:1 ermA (plasmid 1) 
664 3 6:0  
673 3 11:2 ermA (plasmid 1) 
tetK (plasmid 2) 
711 3 7:3 Cat (plasmid 1) 
Ant(4')-Ib (plasmid 2) 
ermC (plasmid 3) 
712 3 7:3 Cat (plasmid 1) 
Ant(4')-Ib (plasmid 2) 
ermC (plasmid 3) 
713 3 7:3 Cat (plasmid 1) 
Ant(4')-Ib (plasmid 2) 








Antibiotic resistance genes (and 
plasmid they are found on) 
715 2 7:3 Cat (plasmid 1) 
mupA (plasmid 2) 
Ant(4')-Ib (plasmid 1) 
716 4 7:3 Cat (plasmid 1) Ant(4')-Ib (plasmid 2) 
ermC (plasmid 3) 
Table 4.8: Number of plasmids and the antibiotic resistance genes carried on plasmids 
found in mecA+ S. epidermidis isolates recovered from East and West London 
4.3.6 Phage prediction 
Phage insertion was identified as a different level of completeness in 17 S. epidermidis 
isolates (Table 4.9). All the phage's insertions, which were considered to be complete, 
were phages that are associated with staphylococci. Interestingly, there was incomplete 
phage's insertion prediction with proteins (protease and integrases) that show homology 
to phages associated with Bacillus; Planktothrix and, Streptococcus. There were no 
antibiotic resistance genes identified within the phage insertion sequence. Of the 17 
mecA+ S. epidermidis isolates from public areas, 1 isolate (5.9%) had 4 phage insertion 
regions, 10 isolates (58.8%) had 3 phage insertion regions and 2 isolates (11.8%) that 
have 2 phage insertion regions and 4 isolates (17.7%) had only 1 phage insertion region. 








Most common phages Completeness 
321 3 Staphylococcus phage StB12 
Staphylococcus phage phi5967PVL 




327 3 Staphylococcus phage StB12 
Staphylococcus phage phi5967PVL 




329 3 Staphylococcus phage StB12 
Staphylococcus phage phi5967PVL 




355 1 Staphylococcus phage StB12 Incomplete 
407 3 Staphylococcus phage 187 
Staphylococcus phage CNPx 




435 3 Staphylococcus phage SPbeta-like 
Staphylococcus phage StauST398-2 




436 2 Staphylococcus phage StauST398-2  




465 1 Staphylococcus phage PT1028 Incomplete 
475 4 Planktothrix phage PaV-LD 
Staphylococcus phage SPbeta-like 
Staphylococcus phage StauST398-2 





631 1 Staphylococcus phage PT1028 Incomplete 
664 2 Staphylococcus phage 187 
Staphylococcus phage CNPx 
Incomplete 
Questionable 
673 1 Staphylococcus phage PT1028 Incomplete 
711 3 Staphylococcus phage PT1028 
Staphylococcus phage 187 




712 3 Staphylococcus phage PT1028 
Staphylococcus phage 187 




713 3 Staphylococcus phage 187 
Staphylococcus phage PT1028 




715 3 Staphylococcus phage 187 
Staphylococcus phage 80 




716 3 Staphylococcus phage PT1028 
Staphylococcus phage phi5967PVL 




Table 4.9: Phage prediction in mecA+ S. epidermidis isolates from public areas from 
hospitals from East and West London 
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4.3.6 Phylogenetic analysis 
Phylogenetic analysis was performed to determine the relatedness of environmental 
isolates in this study with those recovered from other sources, including clinical isolates. 
In this study, 17 mecA+ S. epidermidis isolates recovered from East and West London 
were compared to WGS reference and draft isolates from the ENA database that was 
recovered from clinical  samples (n=34); healthy humans (n=9), livestock (cows, pigs and 
sheep) and rodents (n=15), plant isolates recovered from rice (n=4), hospital environment 
from wards (n=7), livestock housing environment (n=2) and natural environment  (n=2). 
MecA gene was present in 59 out of 90 isolates studied. From the core SNP phylogenetic 
tree, two distinctive clades were identified (Figure 4.2). Four isolates from East London 
hospital (321, 327, 329 and 355) belong in clade A whereas 1 East London isolate (407) 
was identified in clade B together with all (n= 12) West London isolates. Interestingly, 
all clinical isolates from ENA database except for VCU128 found in human airways were 
found to be in clade B. S. epidermidis isolates obtained from the ENA database recovered 
from human, animal and environmental were found on both clades where S. epidermidis 
isolates from the ENA database from plants (all rice seeds) were found only in clade A. 
Public setting isolates 355 were genetically related to ENA database isolates recovered 
from healthy humans (MRSE 52-2 and NIHLM057); isolate 407 was genetically related 
to isolates recovered from cow (Y24), pig (PR246B0) and animal housing (M01 and 
M025) and isolates whereas 435, 436, 465, 475, 631, 673, 711, 712, 713, 715 and 716 
were genetically related to isolates from the ENA database recovered from clinical 
samples from blood and an endotracheal tube biofilm of a mechanically ventilated patient 
(ET-0240). 321 327 and 329 from East London Hospital were shown to be not closely 
related to any other isolate. The majority of the isolates that were phylogenetically related 
to isolates recovered from public setting in London carried the mecA gene. Interestingly, 
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there was a phylogenetic clustering of isolates, which were ST2 and ST5 but were broken 
up by isolates 435 (ST118) and isolates 631 and 673 (ST87) respectively.   
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Figure 4.2: SNP core phylogenetic tree of 90 S. epidermidis isolates recovered from different 
sources. ST= MLST sequence type; UT=untypable. Red isolate background indicates 
A 
B 
Time scale 0.1 
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mecA+ S. epidermidis isolates from public settings in East and West London. Red Labels 
are mecA+ isolates from public setting from East and West London.  
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PopPUNK analyses revealed there were 31 groups by their combined core and accessory 
genome. The accessory genome t -SNE analyses set at the perplexity of 20 showed that 
there were 5 distinct clusters with two groups showing a mixed group of isolates 
belonging to different combined clusters (Figure 4.3). No cluster had a single multilocus 
sequence type. In this study, mecA+ S. epidermidis isolates recovered from East and West 
London were found in many different clusters. The accessory genome of mecA+ S. 
epidermidis isolates was related to isolates from the ENA database recovered from 
clinical samples from blood, airways and cerebrospinal fluid, endotracheal tube biofilm 
of a mechanically ventilated patient and central venous catheter; healthy human skin, 
mucosa and airways; from livestock (cows, pigs and sheep), mouse, plants, and natural 
environment. Additionally, cluster 1 had isolates from the ENA database that were 
recovered from a hospital environment in medical wards and isolates recovered from 
clinical blood samples whereas cluster 4 are all isolates from clinical samples (blood) and 




























Figure 4.3: t-SNE analyses of the distance of the accessory genome in 90 S. epidermidis isolates. The analysis was performed using the PopPUNK 
pipeline. A maximum number of mixture components was set at 5 and for perplexity of t-SNE set at 20. (A) Combined cluster from PopPUNK 














































































4.3.7 Pangenomic analysis  
A pangenome analysis was performed using the 90 S. epidermidis isolates used in the 
phylogenetic analysis including the 17 mecA+ S. epidermis isolates from East and West 
London using the Roary pipeline (Page et al., 2015). In total, 8,590 genes were identified, 
of which 930 genes (10.8%) were core. 705 of the genes (8.2%) were soft-core genes (95 
to 99% of isolates have these genes); 1,357 of the genes (15.8%) were shell genes (15 to 
95% of isolates have these genes) and 5,598 genes (65.2%) were cloud genes (≤ 15%). 
From the pangenome analyse, a hierarchy clustering heatmap was constructed on the 
8,590 genes that are present in the pangenome analyse to determine if isolates from the 
same source share the same gene profiles (Figure 4.4). With the S. epidermis isolate that 
were analysed there were no observed difference based on the hierarchy clustering 
heatmap except for isolates recovered from rice seed. 
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Figure 4.4: Hierarchy clustering heatmap of presence and absence of all genes found in 90 S. epidermidis isolates from the pangenome analyse based 






31 antibiotic resistance genes and 36 virulence genes were identified in the isolates in the 
pangenome analysis (Table 4.10 and Table 4.11). Interestingly, norA resistance genes and 
geh and sspB virulence genes were ubiquitous in these isolates. No antibiotic resistance 
genes or virulence genes were unique to mecA+ S. epidermidis isolates in East and West 
London. Antibiotic resistance genes that were only found in a single isolate are fosB3, 
fexA, APH(3’)-IIIa, sat-4a, mepA, mepR, CTX-m-109 and TEM-122. The vatB gene was 
only present in isolates from West London. Virulence genes which were found in single 
isolates were sdrC, sec and sell. FosB3, fexA were found in isolate from the ENA database 
recovered from clinical ward; APH(3’)-IIIa, sat-4a from a healthy human isolate and 
mepA, mepR, CTX-m-109 and TEM-122 from animals. Sec and sell virulence genes were 





List of antibiotic classes Percentage 
( %) 
mecA Penam, monobactam, cephalosporin, 
carbapenem, cephamycin 
65.6 
norA Fluoroquinolone, acridine dye 100.0 




qacA/B Fluoroquinolone 48.9 
blaZ Beta-lactum 80.0 
mupA Muprcion 22.2 
ermC lincosamide, streptogramin, macrolide 25.6 
mphC macrolide phosphotransferase 16.7 
msrA streptogramin, macrolide 20.0 
ANT(4')-Ib aminoglycoside 25.6 
tet(K) Tetracycline 15.6 
dfrG Diaminopyrimidine  3.3 
fusB Fusidic acid 18.9 
fosB3 Fosfomycin 1.1 
fexA Phenicol 1.1 
cfrA oxazolidinone antibiotic, streptogramin 
antibiotic, lincosamide antibiotic, phenicol 
antibiotic, macrolide antibiotic, pleuromutilin 
antibiotic 
5.6 
lnuA Lincosamide 8.9 
APH(3')-IIIa Aminoglycoside 1.1 
SAT-4A Nucleoside antibiotic 1.1 
mgrA peptide 
antibiotic,penam,cephalosporin,acridine 
dye,fluoroquinolone, tetracycline  
24.4 
vgaA streptogramin antibiotic, pleuromutilin 
antibiotic 
2.2 
mepA tetracycline antibiotic, glycylcycline 1.1 
mepR tetracycline antibiotic, glycylcycline 1.1 
CTX-m-109 cephalosporin 1.1 
TEM-122 monobactam, penam, cephalosporin 1.1 
vatB streptogramin antibiotic 2.2 
cat phenicol 12.2 
ermA macrolide, streptogramin, lincosamide 3.3 
isaB pleuromutilin antibiotic, lincosamide 
antibiotic, streptogramin antibiotic 
3.3 
Table 4.10: Resistance genes in the S. epidermidis pangenome
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Virulence gene Function Percentage ( %) 
atl Autolysin 96.7 
ebh Cell wall-associated 
fibronectin-binding protein 
90.0 
ebp Elastin binding protein 93.4 
sdrF Ser-Asp rich fibrinogen-
binding proteins 
38.9 
sdrG Ser-Asp rich fibrinogen-
binding proteins 
66.7 
sdrH Ser-Asp rich fibrinogen-
binding proteins 
80.00 
sspB Cysteine protease 100.0 
geh Lipase 100.0 
lip Lipase 98.9 
sspA Serine V8 protease 97.8 
hlb Beta hemolysin 76.7 
icaA Intercellular adhesion 43.3 
icaB Intercellular adhesion 43.3 
icaC Intercellular adhesion 43.3 
icaD Intercellular adhesion 43.3 
icaR Intercellular adhesion 43.3 
nuc Thermonuclease 95.6 
esaA Type VII secretion system 21.1 
essA Type VII secretion system 20.0 
essB Type VII secretion system 16.7 
essC Type VII secretion system 20.0 
esxA Type VII secretion system 17.8 
cylR2 Cytolysin 8.9 
sdrE Ser-Asp rich fibrinogen-
binding proteins 
6.7 
esaB Type VII secretion system 12.2 
esxB Type VII secretion system 4.4 
esaC Type VII secretion system 3.3 
eno Streptococcal enolase 3.3 
Capsule Polysaccharide capsule 2.2 
capB Polyglutamic acid capsule 100 
capC Polyglutamic acid capsule 100 
gtaB Polysaccharide capsule 7.8 
sdrC Ser-Asp rich fibrinogen-
binding proteins 
1.1 
wbtE LPS 4.44 
clfA Clumping factor A 4. 
sec Enterotoxin C 1.1 
sell Enterotoxin-like L 1.1 
Table 4.11: Virulence genes from 90 S. epidermidis isolates in the pangenome
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A hierarchy clustering heatmap were constructed on the antibiotic resistance genes and 
virulence genes found in these 90 S. epidermidis isolates (Figure 4.5). There was no 
distinct clustering by source or genes for antibiotic resistance genes (Figure 4.5B). 
Interestingly, there was a distinct cluster which can be segregated by their virulence genes 
and isolation source (Figure 4.5A). Cluster A was mainly composed of isolates from ENA 
database recovered from clinical samples (blood and cerebrospinal fluid), natural 
environments, medical wards and a single livestock isolate (SNUC 3608) all of which 
had the icaADBCR operon, encoding the intercellular adhesion proteins for biofilm 
formation. This group contained mecA+ S. epidermidis isolates 435, 436, 465, 711, 712, 
713, 715 and 716 recovered from West London hospital. Cluster C was grouped by the 
essA, essB, essC, esaA, esaB and esxA genes, which encode for type VII secretion system. 
This cluster includes isolates from the ENA database recovered from rodents, rice seeds 
healthy human skin and airways as well as the mecA+ S. epidermidis isolates 321, 327, 
329 and 355 from East London hospital. Cluster B was grouped by the lack of the 
icaADBCR operon or the type VII secretion system genes. This cluster includes isolate 
from the ENA database recovered from clinical samples (blood and urine), livestock (cow, 
pig and sheep); animal housing; groundwater as well as the mecA+ S. epidermidis isolates 


















































































































































Figure 4.5: A hierarchy clustering heatmap analysis of 90 S. epidermidis isolates antibiotic resistance and virulence gene profiles based on their isolation 
source (A) Hierarchy clustered heatmap of antibiotic resistance genes found by source; (B) Hierarchy clustered heatmap of virulence gene by 





















































































































COG family group was identified for core and accessory genome in S. epidermidis (Table 
4.12). Interestingly the core genome showed to have a large portion of the genes which 
have general function prediction only (11.7%) and function unknown (11.1%). For the 
accessory genome, a large portion of the gene's function was for replication, 




Percentage (%) of genes in the 
pangenome 
Function Core Accessory 
Translation, ribosomal structure and biogenesis 9.0 4.4 
RNA processing and modification 0.0 0.0 
Transcription 5.8 7.8 
Replication, recombination and repair 4.1 14.7 
Chromatin structure and dynamics 0.0 0.0 
Cell cycle control, cell division, chromosome 
partitioning 1.0 1.8 
Nuclear structure 0.0 0.0 
Defence mechanisms 1.0 3.9 
Signal transduction mechanisms 2.7 3.6 
Cell wall/membrane/envelope biogenesis 4.0 5.1 
Cell motility 0.1 0.2 
Cytoskeleton 0.0 0.0 
Extracellular structures 0.0 0.0 
Intracellular trafficking, secretion, and vesicular 
transport 1.1 1.2 
Posttranslational modification, protein turnover, 
chaperones 3.5 2.3 
Energy production and conversion 7.8 2.9 
Carbohydrate transport and metabolism 6.7 6.1 
Amino acid transport and metabolism 9.8 8.3 
Nucleotide transport and metabolism 4.9 2.2 
Coenzyme transport and metabolism 5.6 3.0 
Lipid transport and metabolism 2.6 2.4 
Inorganic ion transport and metabolism 5.9 6.3 
Secondary metabolites biosynthesis, transport 
and catabolism 1.7 1.1 
General function prediction only  11.7 12.9 
Function unknow 10.9 9.8 
Table 4.12: COG family of the core and accessory genes in 90 S. epidermidis isolates used in 
pangenome analysis. 
The COG family that was identified for the unique genes found in only the 17 mecA+ S. 
epidermidis isolates from public settings in East and West London was not found in the 
S. epidermidis isolates from the ENA database used in phylogenetic and pangenome 
analysis (Table 4.13). In total, there were 324 functional genes that uniquely found mecA+ 
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S. epidermidis isolates from public settings. Interestingly, 24.4% of these unique 
functional genes were identified to be for replication, recombination and repair 
Gene Function 
Percentage (%) of genes in the pangenome unique to 
S. epidermidis isolates from East and West London 
Translation, ribosomal 
structure and biogenesis 3.8 
Transcription 17.9 
Replication, recombination 
and repair  24.4 
Cell cycle control, cell 
division, chromosome 2.3 
Defense mechanisms  7.5 
Signal transduction 








turnover, chaperones 0.2 
Energy production and 
conversion  2.8 
Carbohydrate transport and 
metabolism 5.8 
Amino acid transport and 
metabolism 1.6 
Coenzyme transport and 
metabolism  2.2 
Inorganic ion transport and 
metabolism  1.8 
General function prediction 
only 11.3 
Function unknown 13.7 
Table 4.13: Unique gene COG family from 17 S. epidermidis isolates recovered from public 
settings in East and West London. 
Comparative analysis of the accessory genes between mecA+ isolates recovered from East 
and West London show that East London isolates had 579 genes that were not found in 
West London isolates whereas East London isolates had 678. For both East and West 
London isolates there was 1 gene that was found in all the isolates recovered from these 
areas. East London had a significantly higher portion of unique genes compared to West 
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London isolates for the COG function cell wall/membrane/envelope biogenesis compared 
with West London isolates (7.7% and 3.8% respectively (P= 0.0027)) and carbohydrate 
transport and metabolism (9.7% and 6.1% respectively (P=0.0158)). West London had a 
significantly higher proportion of unique genes compared to East London unique genes 
for the COG function replication, recombination and repair compared to East London 
isolates (18.3% and 13.4% respectively (P=0.0162)); signal transduction mechanisms 
(3.9% and 1.4% respectively (P=0.0059)) and amino acid transport and metabolism (8.9% 




Percentage (%) of genes in the 
pangenome 
Function East London West London 
Translation, ribosomal structure and biogenesis 2.9 2.7 
RNA processing and modification 0.0 0.0 
Transcription 9.9 9.4 
Replication, recombination and repair 13.4 18.3* 
Chromatin structure and dynamics 0.0 0.0 
Cell cycle control, cell division, chromosome 
partitioning 1.0 1.5 
Nuclear structure 0.0 0.0 
Defence mechanisms 4.5 6.6 
Signal transduction mechanisms 1.4 3.9* 
Cell wall/membrane/envelope biogenesis 7.7* 3.8 
Cell motility 0.1 0.2 
Cytoskeleton 0.0 0.0 
Extracellular structures 0.0 0.0 
Intracellular trafficking, secretion, and vesicular 
transport 1.3 1.9 
Posttranslational modification, protein turnover, 
chaperones 0.3 1.3 
Energy production and conversion 2.1 1.0 
Carbohydrate transport and metabolism 9.7* 6.1 
Amino acid transport and metabolism 5.8 8.9* 
Nucleotide transport and metabolism 1.9 1.8 
Coenzyme transport and metabolism 3.1 2.1 
Lipid transport and metabolism 2.6 1.3 
Inorganic ion transport and metabolism 7.8 8.2 
Secondary metabolites biosynthesis, transport 
and catabolism 2.8 1.4 
General function prediction only  13.0 11.1 
Function unknow 8.6 8.5 
Table 4.14: COG function of genes that were uniquely found in from mecA+ S. epidermidis 
isolates from East London and mecA+ isolates from West London.*= Area where there was 
significantly higher (p=<0.05) percentage of genes for that COG function.
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4.4 Discussion 
4.4.1 MLST of mecA+ S. epidermidis isolates recovered from East and West London 
MLST is still widely used in pathogens to study population genetics and evolution 
(Thomas and Robinson, 2014). MLST data from mecA+ S. epidermidis isolates from 
public settings in East and West London showed a wide range of genetic variability. 
Consistent with previous reports studying ST2 was the most common sequence type 
identified in this study (Deplano et al., 2016; Dong et al., 2018; Widerström et al., 2012). 
In this study isolates that harboured ST2 sequence types were isolated from public areas 
in hospitals. In addition, in this study, two new sequence types designated as ST771 and 
ST779 were identified in isolates recovered from a high frequency touched surfaces from 
a hospital in West London. These results show that are genetic lineages of S. epidermidis 
currently not known about which have the potential to spread antibiotic resistance genes 
within hospitals areas. 
4.4.2 Virulence genes detected in mecA+ S. epidermidis isolates from public areas in 
East and West London 
S. epidermidis has previously been shown to have a large array of virulence genes. One 
of the key virulent factors that have been identified is its ability to produce biofilm which 
helps S. epidermidis adhere to abiotic surfaces (Büttner et al., 2015; Cho et al., 2002; 
Trampuz and Zimmerli, 2005). This virulent factor is encoded by the icaADBC and the 
icaR regulator (Cho et al., 2002). 47.1% of mecA+ isolates from hand-touched surfaces in 
this study, possessed icaADBC operon. Similar data were reported in a hospital from 
Poland which found that 46.9% of the S. epidermidis isolates recovered from air and 
surfaces from surgical theatres and general surgical wards had the icaADBC operon 
(Wojtyczka et al., 2014). Though it was not determined if public setting S. epidermidis 
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isolates have the biofilm phenotype, it was still considered that isolates which have the 
biofilm-producing gene to be a public health risk. Whereas the isolates which lack these 
genes would be considered to be less virulent as biofilm production has been linked to S. 
epidermidis ability to adhere to host cells, invade host immune system as well as being 
more tolerant to several classes of antibiotics (Ghasemian et al., 2012; Kristian et al., 
2008; Otto, 2008)   
 
From this study, the mecA+ S. epidermidis isolates from public settings were found to 
carry genes associated with the type VII secretion system.  These virulent factors have 
been characterised in S. aureus to secrete a nuclease toxin that targets competing bacteria 
as well as protects them against antimicrobial host fatty acids, but this has not been reported in 
S. epidermidis (Cao et al., 2016; Tchoupa et al., 2019). The type VII secretion system is 
encoded by cluster of 12 genes of which four of the genes encode for the membrane-
associated proteins (esaA, essA, essB, and essC); three genes encode for the cytosolic 
proteins (esaB, esaE, and esaG), and five genes encode for the secreted virulence factors 
(esxA, esxC, esxB, esxD, and esaD) (Tchoupa et al., 2019) Interestingly, 6 out of the 12 
type VII secretion system genes were identified in the isolates recovered from East 
London hospital. The 6 genes that were not present in these isolates were two genes that 
encode for the cytosolic proteins (esaE and essG) and four genes that encode for the 
secreted virulence factors (esxC, esxB, esxD, and esaD). Additionally, isolate 321, 327 
and 407 from East London hospital also lacked the esaB gene. Interestingly, all these East 
London hospital isolates all carried the genes which encode for membrane-associated 
proteins. Isolates that lack one of esxA or esxB genes were shown to have a reduced 
virulence (Burts et al., 2008, 2005). This would suggest that these isolates will not be able 
to produce a virulence factor, but it is worrying to see these genes in the first place as it 
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is possible that all genes that are required to cause virulence could be horizontally 
transferred to S. epidermidis.  
Two genes which were identified in 100% of these mecA+ S. epidermidis isolates 
recovered from public setting in East and West London was capB and capC. These genes 
are normally found on the locus with two other genes, capA and capD (Otto, 2012). 
Currently, there are no studies that describe the lack of these genes from the cap locus 
would effects the production of the polyglutamic capsule. Interestingly, capB and capC 
were ubiquitous in isolates included in the pangenome analyses; however, capA or capD 
were not identified. This may be due to lack of references for capA and capD sequences 
to get a sufficient alignment. 
Polysaccharide capsule gene gtaB usually associated with bacillus species virulence was 
identified in 29.4% of the mecA+ S. epidermidis isolates recovered from public settings 
in East and West London. This gene has previously been identified in S. epidermidis in 
sugar metabolism but has not been reported as a virulence factor (Gründling and 
Schneewind, 2007). Therefore, this would suggest that these S. epidermidis mecA+ 
isolates from public settings have a gtaB gene is homolog to that of the Bacillus species 
gtaB gene but has evolved to have a different function. Another noticeable virulence gene 
in these isolates was cylR2 which was predicted to be encoded in 23.5% of the S. 
epidermidis isolates. CylR2 is a virulence gene regulator for the cytolysin operon found 
in Enterococcus spp. but not in staphylococci (Rumpel et al., 2004). Additionally, this 
gene is regulator as part of an 8 gene operon that encodes the cytolysin protein (Shankar 
et al., 2004).   Cytolysin toxin has not been previously reported in S. epidermidis but has 
been reported in S. aureus, therefore, could be horizontally transferred across (Queck et 
al., 2009). As there is no virulence phenotype data in this study, it is not possible to 
determine if these virulence genes are functional.  
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4.4.3 Horizontal transfer of antibiotic resistance and virulence genes 
HGT is an essential mechanism for bacterial survival (Polz et al., 2013). It has been shown 
that bacteria can acquire antibiotic resistance genes and virulence genes via 
transformation, conjugation and transduction. In this study, 17 mecA+ S. epidermidis 
isolates recovered from public areas in East and West London Hospitals were analysed 
for potential HGT, in particular, to evaluate plasmid and prophage insertion into their 
genomes.  
HGT was predicted to range from 8.6% to 10.8% of the total genome of the isolates from 
East and West London. In comparison, this was similar to that of the reference S. 
epidermidis genome ATCC 12288  (8.6%) from healthy human skin and mucosa used in 
this study though it was less than S. aureus isolates (15-20%) (Lindsay, 2010). For S. 
epidermidis there have been no previous genomic studies on the proportions of their 
genome that may have been horizontally transferred. 
 From the 17 mecA+ S. epidermidis isolates it was predicted that a large portion of the 
horizontally transferred genes was predicted to be transferred from Bacillus, 
Macrococcus and Salinicoccus genus. These three genera are quite closely related to 
Staphylococcus as they belong to the same taxonomy order (bacillales) and Macrococcus 
and Salinicoccus are the same taxonomy family (Staphylococcaceae) (Becker et al., 2014; 
Fritze, 2004; Kumar et al., 2015; Kwok, 2003). 
 Interestingly, the mecA gene in all isolates was predicted to be horizontally transferred 
from Macrococcus canis, a bacteria which causes infection in dogs (Mašlaňová et al., 
2018). Previous studies suggest that mecA gene and surrounding chromosomal region 
originated from S. fleurettii genome, although other studies found the mecA gene to be 
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encoded on a plasmid in Macrococcus caseolyticus, an ancestor of staphylococci (Baba 
et al., 2009; Tsubakishita et al., 2010). The HGTector tool explains that the predicted 
donor species should be considered as a "donor link" to describe the direction of gene 
transfer and the relationship between organisms (Zhu et al., 2014). Therefore, it is 
possible that the mecA gene was donated from M. caseolyticus as they have 
phylogenetically been shown to be close relatives to M. canis (Mašlaňová et al., 2018).  
Antibiotic resistance genes and virulence genes, which were found in different mecA+ S. 
epidermidis isolates recovered from public setting in East and West London to have 
different donors. For example, there were two different predicted donor species for 
antibiotic resistance genes ermC in isolate AAC(6')-Ie-APH(2'')-Ia, and mupA and 
virulence gene icaR and hlb. This would suggest that these genes were acquired from 
different ancestors. From the virulence genes that were predicted, not all the genes were 
found within the icaADBC operon. In addition, the genes that encode type VII secretion 
system machinery were predicted as being horizontal transfer. Only icaA of the icaADBC 
operon and essC and esxA of type VII secretion system were predicted to be horizontal 
transferred. IcaA was predicted to be donated from a biofilm-producing Macrococcus 
caseolyticus; a close relative of staphylococci and been previously shown to have DNA 
fragments overlapped between the two genera (Mašlaňová et al., 2018). For essC and 
esxA gene, the predicted donors were Listeria booriae and Bacillus spp. UNC41MFS5 
respectfully. There were no previous reports of the two species to have type VII secretion 
genes before, but they were closely related to known pathogenic species like Bacillus 
subtilus and Listeria monocytogenes (Simeone et al., 2009). The method that was used 
for HGT detection was reported to have an 81.6% precision in predicting genomes. Errors 
in HGT detection can come from database errors and incompleteness, ambiguity in the 
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genomic makeup and phyletic pattern and the difficulties of phylogenetic reconstruction 
(Zhu et al., 2014). 
Plasmids were identified in all isolates which ranged from having 1 to 4 plasmids of 
which 0 to 6 antibiotic resistance genes were carried on these isolates’ plasmids. All the 
antibiotic resistance genes found to be carried on the plasmid in S. epidermidis have been 
identified in other S. epidermidis isolated before as reported on the comprehensive 
antibiotic resistance database except for fusB (Jia et al., 2017). The fusB gene has 
previously been reported to be carried on the S. aureus plasmid pUB101(O’Brien et al., 
2002). This might suggest that these S. epidermidis isolates may have acquired the fusB 
gene by conjugating with S. aureus (LaBreck et al., 2018). Antibiotic resistance genes 
were both identified to be found a plasmid and predicted as being present within a 
genomic island in the same isolates. This is due to the software detecting plasmid DNA 
as foreign compared to the rest of the genome, based on the dinucleotide biased in 8 genes 
or more, identification of a mobility gene and/or codon usage ((Bertelli et al., 2017; 
Bertelli and Brinkman, 2018; Waack et al., 2006). Genes that were predicted to be part 
of a genomic island have always encoded on a plasmid was blaZ, vatB, vgaB, qacA/B, 
AAC(6')-Ie-APH(2") -Ia, mupA and mecA. From these isolates, the mecA should be able 
to identify within a genomic island, but only 4 of the 17 isolates were correctly identified. 
However, the mecA gene was near predicted genomic islands. This would suggest that 
the software identifies mecA and some genes nearby as being native to S. epidermidis. 
Interestingly, little is reported about resistance island in S. epidermidis except for 
SCCmec element (Barbier et al., 2010; Seng et al., 2017b; Xu et al., 2015). Further studies 
into genomic islands would help better understand the epidemiology of S. epidermidis 
and from where they might have acquired antibiotic resistance and virulence genes. 
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In the S. epidermidis isolates from public settings, there was no detectable antibiotic 
resistance gene or virulent genes within prophage insertion regions. This shows that the 
transfer of antibiotic resistance genes in phages in S. epidermidis is rare (Deghorain and 
Van Melderen, 2012). However, phage sequences that show homology to phages that are 
not associated with staphylococci. These incomplete phages insertion sequence were 
shown to have homology to phages associated with Bacillus, Planktothrix and 
Streptococcus. Different phages have shown to have a range of host they can affect from 
a single strain, species, genus or even bacteria in different genera (Ross et al., 2016). 
There are no known phages that can affect Staphylococcus and other bacterial genera. 
Therefore, it is most likely that these sequences are from uncharacterised Staphylococcus 
phages. Of the intact phages inserted into public setting  S. epidermidis isolates the most 
interesting were Staphylococcus phage STB12 which has only been previously reported 
before in S. hominis and S. capitis isolates,  Staphylococcus phage 187 which been 
identified to infect S. aureus and Staphylococcus phage phi5967PVL which also infects 
S. aureus and has previous shown to transfer  the lukS-PV and lukF-PV  genes which 
encodes for Panton-Valentine leukocidin (PVL) toxin in S. aureus. These genes were not 
found in the mecA+ S. epidermidis isolates from public settings.  (Daniel et al., 2007; 
Deghorain et al., 2012; Gutiérrez et al., 2012; M. Zhang et al., 2011).  These findings 
show that Staphylococcus phages can infect and integrated into genomes across the genus. 
Therefore, it is possible for a reciprocal exchange of phages related to S. aureus and CoNS. 
This could indicate that these S. epidermidis isolates from public settings could acquire 
staphylokinases, superantigens, PVL virulent genes that are  horizontally transferred 
between  S. aureus strains via phages (Goerke et al., 2009). Acquiring these genes will 
likely make S. epidermidis more virulent and a more significant risk to public health.  
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4.4.4 Phylogenetic comparison of S. epidermidis isolates recovered from public areas 
in East and West London with reference S. epidermidis isolates from ENA database. 
Previous phylogenetic studies for the core genome S. epidermidis have shown that the 
majority of isolates recovered from healthy humans, clinical isolates, sheep and some 
rodents can be found within one clade whereas the majority of isolates recovered from 
rodents; rice seeds and some isolates recovered from healthy humans can be found within 
a separate clade (Chaudhry and Patil, 2016; Conlan et al., 2012). In this study, there was 
a similar observation except for one isolate recovered from a clinical sample from airways 
(VCU128) was found in a separate clade to the other S. epidermidis isolates recovered 
from clinical samples (blood, cerebral spinal fluid and urine). 
Isolates from the ENA database recovered from cows, pigs, sheep and their housing were 
found in a clade where the majority of the isolates were associated with humans. The 
mecA+ S. epidermidis isolates from public areas from East and West London hospitals 
occupy in both clades showing they are genetically diverse. The majority of these isolates 
recovered from public settings in West London hospitals (711, 712, 713, 715 and 716) 
were shown to be genetically related to clinical isolates recovered from blood,  by their 
core genome as well as their MLST (ST2) which has been reported to be one of the most 
common sequence types found in hospital-acquired infections (Deplano et al., 2016). This 
shows that strains that cause infection on medical wards can be found in public areas in 
hospitals. MecA+ isolate 435, 475, 631 from West London hospital to be genetically 
related to clinical isolates from blood; isolates 436 from west London was genetically 
related to isolate from urine (FDAARGOS-83) and isolate 465 was genetically related to 
isolate recovered from endotracheal tube biofilm of a mechanically ventilated patient 
(ET-024). Additionally, some isolates from the ENA database were recovered from 
livestock, and their housing was genetically related to an isolate which was recovered 
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from public areas in hospitals (407). These isolates belong to the same MLST (ST59), 
which has previously been reported to be both livestock and human-associated sequence 
type (Argudín et al., 2015). The mecA+ public setting isolates were genetically related to 
ENA database isolates from cows which have bovine mastitis (Y24). These findings 
indicate that isolates found in public areas in hospitals could also cause blood infections 
(septicaemia), urinary tract infection in humans and cause bovine mastitis in cows due to 
them being in the same genetic lineage of isolates that have caused these infections. Other 
studies have shown mecA+ S. epidermidis to be a common cause in bovine mastitis and 
been recovered from cows milk (Fernandes Dos Santos et al., 2016; Feßler et al., 2010). 
Additionally, reports have shown that pigs are also a reservoir of mecA+ S. epidermidis 
and there is an indication of strains exchanging between human and pigs by their 
virulence and antibiotic resistance gene profile (Argudín et al., 2015; Tulinski et al., 2012). 
These reports, combined with data from this study, suggest that S. epidermidis is zoonoses 
(spread between animal and humans) and that livestock mecA+ S. epidermidis isolates are 
from the same genetic lineages of the isolates shown to cause infections in humans. It is 
possible that some known isolates that can cause infections in humans originate from 
animals and have been transferred to humans and their associated environment either via 
direct contact with farmers or via food. 
The t-SNE accessory genome analyses show that 2 out of the 5 accessory clusters isolates 
evolutions were different from the predicted combined core and accessory genome. These 
two clusters also have a collection of isolates recovered from different sources where all 
clusters were shown to have many different MLST. This would suggest that isolates that 
have similar core genomes have different accessory genome due to horizontal transfer of 
genes from other organisms that might be present in different isolation sites. Additionally, 
it was observed that all the clusters in S. epidermidis t-SNE analyse had a mixture of 
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isolates that were recovered from many different sources. Though it was observed that a 
cluster (cluster 1) had isolates from the ENA database that were recovered from medical 
wards and from clinical samples and another cluster (cluster 3) to have isolates that were 
only recovered from clinical samples or healthy human skin. This would suggest that 
cluster 1 isolates are only present within hospitals and have not spread outside clinical 
settings and cluster 3 isolates only associated with humans. 
MecA+ isolates that were recovered from public areas in hospitals were shown to be 
similar in the accessory genome to isolates from the ENA database recovered from 
clinical samples (blood, urine and cerebrospinal fluid) from livestock (cow, pigs and 
sheep), mouse, plants, and natural environment. This suggests that MecA+ S. epidermidis 
isolates from public setting likely originated from bacteria species associated with a 
particular niche that has been transmitted to new niche via humans or via food in S. 
epidermidis. Public areas in hospitals could be a place where isolates from different areas 
can mix and horizontally transfer genes to each other from bacteria usually associated 
with a particular environment.  Additionally, virulent factors are typically associated as 
part of the accessory genome in Staphylococcus (Bosi et al., 2016). As findings from this 
study show that isolates from public settings, livestock and plants were genetically related 
in their accessory genome to that of S. epidermidis isolates that have been shown to cause 
septicaemia, urinary tract infection and meningitis it would suggest isolates recovered 
from these environments may also have the potential to cause this infection.  
4.4.5 Pangenome and comparison of antibiotic resistance and virulence genes of 
isolates recovered from public settings with isolates obtained from the ENA 
database 
Pangenome analysis showed that S. epidermidis has a minimal core genome (10.8% of 
the total number of genes) in comparison to S. aureus (19.3% of the total number of genes) 
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(Bosi et al., 2016). Interestingly, there was a large number of genes (65.2%) that were 
only present in ≤15% of the isolates. This suggests that S. epidermidis isolates have an 
open pangenome with many variable genes. There was no predicted clustering by 
presence/absence of genes except for the rice samples. This would suggest that isolates 
from East and West London or other sources in this study do not have a gene or genes 
found in the accessory genome required for survival in a particular niche. 
In pangenome analysis, norA resistance gene and geh and sspB virulence genes were 
found to be part of the core genome. NorA is an efflux transporter that can actively pump 
out quinolone antibiotics, whereas geh encodes for lipase which breaks down fatty acids, 
and sspB encodes for cysteine protease, which is able to breakdown elastin, fibronectin 
and kininogen (Cadieux et al., 2014; Massimi et al., 2002; Yu et al., 2002). It is possible 
that these genes are essential for S. epidermidis survival and may well employ roles other 
than antibiotic resistance and virulence. Interestingly, S. epidermidis can be put into three 
distinct groups by their virulence gene profile. One group had the icaADBCR operon for 
biofilm production but lacked the type VII secretion genes; the second group had the type 
VII secretion genes but lacked the icaADBCR operon and the final group lacked genes 
for both of these virulent factors. Further laboratory studies would be required to 
understand why the S. epidermidis isolate cannot have both the genes that encode biofilm 
production and the type VII secretion system.   
From this study, there were a few antibiotic resistance genes and virulence genes that 
were identified that have not been reported before in S. epidermidis. IsaB antibiotic 
resistance gene has previously been reported in S. sciuri where CTX-m-109 and TEM-122 
have only been reported to be present in Gram-negative bacteria (Kaye et al., 2004; 
Kehrenberg et al., 2004; Zhang et al., 2011). Both CTX-m-109 and TEM-122 encode for 
alternative beta-lactamase (Kaye et al., 2004; Zhang et al., 2011). These last two genes 
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were found in isolates recovered from livestock, suggesting that these genes may be 
unique to this environment. The sdrC virulence gene which encodes for the Ser-Asp rich 
fibrinogen-binding proteins has not been reported before in S. epidermidis, however, the 
known S. aureus virulent gene sell which encodes for Enterotoxin-like L and sec which 
encodes for the Enterotoxin C have been reported in few cases in S. epidermidis (Barbu 
et al., 2010; Madhusoodanan et al., 2011). The two enterotoxin genes have been identified 
to be part of the pathogenicity island SePI were previously identified in clinical S. 
epidermidis isolate FRI909 (Argemi et al., 2018). Though these virulence factors were 
not found in isolates recovered in this study, it is worrying to see virulent genes associated 
with S. aureus which could transform S. epidermidis to possess more aggressive virulence 
determinants contributing to its spread to other environments.  
COG analyses of the core and accessory genome showed there was a large portion of the 
accessory genome genes responsible for replication, recombination and repair (14.8%). 
This was also noted from the unique genes that were only found in the mecA+ S. 
epidermidis isolates recovered from public areas from East and West London (24.4%). 
The large percentage of S. epidermidis isolates genomes from London hospitals that were 
detected as HGT genes suggest that these unique genes are essential for acquiring mobile 
genetic elements as they may contribute to the survival of these organisms on high-
frequency touched surfaces which is not their usual and preferred niche to live on. 
Additionally, in these environments, these isolates might experience reactive oxygen 
species (ROS) that can be found in disinfectants that can cause DNA damage to the 
bacteria cell by damaging protein and DNA (Sheng et al., 2015). Genes that are members 
of this COG group have previously been shown to help repair damage caused by ROS 
and protect the bacteria from disinfectants (Gaupp et al., 2012). There was a significant 
difference between a few of the COG functions found between S. epidermidis isolates 
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from East London hospital and West London hospital. As these isolates were recovered 
from similar areas in hospitals, it was expected that these differences are mainly due to 
horizontal transference of genes from bacteria found in that area than adaption required 
to survive that particular niche.  
4. 5 Conclusion 
In this chapter, public setting mecA+ S. epidermidis isolates from East and West London 
was genetically compared to S. epidermidis isolates recovered from clinical samples 
(blood, cerebrospinal fluid, urine); healthy humans skin, nares and nasopharynx; 
livestock (cows, pigs and sheep); rodents (rats), plants, hospital environment from wards 
and catheters, animal housing and natural environment from the ENA database. From 
phylogenetic analysis, the genetic relatedness of S. epidermidis isolates from public 
settings was determined to that of other isolates from the ENA database. Additionally, 
the antibiotic resistance genes, virulent genes, mobile elements and pangenome were 
compared. From these analyses, there were novel findings. These findings were: 
1. S. epidermidis carried part of Type VII secretion system operon found S. aureus, 
which has not been previously characterised in S. epidermidis. Additionally, Type 
VII secretion genes were only found in isolates lacking the icaADBC operon 
which encodes for biofilm production.  
1. MecA+ S. epidermidis isolates from public areas were shown to carry novel genetic 
elements including phages that only been reported in S. aureus or other CoNS 
isolates. This shows S. epidermidis has the potential of acquiring virulence 
determents from S. aureus, which will make S. epidermidis more virulent. 
2. Many of the mecA+ S. epidermidis isolates from high-frequency touched surfaces 
from East and West London belong to same genetic lineages of isolates from the 
ENA database that can cause blood and urine infection which suggests these 
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isolates are a public threat. Additionally, the mecA+ S. epidermidis isolates from 
public areas in hospitals accessory genome to be related to isolates from the ENA 
database that were recovered from clinical infection associated with septicaemia, 
urinary tract infection and meningitis; livestock (cows, pig and sheep) healthy 
humans and natural environment. This suggests that these areas of the hospital are 
a mixing area of different genetic lineages of S. epidermidis in which they could 
horizontally transfer genes that may be associated to a particular niche to another 
S. epidermidis isolate. 
3. MecA+ isolates from public setting had more unique genes compared to isolates 
from ENA database that encode for replication, recombination and repair. This 
may be due to ROS that can be found in disinfectants that can cause DNA damage 
to the bacteria cell by damaging protein and DNA. 
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Chapter 5: Comparative genomics of mecA positive S. haemolyticus isolates 
recovered from public settings using the One Health approach; determining 
horizontal gene transfer in these isolates  
5.1. Introduction 
Staphylococcus haemolyticus is an emerging opportunistic pathogen, primarily isolated 
from neonatal patients and care units (Pereira et al., 2014). Like S. epidermidis, S. 
haemolyticus can produce biofilm (Fredheim et al., 2009). Additionally, S. haemolyticus 
can produce a capsule similar to S. aureus, which protects the bacteria from phagocytosis 
(Flahaut et al., 2008). Previous studies have demonstrated this bacterium recovered from 
both clinical and environmental sources can harbour multidrug resistance genes (Barros 
et al., 2012; Seng et al., 2017b; Xu et al., 2015). However, little is known about the genetic 
diversity and molecular epidemiology of S. haemolyticus recovered from general public 
settings. 
5.2 Method 
In this chapter, comparative genomic analyses were performed on the mecA+ S. 
haemolyticus isolates from public settings from East and West London. This included 
identification of horizontal gene transfer (HGT) within the genome and the potential 
donor organisms of horizontally transferred antibiotic resistance and virulence genes. 
Additionally, it was investigated if virulence or antibiotic resistance genes were 
transferred via plasmids, phages or by other mobile genetic elements. A phylogenetic tree 
was constructed to determine the genetic relationship of mecA+ isolates from this study 
with S. haemolyticus isolates using reference and draft WGS isolates from the European 
Nucleotide Archive (ENA) database that were previously recovered from different 
sources, including isolates recovered from clinical samples (eye, blood, sputum, colon), 
healthy humans skin and nares, eye; livestock (cows) and companion animal (dog), 
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hospital environment from central venous catheters, various public settings and from the 
natural environment, including from plants. In addition, a pangenome was constructed to 
identify the core and accessory genes in the genome. It was compared Clusters of 
Orthologous Groups (COG) function family of the unique genes found in mecA+ S. 
haemolyticus isolates collected from public settings in East and West London, general 
public settings and in public areas in hospitals.  
5.3 Results 
5.3.1 Identification of virulence genes in S. haemolyticus isolates recovered from 
public settings in East and West London 
11 virulence genes were identified in the 10 mecA+ S. haemolyticus isolates recovered 
from public settings from East and West London (Table 5.1). These included: the ebp 
gene (encoding elastin binding protein involved in bacterial adhesion); the lip gene 
(encoding lipase enzyme which is involved in the detachment of bacterial cells from 
colonised sites); the atl gene (encoding autolysin involved in bacterial adhesion); capsule 
genes (involved in immune invasion); the capB and capC genes (encoding polyglutamic 
acid capsule for immune invasion), the nuc gene (encoding thurmonuclease an enzyme 
that can hydrolyse the host cell DNA and RNA) and the cylR2 gene (encoding cytolysin, 
which is involved in lysing erythrocytes, polymorphonuclear leukocytes and 
macrophages). In addition, the wbtP gene (encoding for lipopolysaccharide modification 
in Francisella spp. essential for immune invasion) and the sdrC gene (encoding Ser-Asp 
rich fibrinogen-binding proteins which are involved in bacterial adhesion) were found in 
20% of the isolates and the clfB gene (encoding clumping factor B which is involved in 
adhesion) were found in 10% of the isolates. Interestingly, all isolates had two capsule 
genes except for isolates 445 and 538, which had 14 capsule genes. It was also identified 
that there were two copies cylR2 genes in sample 93, 373, 445 and 492. A hierarchical 
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cluster heatmap of public setting isolates shows there was no clustering of isolates based 
on location i.e. if they were recovered from West London or East London or general 
public settings or public areas in hospitals for virulent gene profiles (Figure 5.1). 
Virulence genes Function 
Percentage (%) of 
the mecA isolates 
from public areas 
East and West 
London 
nuc Thermonuclease 100 
lip Lipase enzyme 100 
capsule Capsule genes 100 
atl Autolysin  100 
ebp Elastin binding protein  100 
capB Polyglutamic acid capsule  100 
capC Polyglutamic acid capsule  100 
cylR2 Cytolysin enzyme 100 
wbtp lipopolysaccharide modification 20.0 
sdrC Ser-Asp rich fibrinogen-binding proteins 20.0 
clfB clumping factor B 10.0 
Table 5.1: Percentage of Virulent genes found in the 10 mecA+ S. haemolyticus from East 
and West London 
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Figure 5.1: Hierarchy clustering heatmap of virulence genes found in mecA+ S. haemolyticus isolates recovered from public setting in East and West 


































5.3.2 Horizontal gene transfer events identified in whole genome sequenced S. 
haemolyticus isolates recovered from public settings from East and West London  
Horizontal Gene Transfer (HGT) was detected in the 10 mecA+ S. haemolyticus isolates 
from public settings in East and West London using the HGTector pipeline (Table 5.2). 
It was predicted that 8.9% to 11.2% of the isolate's genome were HGT-derived genes in 
comparison to the reference isolate JCSC 1435 recovered from humans skin in which 
13.5% of its genome was predicted to be horizontally transferred based on BLAST hit 
distribution patterns from NCBI non-redundant protein sequences database (Pruitt et al., 
2007; Zhu et al., 2014). One hundred and four genera were predicted to be donors for the 
mecA+ S. haemolyticus isolates from those examined in this study based on the best hit of 
the non-redundant protein sequences database and NCBI taxonomy database. The highest 
portion of these genes predicted to be donated from Bacillus (mean n=31); Salinicoccus 










JCSC 1435 2555 345 13.50 
1 2344 221 9.43 
93 2370 223 9.41 
99 2575 228 8.85 
105 2349 264 11.24 
361 2418 224 9.26 
373 2290 217 9.48 
445 2403 264 9.32 
492 2295 214 9.32 
506 2380 217 9.12 
538 2399 252 10.50 
Table 5.2: Number of HGT genes in mecA+ S. haemolyticus isolates from East and West 









1435 1 93 99 105 361 373 445 492 506 538 
Aeribacillus 0 1 1 1 0 1 0 2 1 1 1 
Aerococcus 2 1 0 1 1 1 0 1 2 2 1 
Alicyclobacillus 1 1 1 1 1 2 1 2 1 1 1 
Alkalibacter 1 0 0 0 0 0 0 1 0 0 1 
Alkalibacterium 0 0 0 0 0 1 0 0 0 0 1 
Amphibacillus 0 0 0 0 0 0 0 0 2 0 0 
Anaerovorax 0 1 0 0 1 0 0 0 0 0 0 
Aneurinibacillus 2 2 2 2 2 2 2 2 2 2 2 
Anoxybacillus 1 0 1 0 0 1 1 1 0 0 0 
Anthococcus 0 1 1 0 1 0 0 0 1 0 0 
Atopobacter 1 1 1 1 1 1 1 1 1 1 1 
Auricoccucs 3 9 6 7 8 4 3 3 6 3 4 
Avibacterium 1 1 1 1 1 1 1 1 0 1 1 
Bacillus 36 26 32 31 29 32 31 40 27 34 32 
Blautia 1 1 0 2 1 1 0 1 0 1 0 
Brevibacillus 6 5 6 6 5 6 7 5 4 6 6 
Caenibacillus 1 0 0 0 0 0 0 0 1 0 0 
Caloramator 1 0 0 0 0 0 0 1 0 0 1 
Carnobacterium 7 4 5 5 4 5 5 7 4 6 7 
Caryophanon 0 0 0 0 0 0 0 0 1 0 0 
Clostridioides 0 0 0 0 0 0 0 0 0 1 0 
Clostridium 8 4 4 4 4 4 4 7 6 4 6 
Corynebacterium 8 1 3 2 1 0 1 1 1 3 2 
Cupriavidus 0 0 0 0 0 0 0 0 0 0 1 
Cutibacterium 1 1 1 1 1 3 1 4 2 4 3 
Desulfitobacterium 1 0 0 0 0 0 0 0 0 0 0 
Domibacillus 2 1 2 1 1 1 1 0 1 0 0 
Effusibacillus 0 0 0 0 0 0 0 0 1 0 0 
Enterobacter 0 0 0 0 0 0 1 0 0 0 1 
Enterococcus 34 8 9 7 8 6 9 9 11 12 7 
Eremococcus 0 0 0 0 0 0 0 1 0 0 0 
Erysipelatoclostridium 1 1 0 1 1 1 0 1 0 0 0 
Eubacterium 0 0 0 0 0 0 0 1 0 0 0 
Exiguobacterium 0 1 0 1 1 2 0 2 2 1 2 
Faecalicatena 0 0 1 1 0 0 0 0 0 0 0 
Faecalitalea 1 0 0 1 0 0 0 1 0 0 0 
Fructobacillus 0 0 0 0 0 0 0 0 0 0 1 
Gemella 1 0 0 0 0 0 0 0 0 0 0 
Gemmiger 1 0 1 1 0 1 1 1 0 1 0 
Geobacillus 2 0 0 0 1 0 1 1 0 0 1 
Globicatella 0 0 0 1 0 0 0 0 0 1 0 
Gracilibacillus 1 1 1 1 1 1 1 3 1 3 3 
Haemophilus 1 0 1 1 0 1 1 1 1 1 1 
Halarchaeum 0 0 1 0 0 1 1 1 0 1 1 
Halobacillus 1 0 0 3 0 1 0 0 2 0 0 
Halobacterium 0 1 0 1 1 0 0 0 0 0 0 
Halolactibacillus 0 0 0 1 0 0 0 0 0 0 0 
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1435 1 93 99 105 361 373 445 492 506 538 
Helcococcus 1 0 0 0 0 0 0 1 0 0 1 
Jeotgalibaca 1 1 1 1 1 2 1 1 1 1 1 
Jeotgalibacillus 1 0 0 0 0 0 0 0 0 0 0 
Jeotgalicoccus 14 16 13 17 16 16 13 11 12 9 11 
Kurthia 4 3 2 1 3 3 3 2 2 1 3 
Kutzneria 0 0 0 1 0 0 0 0 0 0 0 
Lacimicrobium 1 0 0 0 0 0 0 1 0 0 1 
Lactobacillus 7 8 8 10 8 8 10 9 2 7 8 
Lactococcus 0 0 1 1 0 0 1 1 0 0 0 
Leptotrichia 1 1 1 1 1 1 1 1 2 1 1 
Listeria 8 6 6 4 6 6 6 8 6 5 8 
Loktanella 0 0 0 0 0 1 0 0 0 0 0 
Lysinibacillus 11 8 12 9 8 9 11 9 8 9 11 
Macrococcus 25 19 21 30 20 19 23 27 19 17 27 
Maribacter 0 0 0 0 0 1 0 0 0 0 0 
Marinilactibacillus 1 1 1 1 1 1 1 1 0 1 1 
Marinococcus 0 0 0 1 0 0 0 0 0 1 1 
Mycoplasma 0 0 0 0 0 2 0 0 0 0 0 
Nosocomiicoccus 8 2 2 2 2 3 3 7 5 0 7 
Novibacillus 0 1 0 0 0 1 1 1 1 0 1 
Oceanobacillus 6 10 9 13 10 10 9 8 6 8 6 
Ochrobactrum 1 1 1 2 1 2 1 1 2 1 1 
Oenococcus 0 1 0 0 1 0 0 0 0 0 0 
Oscillibacter 0 0 0 1 0 0 0 0 0 1 0 
Paenibacillus 8 9 6 9 7 8 7 10 6 10 10 
Paucisalibacillus 1 0 1 1 1 0 0 0 0 1 0 
Pediococcus 1 0 0 0 0 1 0 2 2 1 0 
Peptoclostridium 1 1 1 1 1 1 1 1 1 1 1 
Peptoniphilus 1 0 0 0 0 1 0 1 0 1 1 
Planococcus 1 2 2 3 2 4 3 1 2 3 1 
Planomicrobium 1 2 2 1 1 1 1 1 2 2 0 
Pseudomonas 23 1 1 2 1 1 1 2 1 0 4 
Rheinheimera 1 1 1 1 1 1 1 1 0 1 1 
Rhizobium 1 1 0 1 1 1 0 2 1 2 1 
Rhodococcus 0 1 0 1 1 1 0 0 1 1 1 
Saccharomonospora 0 0 1 0 0 0 1 1 0 0 0 
Salinicoccus 35 23 21 24 25 17 18 23 24 20 24 
Salsuginibacillus 1 0 0 0 1 0 0 0 1 1 0 
Selenomonas 0 1 1 1 1 0 1 0 0 0 1 
Sharpea 0 0 1 0 0 0 1 0 0 0 0 
Solibacillus 0 0 0 0 0 0 0 0 1 0 0 
Sporosarcina 0 0 1 1 1 1 0 0 3 0 0 
Streptococcus 11 9 9 11 9 9 9 9 9 8 10 
Streptomyces 1 2 0 2 2 0 0 0 0 3 0 
Terribacillus 1 2 2 1 2 0 2 1 1 0 1 
Tetragenococcus 4 1 1 1 1 2 2 2 1 2 4 
Thalassobacillus 0 0 0 0 0 0 0 0 1 0 0 
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1435 1 93 99 105 361 373 445 492 506 538 
Thermoactinomyces 2 0 2 0 0 2 2 2 0 0 0 
Tissierella 0 1 0 0 1 0 0 0 0 0 0 
Tolumonas 1 1 0 0 1 0 0 0 0 1 0 
Trichococcus 2 0 1 1 0 1 1 2 0 1 3 
Tuberibacillus 0 0 0 0 0 0 0 0 1 0 0 
Vagococcus 1 2 1 3 2 3 1 1 1 0 0 
Veillonella 2 2 0 0 2 1 0 3 2 0 0 
Virgibacillus 2 2 1 0 2 0 1 1 2 1 4 
Viridibacillus 1 0 1 0 0 1 1 1 1 1 1 
Weissella 2 3 3 2 3 3 3 3 2 2 3 
Table 5.3: MecA+ S. haemolyticus and reference JCSC 1435 HGT-derived from by the best 
match putative donor genus as indicated by the best distal match. 
13 out of 14 antibiotic resistance genes in mecA+ S. haemolyticus isolates in this study 
were predicted to be horizontally transferred (Table 5.4). The only gene not predicted to 
be horizontally transferred was blaZ. Antibiotic resistance gene AAC(6')-Ie-APH(2'')-Ia 
and APH(3')-IIIa were predicted to be donated by a different organism in different 
isolates. AAC(6')-Ie-APH(2'')-Ia was predicted to be donated by 3 species in isolate 1, 93, 
99, 105. These species were Clostridiales bacterium VE202-16, Streptococcus mitis B6 
and Enterococcus faecalis V583. APH(3')-IIIa was predicted to be donated by 2 species 










S. haemolyticus ID. 
Antibiotic resistance 
genes Predicted donor organism 
1 ANT(4')-Ib Arcobacter thereius 
 MecA Macrococcus canis 
 lnuA Lactobacillus johnsonii 
 AAC(6')-Ie-APH(2'')-Ia Clostridiales bacterium VE202-16 
 tet(k) Streptomyces cinnamoneus 
 dfrG Vagococcus teuberi 
93 AAC(6')-Ie-APH(2'')-Ia Streptococcus mitis B6 
 mecA Macrococcus canis 
 dfrG Vagococcus teuberi 
 APH(3')-IIIa Streptococcus mitis B6 
99 lnuA Lactobacillus johnsonii 
 AAC(6')-Ie-APH(2'')-Ia Enterococcus faecalis V583 
 mecA Macrococcus canis 
 dfrG Vagococcus teuberi 
 APH(3')-IIIa Enterococcus faecium DO 
 tet(k) Streptomyces cinnamoneus 
105 ANT(4')-Ib Arcobacter thereius 
 lnuA Lactobacillus johnsonii 
 AAC(6')-Ie-APH(2'')-Ia Clostridiales bacterium VE202-16 
 mecA Macrococcus canis 
 tet((k) Streptomyces cinnamoneus 
 dfrG Vagococcus teuberi 
361 fusB Enterococcus thailandicus 
 mecA Macrococcus canis 
 qacA/B Bacillus ndiopicus 
373 dfrG Vagococcus teuberi 
 mecA Macrococcus canis 
 fusB Enterococcus thailandicus 
445 mphC Veillonella atypica 
 msrA Veillonella atypica 
 mecA Macrococcus canis 
 vgaA Aeribacillus pallidus 
 qacA/B Bacillus ndiopicus 
492 mphC Veillonella atypica 
 mecA Macrococcus canis 
 msrA Veillonella atypica 
506 qacA/B Bacillus ndiopicus 
 mecA Macrococcus canis 
 ermA Enterococcus spp. HMSC29A04 
 tet(K) Streptomyces cinnamoneus 
538 qacA/B Bacillus ndiopicus 
 mecA Macrococcus canis 
 fusB Enterococcus thailandicus 
Table 5.4: MecA+ S. haemolyticus isolates from public settings in East and West London and 
reference S. haemolyticus isolate JCSC 1435 HGT-derived genes by their putative donor 
genus as indicated by the best distal match. 
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Only 3 virulence genes were predicted to be horizontally transferred (Table 5.5). 
Interestingly the cylR2 gene, which was found in all the isolates were also predicted to be 
horizontally transferred. 9 of the 14 predicted capsule genes in isolates 445 and 538 were 
predicted to be horizontally transferred. 4 of the 9 capsule genes that were horizontally 
transferred were predicted to be donated by Nosocomiicoccus genus, whereas the other 3 
capsules genes were predicted to be donated by Listeria grayi DSM 20601 and the other 




ID genes Predicted donor species 
1 cylR2 Virgibacillus spp. SK37 
 cylR2 Streptococcus spp. HMSC10A01 
93 cylR2 Streptococcus spp. HMSC10A01 
99 cylR2 Streptococcus spp. HMSC10A01 
105 cylR2 Virgibacillus spp. SK37 
 cylR2 Streptococcus spp. HMSC10A01 
361 cylR2 Streptococcus spp. HMSC10A01 
373 cylR2 Streptococcus spp. HMSC10A01 
445 Capsule Nosocomiicoccus spp. HMSC067E10 
 Capsule Listeria grayi DSM 20601 
 Capsule Nosocomiicoccus spp. HMSC059G07 
 Capsule Nosocomiicoccus ampullae 
 Capsule Listeria grayi DSM 20601 
 Capsule Caloramator mitchellensis 
 Capsule Listeria grayi DSM 20601 
 Capsule Bacillus massilionigeriensis 
 Capsule Nosocomiicoccus spp. HMSC09A07 
 CylR2 Streptococcus spp. HMSC10A01 
492 cylR2 Streptococcus gordonii str. Challis substr. CH1) 
506 cylR2 Streptococcus spp. 2_1_36FAA 
538 wbtP Lacimicrobium spp. SS2-24 
 cylR2 Streptococcus spp. HMSC10A01 
 cylR2 Virgibacillus spp. SK37 
 Capsule Nosocomiicoccus spp. HMSC09A07 
 Capsule Bacillus massilionigeriensis 
 Capsule Listeria grayi DSM 20601 
 Capsule Caloramator mitchellensis 
 Capsule Listeria grayi DSM 20601 
 Capsule Nosocomiicoccus ampullae 
 Capsule Nosocomiicoccus spp. HMSC059G07 
 Capsule Listeria grayi DSM 20601 
 Capsule Nosocomiicoccus spp. HMSC067E10 
Table 5.5: Horizontally transferred virulence genes in mecA+ S. haemolyticus isolates 
recovered from public areas from East and West London 
5.3.3 Antibiotic resistance genes carried within a genomic island in mecA+ S. 
haemolyticus from public settings in East and West London 
Genomic islands were predicted in the 10 mecA+ S. haemolyticus isolates from East and 
West London based on the Islandviewer 4 method (Table 5.6). All samples were predicted 
to have regions in their genome that were considered as genomic islands. Interestingly, 
 223 
the mecA gene was not predicted within a genomic island via this method but the mecA 
gene was found in near a predicted genomic island. Out of this 10 S. haemolyticus isolates 
2 (20%) had 4 antibiotic resistance genes; 5 (50%) had 2 antibiotic resistance genes and 
2 (20%) had 1 antibiotic resistance genes within genomic island regions. The most 
common antibiotic-resistance genes found within genomic island regions were blaZ (n=6); 
followed by qacA/B (n=3); tet(K) (n=2); ANT(4')-IB, APH(3')-IIIa, fusB, vgaA, msrA, 









1 7 lnuA 
  AAC(6')-Ie-APH(2'')-Ia 
  blaZ 
  ANT(4')-IB 
93 4 blaZ 






105 8 tetK 
  AAC(6')-Ie-APH(2'')-Ia  
361 6 blaZ 
  qacA/B 
373 7 fusB 
445 7 vgaA 
492 8 msrA 
  mphC 
506 6 ermA 
  qacA/B 
  tet(k) 
  blaZ 
538 5 qacA/B 
  blaZ 
Table 5.6: Genomic islands of 10 mecA+ S. haemolyticus isolates recovered from East and 
West London 
5.3.4 Antibiotic resistance and virulence genes carried on a plasmid. 
All mecA+ S. haemolyticus isolates from the public settings (n=10) were identified to 
carry between 1 to 5 plasmids. Three isolates had the majority of their antibiotic resistance 
genes encoded on the plasmids (Table 5.7). 8 out of 10 of these isolates carried antibiotic 
resistance genes of which 3 isolates (30%) had 5 antibiotic resistance genes carried on 
their plasmids; 1 isolate (10%) had 3 antibiotic resistance genes carried on their plasmids; 
2 isolates (20%) had 2 antibiotic resistance genes carried on their plasmid and 1 isolate 
(10%) had 1 antibiotic resistance gene carried on their plasmid. Interestingly, isolate 445 
had 5 of its antibiotic resistance genes on a single plasmid.  BlaZ (n=6) was the most 
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common antibiotic resistance gene found on the plasmid; followed by AAC(6')-Ie-
APH(2'')-Ia, qacA/B and lnuA (n=3); tet(K) (n=2) and mphC, msrA and vgaA (n=1).  
There were no detectable virulence genes to be encoded on any of the mecA+ S. 









Antibiotic resistance genes (and 
plasmids they were found on) 
1 2 2:5 AAC(6')-Ie-APH(2'')-Ia (plasmid 1) 
   blaZ (plasmid 1) 
   tet(K) (plasmid 2) 
   ANT(4')-Ib (plasmid 2) 
   lnuA (plasmid 2) 
93 3 5:0 No genes 
99 5 4:3 lnuA (plasmid 1) 
   blaZ (plasmid 1) 
   AAC(6')-Ie-APH(2'')-Ia (plasmid 2) 
105 2 2:5 AAC(6')-Ie-APH(2'')-Ia (plasmid 1) 
   blaZ (plasmid 1) 
   tet(K) (plasmid 2) 
   ANT(4')-Ib (plasmid 2) 
   lnuA (plasmid 2) 
361 3 2:2 blaZ (plasmid 1) 
   qacA/B (plasmid 1) 
373 1 4:0 No genes 
445 2 1:5 qacA/B (plasmid 1) 
   mphC (plasmid 1) 
   msrA (plasmid 1) 
   blaZ (plasmid 1) 
   vgaA (plasmid 1) 
492 2 3:0  
506 3 4:1 qacA/B (plasmid 1) 
538 1 1:2 qacA/B (plasmid 1) 
   blaZ (plasmid 1) 
Table 5.7: Number of plasmids and the antibiotic resistance genes carried on plasmids 
identified in mecA+ S. haemolyticus isolates recovered from East and West London. 
5.3.5 Phage prediction 
Phage insertion was identified in all the mecA+ S. haemolyticus isolates recovered from 
public setting to different degrees of completeness using the PHASTER software (Table 
5.8). 6 of the isolates were identified to have incomplete phage insertion, whereas 3 
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isolates (93, 99 and 361) had intact phage sequences. The intact phages insertion was 
identified as known ‘phages to infect Staphylococcus’. Two phages insertion sequences 
were identified with proteins showing homology to phage proteins associated with 
infecting Synechococcus and Prochlorococcus genus. Isolate 445 had phage inserted into 
6 regions in the genome, isolate 492 had phage insertion in 5 regions in the genome. 
Isolate 99 was identified to have phage insertion in 3 regions in the genome, whereas the 
other 8 isolates (80%) had phage insertion in 1 region of their genome. APH(3')-IIIa and 
fusB antibiotic resistance genes were identified to be within the phage insertion region for 








1 Staphylococcus phage PT1028 Incomplete  
93 Staphylococcus phage CNPx Intact APH(3')-IIIa 
99 Staphylococcus phage PT1028 Incomplete  
 Staphylococcus phage StB27 Intact  
 Staphylococcus phage StB12 Intact  
105 Staphylococcus phage PT1028 Incomplete  
361 Staphylococcus phage StB12 Intact  
373 Staphylococcus phage PT1028 Incomplete  
445 Synechococcus phage S-SSM7 Incomplete  
 Staphylococcus phage PT1028 Incomplete  
 Staphylococcus phage PT1028 Incomplete  
 Staphylococcus phage StB2- like Incomplete  
 Staphylococcus phage CNPH82 Incomplete  
 Staphylococcus phage Spbeta-like Incomplete  
492 Staphylococcus phage Spbeta-like Incomplete  
 Staphylococcus phage PT1028 Incomplete  
 Staphylococcus phage CNPH82 Incomplete  
 Staphylococcus phage PT1028 Incomplete  
 Prochlorococcus phage P-SSM7 Incomplete  
506 Staphylococcus phage PT1028 Incomplete  
538 Staphylococcus phage PT1028 Incomplete fusB 
Table 5.8: Phage prediction in mecA+ S. haemolyticus isolates recovered from East and West 
London; identification of antibiotic resistance genes carried by phages 
5.3.6 Phylogenetic analyses of mecA+ S. haemolyticus isolates recovered from East 
and West London compared with S. haemolyticus reference isolates from the ENA 
database  
Phylogenetic analyses were performed for the 10 mecA+ S. haemolyticus isolates 
recovered from public areas from East and West London to compare their relatedness 
with reference and draft isolates from the ENA database that was recovered from different 
sources. These sources included isolates recovered from clinical samples (n=48); human 
commensal isolates from skin, nares and eyes (n=7); livestock (cow) and companion 
animal (dog) isolates  (n=8); other public settings and natural environment isolates (n=5), 
hospital environment from catheters from central venous catheter (n=2) and plant-
associated isolates (n=3). From the core SNP phylogenetic tree, two distinctive clades 
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were identified (Figure 5.2). Clade A consists of isolates from the ENA database 
recovered from clinical samples (blood, vagina and sputum), livestock (cows), a 
companion animal (dog), groundwater and a healthy human eye. Clade B consist of 
isolates from the ENA database recovered from clinical samples (blood, eye and colon) 
healthy human skin, central venous catheter, Kefir seed, willow tree, livestock (cows), 
tropical air samples, copper alloy coin, surface area of a building and waste and hygiene 
compartment of the International Space Station. All mecA+ S. haemolyticus isolates 
recovered from public areas in London were found in clade B, but one isolate (492) 
recovered from West London hospital belonged to clade A. Genetic relatedness between 
isolates recovered in this study from public areas in hospital (373, 445 and 538) and 
isolates (1, 93, 99 and 105) recovered from public setting to that of the clinical isolates 
from the ENA database recovered from an eye (SH1572), blood (M-176), and central 
venous catheter (95671). Interestingly, one isolate recovered from public areas in 
hospitals (492) in this study were genetically related to an isolate from the ENA database 
recovered from a dog (SW007); and another isolate recovered from public areas in 
hospitals (445) was genetically similar to ENA database isolate from Kefir seeds (OG2). 
Additionally, from the ENA database isolates two livestock-associated isolates from cows 
(BC05211 and NW19) and two isolates recovered from a plant (OG2 from Kefir seeds 
and RIT283 from willow) to be genetically related to isolates recovered from clinical 
blood samples from the ENA database. There were no S. haemolyticus isolates from the 
ENA database which belong to the same genetic lineage of isolate 506 which was 


















   
 
 
Figure 5.2: SNP core maximum likelihood phylogenetic tree of 83 S. haemolyticus isolates 
recovered from different sources and mecA+ S. haemolyticus isolates recovered from public 
settings in East and West London. Red background labels mecA+ S. haemolyticus isolates 




PopPUNK analyses revealed that there were 38 combined core and accessory gene 
clusters predicted of which the accessory genome was found within 11 clusters (Figure 
5.3). Five of these clusters had isolates that were identified to be from the same combined 
cluster and 6 clusters had isolates that only contained isolates from the ENA database that 
were recovered from clinical samples. Interestingly, isolates from the East London 
Community and the East London Hospital were found together in the same cluster despite 
not always having the same combined core and accessory cluster (Cluster 3). West 
London isolates can be found in multiple different clusters (Clusters 2, 3 and 6). The 
accessory genomes of all isolates recovered from East London had genetic similarities 
with isolates from the ENA database recovered from clinical samples from an eye 
(SH1572), venous catheter (95671) and environmental isolates recovered from a copper 
alloy coin (R1P1), whereas the accessory genomes of isolates recovered from West 
London were genetic similarities to isolates from ENA database recovered from clinical 
samples from an eye (SH1572 and SH1574), colon (1HT3), blood (FDAARGOS-148), 
vagina (DNF00585) and sputum (C10F), healthy humans, plants (RIT283 and S167) , 
















Figure 5.3: t-SNE analyses of the distance of the accessory genome in 83 S. haemolyticus 
isolates including mecA+ S. haemolyticus isolates recovered from public settings in East and 
West London. The Analysis was performed using PopPUNK pipeline Maximum number 
of mixture components was set at 4 and for the perplexity of the t-SNE set at 15. (A) 








































5.3.7 Pangenome analysis of S. haemolyticus 
A pangenome analysis was performed on the 83 S. haemolyticus genomes that were used 
in the phylogenetic analysis, including the 10 mecA+ S. haemolyticus isolates recovered 
from public settings in East and West London. In total, 8,978 genes were identified in the 
pangenome of which 1,200 (13.4%) were considered to be core genes. 458 (5.1%) of 
these genes were considered to be softcore genes (95 to 99% of isolates have these genes); 
1,218 (13.6%) were considered to be shell genes (15 to 95% of isolates have these genes) 
and 6,102 (68.0%) were considered to be cloud genes (≤ 15% of isolates have these genes). 
Hierarchy clustering heatmap of all 8,978 genes found in the pangenome shows there was 
no clustering by their isolation source (Figure 5.4). 
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Figure 5.4: Hierarchy clustering heatmap of  8,978 genes found in pangenome of 83 S. heamolyticus isolates base on their isolation source. Red tile 






23 antibiotic resistance genes and 18 virulence genes were identified in the pangenome 
(Table 5.9 and 5.10). The nuc gene and capsule gene were ubiquitous in all 83 S. 
haemolyticus isolates. MecA and qacA/B were identified in 78.3 and 72.3% of S. 
haemolyticus isolates, respectively. FosB3 and dfrC antibiotic resistance genes were 
unique to isolates from the ENA database recovered from clinical samples where eno 
virulence gene (Streptococcal enolase enzyme responsible for adhesion) was unique to a 
clinical isolate. Multiple capsule genes were identified in these isolates. 34 ( 41.0%) of 
the isolates had 2 capsule genes; 3 (3.6%) isolates had 3 capsule genes; 1 (1.2%) isolate 
had 4 capsule genes; 3 (3.6%) isolates had 6 capsule genes; 7 (8.4%) isolates had 7 
capsule genes;  11 (13.3%) isolates had 14 capsule genes; 5 (6.0%) isolates had 15 capsule 
genes; 1 (1.2%) isolate had 16 capsule genes; 3 (3.6%) isolates had 17 capsule genes and 
15 (18.1%) isolates had 18 capsule genes. The number of capsule genes was not unique 
to a single isolation source (Table 5.11). 
A hierarchy clustered heatmap showed there was no clustering by isolation source for 
antibiotic resistance genes or virulence (Figure 5.5). It did, however, show that isolates 
from public settings had similar antibiotic resistance and virulence genes profiles of the 
isolates from the ENA database recovered from clinical samples, livestock, companion 




genes List of antibiotic classes 
Percentage 
(%) 
AAC(6')-Ie-APH(2'')-Ia Aminoglycoside 65.1 
dfrG Diaminopyrimidine 25.3 
mecA 
Penam, monobactam, cephalosporin, carbapenem, 
cephamycin 78.3 
blaZ Penam 72.3 
ermC lincosamide, streptogramin, macrolide 9.6 
qacA/B Fluoroquinolone 56.6 
mphC Macrolide phosphotransferase 47.0 
mupA Mupirocion 10.8 
msrA Streptogramin, macrolide 51.8 
vgaALC Streptogramin, pleuromutilin  8.4 
dfrC Diaminopyrimidine 12.1 
APH(3')-IIIa Aminoglycoside  37.3 
SAT-4A Nucleoside antibiotic 32.5 
fusC Fusidic acid 9.6 
tet(K) Tetracycline 25.3 
ermC Lincosamide, streptogramin, macrolide 15.7 
erm(33) Macrolide, Streptogramin, lincosamide 2.4 
fusB Fusidic acid  21.7 
cat Phenicol 6.02 
ANT(4')-Ib Aminoglycoside 13.3 
FosB3 Fosfomycin 4.8 
lnuA Lincosamide 4.8 
ermA Macrolide, Streptogramin, lincosamide 2.4 
Table 5.9: Percentage of antibiotic resistance genes present in 83 S. haemolyticus isolate in pangenome analysis
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Virulence genes Gene function 
Percentage 
( %) 
atl Autolysin 96.4 
clfB Clumping factor B 3.6 
ebp Elastin binding protein 98.8 
lip Lipase 97.6 
nuc Thermonuclease 100.0 
capsule capsule 100.0 
capB Polyglutamic acid capsule 86.8 
cylR2 Cytolysin 95.2 
capC Polyglutamic acid capsule 86.8 
polysaccharide 
capsule polysaccharide capsule 7.2 








(Acinetobacter) Capsule (Acientobacter) 4.8 
uge Capsule (Klebsiella) 6.0 




wbtP LPS 9.6 
Table 5.10: Percentage of virulence genes present in 83 S. haemolyticus isolate in pangenome 
analysis 
 
S. haemolyticus ID Source 
Number of capsule 
genes 
BC05211 Animal 2 
SW007 Animal 2 
M-176 Clinical 2 
1HT3 Clinical 2 
25-12 Clinical 2 
6035 Clinical 2 
6249 Clinical 2 
8074328 Clinical 2 
95671 Hospital environment 2 
ERR085165 Clinical 2 
ERR085166 Clinical 2 
ERR085168 Clinical 2 
ERR085169 Clinical 2 
ERR085170 Clinical 2 
ERR085171 Clinical 2 
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S. haemolyticus ID Source 
Number of capsule 
genes 
ERR085172 Clinical 2 
ERR085173 Clinical 2 
ERR085174 Clinical 2 
ERR085176 Clinical 2 
ERR085181 Clinical 2 
FDAARGOS_148 Clinical 2 
SH1574 Clinical 2 













361 East London Hospital 2 
373 East London Hospital 2 
IPK_TSA25 Environment 2 
R1P1 Environment 2 
105731 Hospital environment 2 
492 West London Hospital 2 
506 West London Hospital 2 
SNUC_1450 Animal 3 
DNF00585 Clinical 3 
SH1752 Clinical 3 
G811N2B1 Human 4 
2263-3461 Clinical 6 
C10F Clinical 6 
SHN36 Human 6 
OG2 Plant 7 
SNUC_128 Animal 7 
SNUC_1408 Animal 7 
C10A Clinical 7 
IIF2SW-P5 Environment 7 
Z52 Environment 7 
MTCC_3383 Human 7 
0894-2001-2009 Clinical 14 
285_SHAE Clinical 14 
6682 Clinical 14 
708075 Clinical 14 
ERR085175 Clinical 14 
ERR085180 Clinical 14 
FDAARGOS_130 Clinical 14 
AB Human 14 
JCSC1435 Human 14 
445 West London Hospital 14 
538 West London Hospital 14 
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S. haemolyticus ID Source 
Number of capsule 
genes 
51-06 Clinical 15 
51-07 Clinical 15 
ERR085177 Clinical 15 
ERR085178 Clinical 15 
NW19 Human 15 
SNUC_1317 Animal 16 
SNUC_4966 Animal 17 
A109N1B1 Human 17 
RIT283 Plant 17 
SNUC_1584 Animal 18 
115601 Clinical 18 
51-30 Clinical 18 
83131A Clinical 18 
83131B Clinical 18 
ERR085179 Clinical 18 
ERR085182 Clinical 18 
ERR085183 Clinical 18 
S167 Plant 18 
SRR1182428 Clinical 18 
SRR1182429 Clinical 18 
SRR1182430 Clinical 18 
SRR1182431 Clinical 18 
SRR1182432 Clinical 18 
SGAir0252 Environment 18 
Table 5.11: Number of capsule genes to the isolation sources found in the 83 S. haemolyticus 
isolates. Red highlight = East London Community, Blue label= East London Hospital, 














































































































Figure 5.5: Hierarchy cluster heatmap of antibiotic resistance and virulence genes found in 83 S. haemolyticus isolates used in the pangenome analysis 
 (A) Hierarchy clustered heatmap of antibiotic resistance genes found by source; (B) Hierarchy clustered heatmap of virulence gene by source. 













































































The COG family group was identified for the core and the accessory genome in S. 
haemolyticus pangenome analysis (Table 5.12). From the core genome, the highest 
proportion of the genes were classified as general function prediction only or function 
unknown genes (11.9% and 9.7% respectively). The core genes group translational, 
ribosomal structure and biogenesis and amino acid transport and metabolism (9.5% and 
9.5% respectively) were the highest proportion of known functional COG group. For the 
accessory genome, the highest portion of the genes belonged to the COG group were 





Percentage of genes found in the 
pangenome 
 Core genes Accessory genes 
Translation, ribosomal structure and biogenesis  9.5 2.5 
Transcription  6.3 9.4 
Replication, recombination and repair  4.8 15.0 
Chromatin structure and dynamics  0.1 1.2 
Cell cycle control, cell division, chromosome 
partitioning  0.9 3.1 
Defense mechanisms  1.2 2.2 
Signal transduction mechanisms  3.2 8.5 
Cell wall/membrane/envelope biogenesis  3.4 0.1 
Cell motility  0.2 0.0 
Intracellular trafficking, secretion, and vesicular 
transport  1.2 0.9 
Posttranslational modification, protein turnover, 
chaperones  3.7 1.6 
Energy production and conversion  7.4 2.8 
Carbohydrate transport and metabolism  5.8 8.0 
Amino acid transport and metabolism  9.5 6.6 
Nucleotide transport and metabolism  4.6 1.7 
Coenzyme transport and metabolism  6.2 2.4 
Lipid transport and metabolism  2.7 2.3 
Inorganic ion transport and metabolism  6.6 5.7 
Secondary metabolites biosynthesis, transport and 
catabolism  1.5 1.6 
General function prediction only  11.8 13.6 
Function unknown  9.7 10.7 
Table 5.12: COG family group of genes in the core and accessory genomes of S. haemolyticus 
isolates 
The COG family group were identified for the unique genes found in the 10 mecA+ S. 
haemolyticus isolates from East and West London that were not found in the other S. 
haemolyticus isolates from the ENA database (Table 5.13). 306 unique genes were 
identified of which the highest proportion of the genes have been identified to belong the 




Percentage (%) of genes in the pangenome unique to S. 
haemolyticus isolates from East and West London 
Translation, ribosomal structure 
and biogenesis  0.2 
Transcription  15.2 
Replication, recombination and 
repair  34.3 
Cell cycle control, cell division, 
chromosome partitioning  4.9 
Defense mechanisms  2.4 
Signal transduction mechanisms  0.6 
Cell wall/membrane/envelope 
biogenesis  5.7 
Intracellular trafficking, 
secretion, and vesicular transport  0.8 
Posttranslational modification, 
protein turnover, chaperones  1.4 
Carbohydrate transport and 
metabolism  9.3 
Amino acid transport and 
metabolism  0.6 
Inorganic ion transport and 
metabolism  3.5 
General function prediction only  13.4 
Function unknown  7.7 
 Table 5.13: Unique gene COG family from 10 mecA+ S. haemolyticus isolates recovered 
from public settings in East and West London.
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Comparative analyses of the accessory genomes within mecA+ S. haemolyticus isolates 
recovered from public settings in East and West London showed that East London isolates 
had 677 genes not found in those recovered from West London and that West London 
isolates had 676 genes not found in those recovered from East London. 7 out of these 
unique genes were ubiquitous in mecA+ isolates recovered from East London, whereas 8 
genes were ubiquitous in mecA+ isolates recovered from West London. The known 
functions for the genes that were unique and found in all mecA+ East London isolates 
were phosphomethylpyrimidine kinase, 3-hexulose-6-phosphate synthase, putative 
protein, long-chain fatty acid CoA ligase. The known function of unique genes found in 
mecA+ West London isolates was tRNA-Val (tac), 3-hexulose-6-phosphate synthase, 
MFS family major facilitator transporter, proline/betaine: cation symporter and 
phosphomethylpyrimidine kinase. The difference in the accessory genome for the mecA+ 
general public settings and mecA+ public setting in hospital isolates was that general 
public setting isolates had 392 genes not found in isolates from public areas in hospitals, 
whereas from public areas in hospitals had 958 genes that were not found in public areas 
in the community isolates. For the isolates from the mecA+ general public settings, there 
were 9 genes that were ubiquitous in these isolates where mecA+ public area in hospitals 
isolates had 6 genes that were ubiquitous in these isolates but were not found in isolates 
from general public settings. The known function of ubiquitous genes in the general 
public settings was bifunctional acetyltransferase/phosphotransferase, ISSau3 
transposase, GNAT family acetyltransferase, transposase for IS431mec. The known 
functions of ubiquitous genes in the hospital isolates were recombinase/resolvase; 
Alpha/beta hydrolase fold-3 domain-containing protein, serine-type D-Ala-D-Ala 
carboxypeptidase and a replication initiator protein A. MecA+ East London had a 
significantly higher proportion of unique genes compared with mecA+ West London 
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isolates for replication, recombination and repair (22.8% and 14.0% respectfully (P= 
<0.0001) and amino acid transport and metabolism (7.7% and 4.1% respectfully (p= 
0.0054)) (Table5.13). For West London isolates there was a significantly higher 
proportion of unique genes compared to mecA+ East London isolates that had functions 
for carbohydrate transport and metabolism (10.4% and 4.6% respectfully (P=0.0001)); 
translation, ribosomal structure and biogenesis (3.3% and 1.0% respectfully (P=0.0047)); 
defense mechanisms (5.2% and 1.8% respectfully (P=0.0008)); carbohydrate transport 
and metabolism (10.5% and 4.6% respectfully (P=0.0001)); inorganic ion transport and 
metabolism (8.8% and 5.2% respectfully (P= 0.0106)) and secondary metabolism 
biosynthesis, transport and catabolism (2.6% and 0.9% respectfully (P=0.0183)). For 
mecA+ general public setting isolates there was a significantly higher portion of unique 
genes that were responsible for replication, recombination and repair compared with 
mecA+ hospital isolates from public area (33.2% and 13.4% respectfully (P=0.001)); cell 
cycle control, cell division, chromosome partition (2.5% and 1.4% respectfully (P=0.0423) 
compared with mecA+ hospital isolates from public areas (Table 5.14). MecA+ hospital 
isolates from public areas had a significant higher proportion of unique genes compared 
to mecA+ general public settings isolates that had functions for carbohydrate transport and 
metabolism (9.7% and 3.8% respectively (P=0.0003)); defense mechanisms (4.5% and 
1.1% respectfully (P=0.0023)); amino acid transport and metabolism (5.8% and 2.3% 
respectively (P=0.0052)); coenzyme transport and metabolism (3.1% and 0% respectively  
(P=0.0005)); Intracellular trafficking, secretion, and vesicular transport (1.3% and 0% 
respectively (P=0.0254)) and secondary metabolites biosynthesis, transport and 




Percentage (%) of isolates genes in the pangenome that 
were unique to isolates recovered from public settings 
Function East London West London 
Translation, ribosomal 
structure and biogenesis  1.0 3.2 
RNA processing and 
modification  0.0 0.0 
Transcription  9.9 9.4 
Replication, recombination 
and repair  22.8* 14.0 
Chromatin structure and 
dynamics  0.0 0.0 
Cell cycle control, cell 
division, chromosome 
partitioning  1.7 1.1 
Nuclear structure  0.0 0.0 
Defense mechanisms  1.8 5.2* 
Signal transduction 
mechanisms  1.4 0.0 
Cell wall/membrane/envelope 
biogenesis  7.0 8.6 
Cell motility  0.0 0.1 
Cytoskeleton  0.0 0.0 
Extracellular structures  0.0 0.0 
Intracellular trafficking, 
secretion, and vesicular 
transport  0.5 1.1 
Posttranslational modification, 
protein turnover, chaperones  0.8 0.5 
Energy production and 
conversion  1.9 1.8 
Carbohydrate transport and 
metabolism  4.6 10.4* 
Amino acid transport and 
metabolism  7.7* 4.1 
Nucleotide transport and 
metabolism  2.4 1.9 
Coenzyme transport and 
metabolism  2.8 3.1 
Lipid transport and 
metabolism  2.2 2.2 
Inorganic ion transport and 
metabolism  5.2 8.8* 
Secondary metabolites 
biosynthesis, transport and 
catabolism  0.9 2.6 
General function prediction 
only  12.8 12.9 
Function unknown  12.5 7.9 
 247 
Table 5.14: Difference in COG function of the unique genes in mecA+ S. haemolyticus isolates 
recovered from East and West London*= The area where there was significantly higher 
(p=<0.05) percentage of genes for that COG function 
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Table 5.15: Difference in COG function of the unique genes in mecA+ S. haemolyticus isolates 
recovered from public setting and West London.*= The area where there was significantly 
higher (p=<0.05) percentage of genes for that COG function  
 
 
Percentage of isolates genes in the pangenome that 
were unique to Isolates recovered from public settings 
Function Community Hospital 
Translation, ribosomal structure 
and biogenesis 1.9 2.9 
RNA processing and 
modification 0.0 0.0 
Transcription 9.2 9.9 
Replication, recombination and 
repair 33.2* 13.4 
Chromatin structure and 
dynamics 0.0 0.0 
Cell cycle control, cell division, 
chromosome partitioning 2.5* 1.0 
Nuclear structure 0.0 0.0 
Defence mechanisms 1.1 4.5* 
Signal transduction 
mechanisms 2.6 1.4 
Cell wall/membrane/envelope 
biogenesis;  8.7 7.7 
Cell motility 0.0 0.1 
Cytoskeleton 0.0 0.0 
Extracellular structures 0.0 0.0 
Intracellular trafficking, 
secretion, and vesicular 
transport 0.0 1.3 
Posttranslational modification, 
protein turnover, chaperones 0.8 0.3 
Energy production and 
conversion 1.1 2.1 
Carbohydrate transport and 
metabolism 3.8 9.7* 
Amino acid transport and 
metabolism 2.3 5.8* 
Nucleotide transport and 
metabolism 2.9 1.9 
Coenzyme transport and 
metabolism 0.0 3.1* 
Lipid transport and metabolism 1.0 2.6 
Inorganic ion transport and 
metabolism 5.1 7.8 
Secondary metabolites 
biosynthesis, transport and 
catabolism 0.0 2.8 
General function prediction 
only  13.0 13.0 
Function unknown 10.7 8.6 
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5.4 Discussion 
5.4.1 S. haemolyticus: Virulence genes and HGT  
S. haemolyticus is the second most common CoNS nosocomial infection behind S. 
epidermidis (Czekaj et al., 2015). The virulence genes can be acquired horizontally, but 
little is known of the origins of these genes in S. haemolyticus (O'Riordan and Lee, 2004). 
One key virulence gene in S. haemolyticus is the polysaccharide capsule genes which 
were identified in all mecA+ isolates recovered from public settings and all isolates from 
ENA database used in the pangenomic analyses carried out in this study. Polysaccharide 
capsules have been previously reported in S. haemolyticus as being important for bacterial 
survival during infection as they impede phagocytosis (O’Riordan and Lee, 2004). This 
function in S. haemolyticus JCSC 1435 has been demonstrated to be encoded by an 
operon comprised of 13 genes in tandem. However,  the majority of the isolates recovered 
from East and West London had only two capsules genes; only two isolates carried 14 
polysaccharide capsule genes (Flahaut et al., 2008). The carriage of these genes was 
compared to the isolates obtained from the ENA database; the highest number of capsule 
genes identified was 18, which were mostly found in clinical isolates (isolates 115601, 
51-30, 83131A, 83131B, ERR085179, ERR085182, ERR085183, SRR1182428, 
SRR1182429,  SRR1182430, SRR1182431, SRR1182432) . This suggests that these 
additional capsule genes may make S. haemolyticus more virulent, whereas it was predict 
isolates with only 2 capsule gene will lack the ability to produce a capsule as each gene 
has been shown to code for different functions in producing polysaccharide capsules 
(Flahaut et al., 2008). These functions include chain length determination; putative 
tyrosine-protein kinase, putative phosphotyrosine-protein phosphatase, putative 4,6-
dehydratase, gylocolesis transferase and amino transferase. Interestingly, from this 
analyses of S. haemolyticus JCSC 1435 there was 14 capsules genes, not 13 capsule genes 
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as reported by Flahaut and co-workers. (Flahaut et al., 2008) This extra capsule gene 
would require further laboratory work to understand if it was involved in capsule 
production along with isolates that are demonstrated to have additional polysaccharide 
capsule genes. Two isolates (445 and 538) recovered from West London Hospital in this 
study possessed 14 capsule genes of which 9 were predicted to be horizontally transferred. 
These genes were predicted to be donated from Nosocomiicoccus, Listeria, Bacillus and 
Caloramator genus. Previous reports have described a polysaccharide capsule in Bacillus 
genus but not in Listeria, Nosocomiicoccus or Caloramator genus (Scarff et al., 2018; 
Vázquez-Boland et al., 2001) It has been noted that Bacillus cereus and Bacillus anthracis 
has a multi-gene operon within a plasmid which encodes for polysaccharide capsules 
(Scarff et al., 2018) This would suggest the possible route of transmission of these genes 
in S. haemolyticus could be via plasmid conjugation. As mentioned in chapter four, these 
predicted donors are just the best match distal organisms and are most likely that the 
actual donor was an ancestor or an extinct donor (Zhu et al., 2014).  
Other capsule genes that were ubiquitous to the S. haemolyticus isolates recovered from 
East and West London were capB and capC which encode the polyglutamic acid capsule 
and are responsible for immune evasion. These genes were identified in 100% of the 
isolates recovered from the public settings and in 86.8% of the isolates used in the 
pangenomic analysis. Similar to the S. epidermidis analyses, the capA and capD genes, 
were absent in S. haemolyticus. Although CapB and capC genes have not previously been 
identified as a virulence factor in S. haemolyticus, they have been identified as such in S. 
hominis (Calkins et al., 2016). Interestingly, a report has shown that S. haemolyticus 
surface-associated protein reacts with antibodies of polyglutamic acid, but no studies 
have shown that they are involved in bacterial virulence (Flahaut et al., 2008). These 
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antibodies may be able to bind to other proteins in S. haemolyticus, which may have a 
similar structure to that of polyglutamic acid. 
The nuc gene which encodes the thermonuclease was identified in all S. haemolyticus 
isolates recovered from public settings and the isolates obtained from the ENA database. 
This suggests that this gene is essential for S. haemolyticus survival than for its virulence. 
This gene has been characterised in S. aureus to hydrolyse DNA and RNA and is involved 
in host cells evasion of neutrophil extracellular traps as well as inhibition of biofilm 
formation via cleavage of extracellular DNA (Kiedrowski et al., 2014). 
In this study, genes were identified that have not previously been identified in S. 
haemolyticus, including the cylR2 gene, which encoded the cytolysin regulator in 
Enterococcus spp. CylR2 was found in 100% of mecA+ S. haemolyticus isolates recovered 
from public setting in East and West London. In addition, it was also found in 95.2% of 
S. haemolyticus isolates used in the pangenome analysis. These genes may have been 
missed as the predicted protein structure has low sequence similarity to that of known 
cytolysin, but they are shown to have close paralog as described by the VFanalyzer 
software (Liu et al., 2019). Additionally, this gene is shown to be part of an 8 gene operon 
in Enterococcus spp. Therefore, the absence of the other 7 genes in S. haemolyticus would 
suggest that they would lack the ability to produce cytolysin (Van Tyne et al., 2013). 
From HGT analyses of the mecA+ S. haemolyticus isolates recovered from public settings 
from East and West London, the cylR2 gene was predicted to be horizontally transferred 
with the closet donor link identified as Streptococcus and Virgibacillus genus that have 
previously been reported to produce cytolysin (Molloy et al., 2015). 
From this study, genes found in the in icaADBC operon that are responsible for biofilm 
production in S. epidermidis were not found in the S. haemolyticus isolates. Fredheim and 
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co-workers found that 53 out of 72 (74%) clinical S. haemolyticus isolates produce 
biofilm, though only 2 isolates had the icaADBC operon (Fredheim et al., 2009). This 
shows that icaADBC operon is not essential in biofilm production in S. haemolyticus as 
in the case of S. epidermidis; therefore, the bacterium uses a different mechanism to 
produce biofilm, which is yet unknown. These findings in this report would suggest that 
it is possible that the mecA+ S. haemolyticus isolates recovered from public setting could 
also produce biofilm although further laboratory experiments will be required to confirm 
this hypothesis.  
No clustering was observed  based on virulence gene profiles or on their isolation sources, 
however, virulence gene profiles of the isolates recovered from public settings were 
similar to those obtained from the ENA database that has previously been recovered by 
others from clinical samples, health humans, livestock and companion animals and 
further ENA database isolates that were recovered from public settings and natural 
environments. Although virulence phenotype was not determined in this study, these 
isolates have potential to cause infection in humans and are a public health risk as they 
are similar virulent genes to that found in known clinical isolates that have cause blood, 
eye, sputum and colon infections. 
5.4.2 S. haemolyticus: Antibiotic resistance genes and HGT 
Understanding which antibiotic resistance genes are horizontally transferred; their mode 
of transfer and their origins is important to understand bacterial evolution. In this study, 
all the genes, except for the beta-lactamase encoding gene blaZ were predicted to be 
horizontally transferred in mecA+ S. haemolyticus isolates recovered from public settings.  
The blaZ gene was carried on the plasmids of 6 isolates. The method used to detect gene 
transfer can only predict if the gene originated from a different genus (Zhu et al., 2014). 
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Therefore, these genes may be transferred from another S. haemolyticus isolate or other 
staphylococcal species. The predicted donor link for the antibiotic resistance genes was 
the same as the majority of antibiotic resistance genes in S. epidermidis analyses in 
chapter 4. This would suggest that antibiotic resistance genes that were horizontally 
transferred have the same ancestral link in CoNS mecA+ isolates from public settings in 
East and West London. The only antibiotic resistance genes in S. haemolyticus isolates in 
which the donor species were different were AAC(6')-Ie-APH(2'')-Ia and APH(3')-IIIa. 
The predicted donor for AAC(6')-Ie-APH(2'')-Ia gene for isolates 1 and 105 was 
Clostridiales bacterium VE202-16 and for isolate 93 Streptococcus mitis B6 and  isolate 
99 was and Enterococcus faecalis V583. The predicted donor for APH(3')-IIIa for isolate 
93 was Streptococcus mitis B6 and isolate 99 was Enterococcus faecium DO. 
Streptococcus mitis, Enterococcus faecalis and Enterococcus faecium are three known 
pathogens that have an array of infection from endocarditis, urinary tract infection and 
even meningitis. This demonstrates that S. haemolyticus could horizontally acquire 
antibiotic resistance genes from other pathogens from the public environment. The 
AAC(6')-Ie-APH(2'')-Ia and APH(3')-IIIa genes were only found in the mecA+ isolates in 
East London public settings which suggests that there is a pool of bacterial species within 
this area that has the potential of transferring the same antibiotic resistance genes into S. 
haemolyticus.  
Among the mecA+ S. haemolyticus isolates from public settings, there were 3 isolates (1, 
105 and 405) that had the majority of their antibiotic resistance genes carried on their 
plasmids with one isolate (405) shown to have at least 5 genes encoded on a single 
plasmid. Bacteria plasmids are very common way of exchanging genetic information to 
other bacteria. By picking multiple genes on a plasmid and then picking multiple plasmids, 
the bacterium becomes multidrug resistant (Millan, 2018).  
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Five antibiotic resistance genes were identified within genomic island regions in mecA+ 
S. haemolyticus isolates recovered from public settings. These included blaZ, APH(3')-
IIIa, fusB, msrA, mphC, ermA, AAC(6')-Ie-APH(2'')-Ia and tet(K). As with mecA+ S. 
epidermidis isolates from public settings, the mecA genes was not found within the 
predicted genomic island regions in mecA+ S. haemolyticus isolates from public settings. 
There is only one previously published report characterising a genomic island in an S. 
haemolyticus isolate (JCSC1435). The authors of this study found that the mecA, blaZ, 
msrA, mphC, AAC(6')-Ie-APH(2'')-Ia antibiotic resistance genes were found within 
known genomic islands. These islands were associated with the SCC, transposons and 
integrated plasmids (Takeuchi et al., 2005).  
Unlike mecA+ S. epidermidis isolates from public areas in East and West London, 
antibiotic resistance genes were identified within the phage insertion sequence in 2 out of 
the 10 S. haemolyticus mecA isolates. These genes were APH(3')-IIIa and fusB. Previous 
studies have shown that the fusB gene was found in a phage-related island in S. 
epidermidis (Chen et al., 2013). Little is known about CoNS of antibiotic resistance genes 
transfer by phages. This may be because phage transduction of antibiotic resistance genes 
is rare (Enault et al., 2017) Nevertheless, it would be interesting to know if a particular 
antibiotic resistance gene was transferred via a phage more often than others. For 
completeness of the phage insertion in the host genome, there were only three isolates 
(93, 99 and 361) out of the 10 mecA+ S. haemolyticus isolates from public setting had 
intact phage insertion sequences.  However, other S. haemolyticus mecA+ isolates 
recovered from public settings to have incomplete phage sequences. This would suggest 
that many of these phages that were found ‘incomplete’ had their genes deleted by the 
host genome as they do not confer any advantage for bacterial survival and may act as a 
metabolic burden (Ramisetty and Sudhakari, 2019). Additionally, two isolates (445 and 
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492) had an incomplete phage insertion sequence was associated with Synechococcus and 
Prochlorococcus species. As mentioned in the previous chapter, these sequences are most 
likely unknown phages that have not previously been studied. The intact phage sequence 
has not been previously identified in S. haemolyticus but has been found in S. hominis 
and S. capitis (Staphylococcus phage StB12, Staphylococcus phage StB27), and S. 
epidermidis (Staphylococcus phage CNPx) (Deghorain et al., 2012; Maniv et al., 2016). 
This shows that Staphylococcus phages can infect and integrate into different 
Staphylococcus species; hence, it is possible for virulence genes horizontally transferred 
via phages into S. aureus to also be transferred into S. haemolyticus isolates. 
Many studies have described antibiotic resistance phenotypes in S. haemolyticus, but few 
studies focused on their antibiotic resistance genes profile (Cavanagh et al., 2014; Maleki 
et al., 2018). For the overall antibiotic resistance gene in all 83 S. haemolyticus isolates 
mecA (78.3%) and blaZ (72.3%) genes were the most common. This was similar to S. 
epidermidis except for the norA which is ubiquitous among S. epidermidis isolates but 
not present in S. haemolyticus isolates. The only antibiotic resistance gene found in this 
study that was not found in S. epidermidis isolates was erm(33). This gene has previously 
only been identified in S. aureus and S. sciuri isolates (Li et al., 2015; Schwarz et al., 
2002). Interestingly, fosB3 (which encodes for resistance to fosfomycin) and dfrC 
(encoding resistance for diaminopyrimidine) were present only in the isolates from ENA 
database recovered from clinical samples suggesting their frequent use in clinics but not 
in other environments (Ltd, 2016).  
A hierarchy clustering heatmap revealed no clustering for the antibiotic resistance gene 
profiles based on their isolation source. However, isolates recovered from public settings 
in East and West London had similar antibiotic resistance gene profiles when compared 
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to profiles of isolates obtained from the ENA database, including isolates recovered from 
clinical sources, healthy humans, livestock and companion animals and those recovered 
from other public settings and natural environments. As antibiotic resistance is higher in 
abundance in hospital environments and livestock animals due to high usage of antibiotics, 
it is expect that many of these isolates have crossed over into different niches as well as 
horizontally transferred their resistance genes to isolates found in public settings (Cantón 
and Morosini, 2011). 
5.4.3 HGT in mecA+ S. haemolyticus isolates recovered from East and West London 
Horizontal transfer of antibiotic resistance and virulence genes is an important 
evolutionary adaption, but little is known about what proportion of the S. haemolyticus 
genome that has been donated from other organisms. In this study, it was predicted that 
8.9% to 13.5% of the genes were HGT-derived from mecA+ S. haemolyticus isolates 
recovered from East and West London. This was similar to that predicted for S. 
epidermidis isolates in this study (8.6% to 10.1%). There were also similarities in the 
predicted common genera which donated the majority of genes (Bacillus and 
Macrococcus). This would suggest that the S. haemolyticus accessory genome had similar 
evolution as in S. epidermidis isolates as the predicted donor species were commonly 
found in these environments (Conlan et al., 2012).  
5.3.4 Phylogenetic and pangenome analysis of S. haemolyticus isolates recovered 
from public settings with S. haemolyticus isolates obtained from the ENA database. 
S. haemolyticus can be found in different ecological niches but little is known about their 
genetic relatedness with each other (Barros et al., 2012; Ruzauskas et al., 2014; Seng et 
al., 2017b; Xu et al., 2015). Here, a phylogenetic analysis was carried out to compare the 
mecA+ S. haemolyticus isolates recovered from public settings from East and West 
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London with isolates obtained from the ENA database that have previously been 
recovered from clinical samples (blood, colon, sputum and eye); healthy human (skin, 
nares and eyes); livestock (cows) and companion animal (dog); other isolates recovered 
from public settings and natural environment (groundwater), catheters from hospital and 
plant-associated isolates (Kefir seeds and willow). Similar to S. epidermidis phylogenetic 
analysis, isolates were split into two distinct clades, although those that were obtained 
from the ENA database and have been designated as ‘clinical’ were found in both clades. 
All but two isolates recovered from public settings in this study were identified as being 
genetically related to isolates recovered from clinical samples from an eye (SH1572), 
blood (M-176) and central venous catheter (95671) obtained from the ENA database. 
These results show that these isolates from public settings are a public health risk as they 
come from the same genetic lineages of isolate's that have shown to cause eye 
(conjunctivitis) and blood infections (Cavanagh et al., 2014; Panda and Singh, 2016). 
This includes the 4 mecA+ isolates that were recovered from general public settings in 
East London (1, 93, 99 and 105). This would suggest that isolates that can cause blood 
infections are not just found in hospital areas but can be found in general public areas. 
Additionally, one isolate from West London hospital (492) was genetically related to 
isolates recovered from a dog (SW007) and another isolate from West London hospital 
(445) was phylogenetically related to an isolate recovered from kefir seeds (OG2) (Bean 
et al., 2017). Previous reports have indicated that companion animals are a potential 
reservoir for the mecA+ S. haemolyticus, which could be transmitted to human via contact. 
Reports of S. haemolyticus recovered from plants is scarce but from this study analysis, 
isolate recovered from Kefir seeds harboured the mecA gene (Gan et al., 2014). In this 
study, it was not determined whether the S. haemolyticus isolates recovered from a dog 
could be a public health risk as there are no studies that have shown there to be a link 
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between genetic lineages of isolates recovered from companion animals and those that 
have caused human infections. However, there was a genetic relatedness between two 
isolates from ENA database recovered from cows’ milk (NW19 and BC05211) and 
isolates recovered from clinical samples including isolate recovered from eye infection 
(SH1574) and blood infection (8074328), potentially posing public health risk. It has not 
been reported that S. haemolyticus from livestock belong to the same genetic lineages 
known to cause infections. Additionally, isolate from the ENA database recovered from 
plants (OG2), were also related to the isolate from the ENA database recovered from 
clinical blood samples (M-176). This shows that infective S. haemolyticus can be 
transmitted to humans via contact from plants or animals either as a foodstuff or direct 
contact with the actual plant or animal (Prado et al., 2015). 
In this study, mecA+ S. haemolyticus isolates recovered from public settings in the 
community and public areas in hospitals from East London were genetically similar based 
on their accessory genome, and clustering, despite that they belonged to different core 
genome clusters (Figure 5.4). This indicates that these isolates have a shared pool of genes 
that may horizontally transfer due to similarities in bacterial species/strains found in the 
same geographical area (Segerman, 2012). The accessory genomes of seven mecA+ S. 
haemolyticus isolates (1, 93, 99, 105, 506, 445 and 538) recovered from public settings 
were similar compared with accessory genomes of clinical isolates obtained from ENA 
database. These seven isolates also belonged to the same core genetic lineages as isolates 
recovered from clinical samples. This provides evidence that S. haemolyticus isolates 
recovered from public settings in this study are not simply harmless bacteria that picked 
resistance genes over the time, but most likely originated from the same niches and 
similarly possess genes typical for human pathogens capable of causing infections. This 
is also indicated by the virulence gene profiles as many of the isolates recovered public 
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settings in this study shared the same known virulence genes found in clinical isolates 
from the ENA database. Moreover, three isolates recovered from public settings (506, 
492 and 361) were genetically different with the clinical isolates based on their core 
genome; however, they were similar based on their accessory genome to clinical isolates 
from ENA database recovered from vagina (DNF00585) sputum (C10F) and colon 
(1HT3). This would indicate that these three isolates originate from a different area to 
these clinical isolates but may have been transmitted to areas where clinical isolates were 
present in which they have horizontal acquired similar genes to each other in their 
accessory genome. Additionally, based on their accessory genomes, these isolates 
recovered from public settings were genetically similar to clinical isolates were also 
shown to be similar to isolates from ENA database recovered from plants, livestock and 
companion animals. This would indicate at one point these isolates recovered from 
livestock, companion animal and plants were transmitted to clinical areas, or clinical 
isolates has been transmitted outside of hospitals via humans. Therefore, these isolates 
may have horizontally acquired virulence genes from clinical isolates, or they are clinical 
isolates that have survived outside of hospital environments. As virulence determinants 
in staphylococci are found in the accessory genome, this suggests that these isolates 
recovered from plants, different environments, livestock and companion animals have 
similarities in their accessory genome with the clinical isolates, may potentially cause 
infection as they carry virulent genes that were responsible for initiating infection (Bosi 
et al., 2016). Additionally, there were 4 clusters that only had S. haemolyticus isolates 
from the ENA database that was recovered from clinical isolates (Figure5. 4). These 
isolates are most likely nosocomial and have not spread into different niches (Degener et 
al., 1994).  
 260 
In a similar manner to the S. epidermidis pangenome analyses, it was observed that the 
mecA+ S. haemolyticus from public settings and the S. haemolyticus isolates from the 
ENA database is an open pangenome in which it seems there is an unlimited number of 
genes as part of the species gene pool (Figure 5.4). This suggests that S. haemolyticus can 
be found in different environments within mixed microbial communities in which they 
can exchange genetic material to increase their gene pool (Bosi et al., 2015). Additionally, 
from the pangenome analysis of S. haemolyticus isolates, it was observed that there were 
no particular genes associated with different isolation sources (Figure 5.5). Despite this, 
it was observed a large proportion of the unique genes found in mecA+ S. haemolyticus 
isolates from public areas from East and West London belonged to the COG family group 
that encode for the function of replication, recombination and repair (34.3%). This was 
more than what was identified in the mecA+ S. epidermidis isolates recovered from East 
and West London (24.4%). This would suggest there were more novel genes acquired 
encoding these functions in S. haemolyticus then in S. epidermidis. As discussed in case 
of S. epidermidis recovered from public settings in this study, these unique genes were 
important for acquiring mobile genetic elements as they might be beneficial for the 
bacterial survival on not very ‘desirable’ high-frequency touched surfaces as these are not 
their preferred niche to live in/on. Interestingly, in this study there was a higher 
percentage of unique genes encoding for replication, recombination and repair in mecA+ 
S. haemolyticus isolates recovered from public settings in the community (33.1%) 
compared to that of isolates recovered from public areas in hospitals (13.4%). This 
indicates that the mecA+ S. haemolyticus isolates from public settings may experience 
more DNA damage than to those found in public areas in hospitals. In public settings the 
bacteria may be exposed more to UV light, ionizing radiation and genotoxic chemicals 
that can cause DNA damage compared to bacteria found in hospitals (Žgur-Bertok, 2013). 
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Additionally, hospital isolates had significantly more unique genes responsible for 
functions such as carbohydrate transport and metabolism; defense mechanisms, amino 
acid transport and metabolism; coenzyme transport and metabolism, secondary 
metabolites biosynthesis, transport and catabolism. Five out of six of these functions is 
for transport or metabolisms which suggests that within hospital areas there is a larger 
amount of carbohydrate, amino acid and molecules for coenzymes than in public areas in 
the hospital. The higher number of unique genes that are for defense mechanisms might 
suggest there is a higher abundance of phages in hospitals than in public settings. Some 
genes that were ubiquitous to mecA+ S. haemolyticus isolates from public settings that 
were absent in the mecA+ isolates in hospitals and vice versa. The genes that were found 
to be unique in the mecA+ S. haemolyticus isolates recovered from public settings were 
most likely not essential for survival in these niches but may be different because of 
horizontal transfer of genes from different bacterial species found in these different areas. 
As in this study, there was only 10 mecA+ S. haemolyticus isolate that was WGS, therefore  
if there were additional sequenced S. haemolyticus isolates from these areas, it would be 
expected not find genes that were ubiquitous and unique to isolates from general public 
setting compared to isolates recovered from public areas in hospitals and vice versa. 
5.5 Conclusion 
In this chapter, public setting mecA+ S. haemolyticus isolates from East and West London 
were genetically compared to S. haemolyticus isolates recovered from clinical samples 
(eye, blood, sputum, colon), healthy humans skin and nares, eye; livestock (cows) and 
companion animal (dog), hospital environment from central venous catheters, various 
public settings and the natural environment, including from plants form the ENA database. 
From the phylogenetic analysis, the genetic relatedness of S haemolyticus isolates from 
public settings was determined to that of other isolates from the ENA database which has 
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not previously done before. Additionally, the antibiotic resistance genes, mobile genetic 
elements, virulent genes and pangenome were compared. From these analyses, there were 
novel findings. These findings were: 
1. S. haemolyticus isolates have a variable number of genes that may be involved in 
polysaccharide capsule production.  
2. S. haemolyticus mecA+ isolates recovered from public settings were shown to be the 
same genetic lineages of isolates from the ENA database recovered from clinical samples 
from an infected eye and blood as well as being similar in their virulence gene profiles. 
This shows that mecA+ S. haemolyticus isolates from public settings pose a potential 
public health risk. 
3. MecA+ S. haemolyticus isolates recovered public areas in the community and public 
areas in hospitals in East London were similar in their accessory genomes suggesting they 
horizontally acquired similar genes due to the similarities in the microbiome in that 
geographical area. 
4. MecA+ S. haemolyticus isolates recovered from general public settings possessed more 
unique genes encoding for replication, recombination and repair compared to mecA+ S. 
haemolyticus isolates recovered from hospitals. This suggests that there are 
environmental factors such as UV light, ionizing radiation and genotoxic chemicals that 
could cause DNA damage to the bacteria found in general public settings than in public 
areas in hospitals.
 263 
Chapter 6: Comparative genomics of mecA positive S. hominis isolates recovered 
from public settings using the One Health approach; determining horizontal gene 
transfer in these isolates 
6.1 Introduction  
Staphylococcus hominis is the third most common coagulase-negative Staphylococcus 
(CoNS) infection from clinical cases which has been shown to cause bacteraemia, 
septicaemia, endophthalmitis, and endocarditis (Chaves et al., 2005; Cunha et al., 2007; 
Iyer et al., 2005).  Pathogenicity studies in S. hominis are limited, but they have been 
characterised to produce biofilms, adhere to host cell, immune invasion and the activity 
of extracellular toxins (Szczuka et al., 2018). Previous reports have also identified them 
to be resistant to multiple antibiotics, but there are no previous studies that have used 
whole genome sequencing (WGS) to understand phylogenetic relatedness of S. hominis 
from public settings to isolates that have been previously recovered from clinical samples, 
healthy humans, livestock and other animals, natural environment and plants (Szczuka et 
al., 2018; Xu et al., 2018b). 
6.2 Method 
In this chapter, comparative genomic analyses were performed on the mecA positive 
(mecA+) S. hominis isolates recovered from public settings in East and West London. This 
included identification of horizontal gene transfer (HGT) within the genome and the 
potential donor organisms of horizontally transferred antibiotic resistance and virulence 
genes. Additionally, it was investigated whether virulence or antibiotic resistance genes 
were transferred via plasmids, phages or by other mobile genetic elements. A 
phylogenetic tree was constructed to determine the genetic relationship of mecA+ isolates 
from this study with S. hominis isolates using reference and draft whole genome 
sequenced (WGS) isolates from the European Nucleotide Archive (ENA) database that 
was previously recovered from different sources, including clinical samples (blood), 
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healthy human skin, livestock (cows), mosquitos, from natural environment and plants. 
Additionally, a pangenome was constructed to identify the core and accessory genes in 
the genome. Additionally,  the Clusters of Orthologous Groups (COG) function family 
was compared between the unique genes found in mecA+ S. hominis isolates collected 
from public settings in East and West London as well as general public settings and public 
areas in hospitals.  
6.3 Results 
6.3.1 Identification of Virulence genes in isolates recovered from public settings in 
East and West London 
Twelve virulence genes were predicted in the 10 mecA+ S. hominis isolates from East and 
West London based on the VFanalyzer software (Table 6.1). The virulence genes that 
were identified in all the isolates were the atl gene (encoding autolysin involved in 
bacterial adhesion); lip gene (encoding lipase enzyme which is involved in the 
detachment of bacterial cells from colonised sites); nuc gene (encoding thurmonuclease 
an enzyme that can hydrolyse the host cell DNA and RNA), capsule genes (involved in 
immune invasion) capB and capC gene (encoding for polyglutamic acid capsule for 
immune invasion). WbtE gene (encoding for lipopolysaccharide modification in 
Francisella spp. necessary for immune invasion) was identified in 20% of the isolates. 
icaA, icaB, icaC genes (encoding for intercellular adhesion proteins involved in biofilm 
formation) and cylR2 gene (encoding cytolysin which is involved in lysing erythrocytes, 
polymorphonuclear leukocytes and macrophages) were found in 10% of the isolates. 
Interestingly, isolate 207 and 209 had 6 copies of the capsule genes, whereas isolate 479 
had 15 copies. 207 and 209 were predicted to have two copies of polysaccharide capsule 
genes. A hierarchical cluster heatmap of virulence gene profiles of public setting isolates 
showed no clustering of mecA+ S. hominis isolates based on whether they were recovered 
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from West London or East London or whether they were recovered from general public 
settings or public areas in hospitals (Figure 6.1). 
Virulence genes Function 
Percentage (%) of 
the mecA isolates 
from public areas 
East and West 
London 
nuc Thermonuclease 100 
lip Lipase enzyme 100 
capsule Capsule genes 20.0 
atl Autolysin  100 
capB Polyglutamic acid capsule  100 
capC Polyglutamic acid capsule  100 
cylR2 Cytolysin enzyme 10 
wbtE lipopolysaccharide modification 20.0 
icaA intercellular adhesion proteins 10.0 
icaB intercellular adhesion proteins 10.0 
icaC intercellular adhesion proteins 10.0 
Polysaccharide 
capsule Polysaccharide capsule 20.0 




Figure 6.1: Hierarchy cluster heatmap of virulence gene profiles of mecA+ S. hominis isolates from public areas in East and West London. Red tile 















































6.3.2. Horizontal gene transfer events in mecA+ S. hominis isolates recovered from 
public settings in East and West London 
Horizontal gene transfer was predicted in the 10 mecA+ S. hominis isolates from public 
settings in East and West London and in the reference S. hominis isolate K1 using the 
HGTector pipeline (Table 6.2). Genes that were horizontally transferred were predicted 
in 7.8% to 9.5% of the mecA+ isolates from public settings in East and West London 
compared to the reference isolate K1 (recovered from a cow) in which 9.4% of its genome 
was predicted to be horizontally transferred based on BLAST hit distribution patterns 
from the NCBI non-redundant protein sequences database (Pruitt et al., 2007; Zhu et al., 
2014). These genes were predicted to be donated from 99 different genera based on the 
best hit of the non-redundant protein sequences database and the NCBI taxonomy 
database. The genera predicted to have most of the genes were donated from Salinicoccus 
(mean n=27); Bacillus (mean n=26) and Macrococcus (mean n=23) (Table 6.3).  










K1 2192 206 9.4 
207 2180 194 8.9 
208 2163 191 8.8 
209 2157 188 8.7 
372 2084 181 8.7 
385 2108 190 9.0 
386 2132 194 9.1 
387 2161 189 8.8 
479 2140 204 9.5 
620 2033 159 7.8 
623 2085 181 8.7 
Table 6.2:Number of HGT genes in mecA+ S. hominis from East and West London and in 
the reference isolate S. hominis K1
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 S. hominis ID 
Predicted donor genus 385 372 387 620 207 623 479 208 209 386 K1 
Acidibacillus 0 0 0 0 0 0 0 0 0 1 0 
Aerococcus 1 1 1 1 2 1 1 1 2 1 2 
Alysiella 0 0 0 0 0 0 0 0 0 0 1 
Amphibacillus 0 0 0 0 1 0 0 0 1 0 1 
Anaerobacillus 0 1 2 1 2 1 2 2 2 2 1 
Anoxybacillus 0 1 1 1 1 1 0 0 1 1 0 
Anthococcus 0 1 1 1 1 1 1 1 1 1 1 
Atopococcus 1 1 1 1 1 1 1 1 1 1 1 
Atopostipes 0 0 0 0 0 0 1 0 0 1 0 
Auricoccucs 4 5 5 4 4 5 5 3 3 4 6 
Bacillus 26 25 26 23 22 27 26 28 23 29 26 
Bariatricus 1 0 0 0 0 0 0 0 0 0 0 
Blautia 1 0 0 0 0 0 0 0 0 1 0 
Brevibacillus 5 5 5 5 4 5 4 2 4 5 5 
Burkholderia 0 0 1 0 0 0 0 0 0 0 0 
Carnobacterium 4 2 2 2 3 2 3 4 3 2 5 
Caryophanon 0 0 0 0 0 0 0 0 0 0 1 
Chloracidobacterium 0 0 1 0 0 0 0 0 0 0 0 
Clostridium 1 1 1 0 1 1 2 2 1 0 1 
Corynebacterium 0 0 1 0 0 0 0 0 0 1 0 
Cutibacterium 3 3 5 3 4 3 3 3 4 4 2 
Desmospora 1 0 0 0 0 0 0 0 0 0 0 
Domibacillus 0 1 2 1 0 1 0 0 0 2 0 
Dorea 0 0 0 0 0 0 1 0 0 0 0 
Edaphobacillus 0 0 0 0 0 0 0 1 0 0 0 
Enteractinococcus 0 0 1 0 0 0 0 0 0 1 0 
Enterobacter 0 0 0 0 1 0 1 0 1 0 0 
Enterococcus 9 9 2 6 10 9 9 5 9 4 4 
Eremococcus 1 1 1 1 1 1 0 1 1 0 1 
Exiguobacterium 2 1 1 1 1 1 2 1 1 1 1 
Faecalibaculum 0 0 0 0 0 0 0 1 0 0 0 
Faecalicatena 0 0 0 0 0 0 0 1 0 0 0 
Fictibacillus 1 1 1 1 1 1 1 1 1 1 1 
Fusobacterium 0 0 1 0 0 0 0 0 0 0 0 
Gemella 0 0 0 0 0 0 0 0 0 1 0 
Geobacillus 1 1 1 1 1 1 1 1 1 1 1 
Gracilibacillus 0 6 3 6 1 6 0 1 1 5 0 
Gulosibacter 0 0 0 0 0 0 0 0 0 0 1 
Halarchaeum 1 1 1 1 1 1 1 1 1 1 1 
Halobacillus 0 1 1 1 2 1 0 0 2 1 0 
Halogranum 1 0 0 0 0 0 0 0 0 0 0 
Halopiger 0 0 0 0 0 0 1 0 0 1 0 
Hathewaya 0 0 1 0 0 0 0 0 0 0 0 
Herbaspirillum 0 0 0 0 0 0 0 1 0 0 0 
Jeotgalibacillus 0 0 0 0 0 0 0 1 0 0 1 
Jeotgalicoccus 7 5 6 3 2 5 10 4 2 4 7 
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 S. hominis ID 
Predicted donor genus 385 372 387 620 207 623 479 208 209 386 K1 
Kroppenstedtia 0 0 0 0 0 0 0 0 0 0 1 
Kurthia 0 1 2 1 3 1 0 1 3 2 1 
Lachnoanaerobaculum 1 0 0 0 0 0 0 1 0 0 0 
Lactobacillus 9 8 9 6 9 8 9 7 9 9 10 
Lentibacillus 0 0 0 0 0 0 4 7 0 0 2 
Leptotrichia 1 0 0 0 0 0 0 0 0 0 0 
Listeria 3 3 3 3 5 3 8 4 5 3 3 
Lysinibacillus 3 5 5 5 5 5 3 2 5 5 2 
Macrococcus 22 24 18 21 26 24 24 25 26 24 34 
Marinilactibacillus 0 0 0 0 0 0 0 0 0 1 0 
Marinococcus 1 1 0 1 0 1 1 1 0 0 1 
Massilibacterium 1 1 1 1 1 1 1 1 1 1 1 
Micrococcus 0 0 0 0 0 0 0 0 0 0 1 
Mycoplasma 0 0 1 0 0 0 0 0 0 0 0 
Neisseria 0 0 0 0 0 0 1 0 0 0 0 
Nocardia 0 0 0 0 0 0 0 1 0 1 0 
Nosocomiicoccus 3 1 1 1 4 1 6 2 4 2 8 
Oceanobacillus 7 7 9 7 10 7 8 10 10 10 10 
Oenococcus 0 0 0 0 1 0 1 0 1 0 0 
Oribacterium 1 2 2 2 2 2 2 2 2 2 2 
Ornithinibacillus 0 1 0 1 2 1 1 1 2 0 0 
Paenibacillus 4 4 6 2 3 3 3 2 2 3 5 
Paucisalibacillus 0 0 0 0 0 0 0 0 0 0 1 
Pediococcus 0 0 0 0 0 0 0 0 0 0 1 
Peptoclostridium 1 1 1 1 1 1 1 1 1 1 1 
Phormidesmis 0 0 0 0 0 0 0 0 0 0 1 
Planococcus 2 2 4 2 3 2 2 2 3 4 3 
Pontibacillus 0 0 0 0 0 0 1 0 0 0 0 
Providencia 0 0 0 0 0 0 0 1 0 0 0 
Pseudomonas 5 0 0 0 0 0 0 0 0 0 4 
Rummeliibacillus 0 0 0 0 0 0 0 0 0 0 1 
Saccharibacillus 0 0 0 0 0 0 0 1 0 0 0 
Salimicrobium 0 0 0 0 1 0 0 0 1 0 0 
Salinicoccus 26 26 28 21 31 26 26 30 26 27 18 
Salsuginibacillus 1 1 0 1 0 1 0 0 0 0 1 
Solibacillus 1 0 0 0 0 0 0 0 0 0 1 
Sporolactobacillus 2 1 0 1 0 1 1 0 0 1 0 
Sporosarcina 3 4 2 4 3 3 4 2 3 4 3 
Streptococcus 8 6 9 6 6 6 8 7 7 7 5 
Streptomyces 0 0 0 0 1 0 4 0 1 0 2 
Sulfobacillus 1 0 0 0 0 0 0 0 0 0 0 
Terribacillus 1 1 1 1 1 1 1 1 1 1 1 
Tetragenococcus 2 1 1 1 2 1 2 2 2 1 1 
Thalassobacillus 0 0 2 0 1 0 0 1 1 1 1 
Thermoactinomyces 0 0 0 0 0 0 0 0 0 0 1 
Trichococcus 0 1 1 0 0 1 0 0 0 2 0 
Tuberibacillus 0 0 1 0 1 0 0 0 1 0 0 
Tumebacillus 0 0 0 0 0 0 0 1 0 0 0 
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 S. hominis ID 
Predicted donor genus 385 372 387 620 207 623 479 208 209 386 K1 
Vagococcus 1 1 1 1 1 1 1 1 1 1 1 
Veillonella 1 0 2 0 1 0 0 3 1 0 0 
Virgibacillus 4 1 1 1 0 1 1 1 0 1 2 
Viridibacillus 0 0 0 0 0 0 0 0 0 0 1 
Vulcanibacillus 0 0 0 0 1 0 0 0 1 0 0 
Table 6.3: MecA+ S. hominis isolates from public settings in East and West London and 
reference S. hominis K1 HGT-derived genes by their putative donor genus as indicated by 
the best distal match. 
Ten out of 12 antibiotic resistance genes were predicted to be horizontally transferred 
from other organisms (Table 6.4). The only genes not predicted to be horizontally 
transferred were ANT(4’)-Ib and APH(3')-IIIa. 
S. hominis ID 
Antibiotic resistance 




 mecA Macrococcus canis 
 qacA/B Bacillus ndiopicus 
 msrA Veillonella atypica 




 mecA Macrococcus canis 
 msrA Veillonella atypica 
 sat-4A Faecalicatena contorta 
 fusC Enterococcus spp. GMD1E 




 mecA Macrococcus canis 
 qacA/B Bacillus ndiopicus 
 msrA Veillonella atypica 




 mecA Macrococcus canis 




 qacA/B Bacillus ndiopicus 




 qacA/B Bacillus ndiopicus 
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 qacA/B Bacillus ndiopicus 
 msrA Veillonella atypica 
 mphC Veillonella atypica 
 fusC Enterococcus spp. GMD1E 
479 lnuA Lactobacillus johnsonii 




 qacA/B Bacillus ndiopicus 
 ermC Neisseria meningitidis MC58 
 tet(K) Streptomyces cinnamoneus 
 fusB Enterococcus thailandicus 








Table 6.4: Horizontally transferred antibiotic resistance genes in mecA+ S. hominis isolates 
from East and West London and the predicted donor organisms 
5 virulence genes out of 12 were predicted to be horizontally transferred but only in 4 of 
the 10 isolates (207, 209, 385, 479) (Table 6.5).  Interestingly, in isolate 479 among three 
intercellular adhesins genes responsible for biofilm production, only the icaA was 
predicted to be horizontally transferred but not icaB and icaC. The majority of the capsule 
genes that were predicted to be horizontally transferred were found to be donated from 
Listeria grayi DSM 20601 and Nosocomiicoccus genus. 
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S. hominis ID Virulence genes Closest predicted donors 
207 capsule Nosocomiicoccus spp. HMSC067E10 
 capsule Nosocomiicoccus ampullae 
 capsule Nosocomiicoccus spp. HMSC09A07 
 capsule Listeria grayi DSM 20601 
 capsule Listeria grayi DSM 20601 
 
Polysaccharide 
capsule Ornithinibacillus californiensis 
 
Polysaccharide 
capsule Vulcanibacillus modesticaldus 
 wbtE Amphibacillus sediminis NBRC 103570 
209 capsule Listeria grayi DSM 20601 
 capsule Listeria grayi DSM 20601 
 capsule Nosocomiicoccus spp. HMSC09A07 
 capsule Nosocomiicoccus ampullae 
 capsule Nosocomiicoccus spp. HMSC067E10 
 
Polysaccharide 
capsule Vulcanibacillus modesticaldus 
 
Polysaccharide 
capsule Ornithinibacillus californiensis 
 wbtE Amphibacillus sediminis NBRC 103570 
385 icaA Macrococcus caseolyticus JCSC5402 
479 capsule Salinicoccus luteus DSM 17002 
 capsule Listeria grayi DSM 20601 
 capsule Nosocomiicoccus spp. HMSC059G07 
 capsule Listeria grayi DSM 20601 
 capsule Listeria grayi DSM 20601 
 capsule Listeria grayi DSM 20601 
 capsule Listeria grayi DSM 20601 
 capsule Listeria grayi DSM 20601 
 capsule Nosocomiicoccus ampullae 
 capsule Listeria grayi DSM 20601 
 capsule Listeria grayi DSM 20601 
 capsule Listeria grayi DSM 20601 
 cylR2 Clostridium spp. W14A 
Table 6.5: Horizontally transferred virulence genes in mecA+ S. hominis isolates recovered 
from public areas in East and West London 
6.3.3 Antibiotic resistance genes carried within a genomic island of mecA+ S. hominis 
recovered from public settings in East and West London  
Genomic islands were predicted in 10 mecA+ S. hominis isolates recovered from East and 
West London based on the Islandviewer 4 method (Table 6.6). The mecA+ gene was not 
identified as being within these predicted genomic islands. From the 10 mecA+ S. hominis 
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isolates 2 (20%) had 4 antibiotic resistance genes, 3 (30%) had 2 antibiotic resistance 
genes, and 2 (20%) had one antibiotic resistance gene and 3 (30%) had no antibiotic 
resistance genes found within their genomic island. The most common antibiotic 
resistance genes found within the genomic island were qacA/B (n=5); then blaZ, msrA 
(n=2); APH(3')-IIIa, sat4A, fusB, lnuA and ANT(4')-lb (n=1). In addition, 2 isolates had 
virulence genes predicted within their genomic island. These genes were carried in isolate 











207 6 msrA  
  qacA/B  
208 10 fusC  
  APH(3')-IIIa  
  blaZ  
  Sat-4A  
209 7 msrA  
  qacA/B  
372 7   
385 9 qacA/B icaA 
   icaB 
   icaC 
386 8 qacA/B  
387 8 fusC  
  blaZ  
479 6 fusB cylR2 
  qacA/B  
  ANT(4')-lb  
  lnuA  
620 6   
623 7   






6.3.4 Antibiotic resistance genes carried on plasmids 
All mecA+ S. hominis isolates from public settings from East and West London (n=10) 
were predicted to possess plasmids of which 4 isolates were identified to carry the 
majority of their antibiotic resistance genes on plasmids (Table 6.7). Between 1 and 5 
plasmids were identified per isolate of which 1 isolate (10%) had 6 antibiotic resistance 
genes carried on plasmids; 2 isolates (20%) had 5 antibiotic resistance gene carried on its 
plasmids; 1 isolate (10%) had 3 antibiotic resistance genes carried on a plasmid; 3 isolates 
(30%) had 1 antibiotic resistance gene carried on a plasmid whereas 3 isolates (30%) had 
no antibiotic resistance gene. Isolate 207 had 5 antibiotic resistance genes encoded on a 
single genome. The most common antibiotic resistance gene encoded on the plasmid was 
qacA/B (n=6) followed by fusB and ANT(4’)-Ib (n=3), blaZ, mphC , ermC and then msrA 
(n=2) and lnuA and tet(K)(n=1). A virulence gene cylR2 was predicted to be carried on a 


















genes (and plasmids 
they were found on) 
207 2 1:5 qacA/B (Plasmid 1) 
   ANT(4')-lb (Plasmid 1) 
   fusB (Plasmid 1) 
   blaZ (Plasmid 1) 
   msrA (Plasmid 1) 
208 5 6:1 msrA (plasmid1) 
209 3 1:6 qacA/B (Plasmid 1) 
   ANT(4')-lb (Plasmid 1) 
   blaZ (Plasmid 1) 
   fusB (Plasmid 1) 
   ermC (Plasmid 2) 
372 1 2:0 No genes 
385 1 1:1 qacA/B (Plasmid 1) 
386 2 1:1 qacA/B (Plasmid 1) 
387 2 3:3 qacA/B (Plasmid 1) 
   mphC (Plasmid 1) 
   msrA (Plasmid 1) 
479 3 2:6 qacA/B (Plasmid 1) 
   ANT(4')-lb (Plasmid 1) 
   fusB (Plasmid 1) 
   tet(K) (Plasmid 1) 
   lnuA (Plasmid 2) 
   ErmC (Plasmid 3) 
620 1 2:0 no genes 
623 1 2:0 no genes 
Table 6.7: Number of plasmids and the antibiotic resistance genes carried on a plasmid in 
mecA+ S. hominis isolates recovered from public areas from East and West London  
6.3.5 Phage prediction in S. hominis isolates 
Phage insertion was predicted in all the S. hominis isolates to different degrees of 
completeness using the PHASTER software (Table 6.8). Two isolates (20%) had 
complete phage insertion, 1 isolate has questionable phage insertion (if the phage is intact 
or not due to missing some phage genes) and the rest were incomplete. Complete phage 
insertion regions were predicted to be phages previous associated with infecting 
Staphylococcus. A few of the incomplete phage insertion regions were predicted to have 
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homology to phage proteins (integrases, head protein and transposase) that were 
associated with infection of Bacillus, Prochlorococcus and lactobacillus.  One isolate 
(10%) had 7 phage insertion regions, 4 isolates (40%) had 4 phage insertion regions, 2 
isolates (20%) had 3 phage insertion regions, 1 isolate (10%) had 2 phage insertion 
regions, and 3 isolates (30%) had 1 phage insertion region. No antibiotic resistance gene 
or virulence genes were predicted to be carried on the phage insertion region. 
S. hominis ID Most common phages Completeness 
207 Staphylococcus phage StB12 Intact 
 Staphylococcus phage SPbeta-like Incomplete 
208 Staphylococcus phage SPbeta-like Incomplete 
 Staphylococcus phage PT1028 Questionable 
209 Staphylococcus phage StB12 Intact 
 Staphylococcus phage SPbeta-like Incomplete 
372 Staphylococcus phage SPbeta-like Incomplete 
385 Bacillus phage JL Incomplete 
 Lactobacillus prophage Lj965 Incomplete 
 Prochlorococcus phage P-SSM7 Incomplete 
 Staphylococcus phage phiIPLA-RODI Incomplete 
 Staphylococcus phage SPbeta-like Incomplete 
 Staphylococcus phage PT1028 Incomplete 
 Staphylococcus phage PT1028 Incomplete 
386 Staphylococcus phage SPbeta-like Incomplete 
387 Staphylococcus phage SPbeta-like Incomplete 
479 Staphylococcus phage phiRS7 Incomplete 
620 Staphylococcus phage SPbeta-like Incomplete 
623 Staphylococcus phage SPbeta-like Incomplete 
Table 6.8: Phage prediction in mecA+ S. hominis isolates recovered from East and West 




6.3.6 Phylogenetic analysis of mecA+ S. hominis isolates recovered from East and 
West London compared with S. hominis reference isolates from ENA database 
10 mecA+ S. hominis isolates from public areas in East and West London in this study 
were phylogenetically compared with S. hominis isolates from the ENA database that was 
recovered from different sources to determine their relatedness. This included isolates 
recovered from clinical samples (from blood; n=11); healthy human skin (n=6); livestock 
(cows) (n=11) and mosquitos isolates (n=3); isolates recovered from environments 
(ancient permafrost and air sample from residential area) (n=2) and plant isolates (Kefir 
seeds and rice seeds) (n=2). SNP core phylogenetic tree of S. hominis isolates contained 
2 distinct clades (Figure 6.2). Clade A consisted of isolates from the ENA database 
recovered from livestock (cows), healthy human skin, air in residential areas, whereas 
clade B consisted of isolates from the ENA database recovered from clinical samples, 
healthy human skin, Kefir grain and rice seeds, mosquitos and ancient permafrost. Among 
mecA+ S. hominis, isolates recovered from public areas in East and West London, isolate 
385 from public areas in hospitals was found in clade A, whereas the remaining of the 
isolates were found in clade B. Isolates recovered from hospitals in East and West London 
(387, 386, 620, 623 and 372) were found in the same subclade and were genetically 
similar to isolates from the ENA database recovered from healthy humans (ZBW5). 
Isolates from West London public areas in the community (207, 208 and 209) were on 
the same subclade and were genetically related to healthy human isolate from skin 
(UMB022), environmental isolates from ancient permafrost in Russia (MMP2) and Asian 
Malaria Mosquito bodies (AS1, AS2 and AS3) and Kefir seeds (KR) (Hughes et al., 2016; 
Kashuba et al., 2017). However, isolate 207, 208 and 209 in this subclade had some 
divergence in their most common ancestor in comparison to the ENA database isolate. 
East London isolate 385 was genetically related to isolates recovered from healthy 
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humans (Hudgins) and air samples from residential areas (H69). Interestingly, isolate 479 
recovered from West London hospital was not genetically related to other isolates. All 
but the mosquito isolates and the permafrost isolates were shown to harbour the mecA 
gene, which was genetically related to isolates from public settings in London. Isolates 
from the ENA database that were recovered from clinical samples and 8 out of 10 isolates 
from the ENA database that were recovered from livestock (SNUC 2444, SNUC 5746, 
SNUC 3403, SNUC 5852, SNUC 4474, SNUC 2620, SNUC 5336 and SNUC 3870) were 
not genetically related to isolates recovered from other areas.
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Figure 6.2: SNP core maximum likelihood phylogenetic tree of 45 S. hominis isolates from 
different sources. Red highlight= Isolates from this study 
 
PopPUNK analyses identified 23 combined clusters, of which at least 5 distinct clusters 
were identified for an accessory genome (Figure 6.3). Clinical isolates accessory genomes 
were found to be clustered together (cluster 5) separately from other isolates recovered 
from different sources. Additionally, 8 of the S. hominis isolates from the ENA database 




Time scale 0.01 
A 
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4474, SNUC 2620, SNUC 5336 and SNUC 3870) were found in a different cluster 
(cluster 2) to isolates recovered from other sources. All of the mecA+ isolate recovered 
from public settings in hospitals except for isolate 385 were found in the same accessory 
genome cluster (cluster 4). This cluster includes isolate 479 which was previously shown 
not to be phylogenetically related to other isolates by its core genome. These isolates from 
public settings in cluster 4 were related by their accessory genome to isolates from the 
ENA database that were recovered from healthy human skin, rice seed (RE2.10) and air 












Figure 6 3: t-SNE analyses of the distance of the accessory genome in 45 S. hominis isolates, including mecA+ S. hominis isolates recovered from public 
settings in East and West London. The analysis was performed using PopPUNK pipeline.  Maximum number of mixture components was set at 5 and for the 
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6.3.7 Pangenome analysis of S. hominis 
A pangenome analysis was performed for 45 S. hominis, including the 10 mecA+ S. 
hominis isolates recovered from public settings in East and West London and those 
obtained from the ENA database. In total, there were 6,386 genes, of which 1,148 (18.0%) 
were considered to be core. 405 (6.3%) of the genes were softcore gene (present in 95-
99% of the isolates); 1,195 (18.7%) of the genes were shell genes (present in 15-95% of 
the isolates) and 3,638 (57.0%) of the genes were considered cloud genes (present in ≤ 15% 
of the isolates). A hierarchy clustering heatmap of the ‘presence/absence’ of the 6,386 
genes showed that there was a clustering of isolates obtained from the ENA database 
(those recovered from clinical samples and 8 out 10 isolates recovered from livestock) 
(Figure 6.4). Twenty-two unique genes were identified in all isolates from the ENA 
database recovered from clinical samples, of which 15 genes were predicted as 
hypothetical. The genes which were not hypothetical were chromosome recombinase 
genes ccrA3/B3; transposition regulatory protein allele tnpB; cadmium resistance genes 
cadA, cadX and cadD allele; putative DNA repair protein, radC and copper-sensing 
transcriptional repressor ricR. For the isolates from the ENA database recovered from 
livestock, there were no unique genes that were present in all 10 isolates.  
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Figure 6.4: Hierarchy clustering heatmap of the presence/ absence of genes in 83 S. hominis based on their isolation source. Red tile present of gene; 






18 antibiotic resistance genes and 16 virulence genes were predicted in 45 S. hominis 
isolates in the pangenome analysis (Table 6.9 and 6.10). No antibiotic resistance genes or 
virulence genes were ubiquitously found in the 45 S. hominis. The most common 
antibiotic resistance genes predicted were mecA, qacA/B and blaZ (51.1%, 51.1% and 
48.9% respectively) and the most common virulence genes predicted were lip, capB and 
polysaccharide capsule (97.8%, 95.6% and 93.3% respectively). Antibiotic resistance 
genes aad(6) and TEM-116 were identified in a single isolate from ancient permafrost 
(MMP2) and mosquito (As3) respectively. Antibiotic resistance gene dfrC was only 
found in isolates recovered from clinical samples. Interestingly, the intercellular adhesion 
genes icaA, icaB and icaC were only found in sample 385 from the East London Hospital. 
From these isolates, 1 isolate (2.2%) had 15 polysaccharide capsule genes; 2 isolates 
(4.4%) had 14 polysaccharide capsule gene; 6 isolates (13.3%) had 7 polysaccharide 
capsule genes; 2 isolates (4.4%) had 6 polysaccharide capsule genes; 1 isolate (2.2%) had 
3 polysaccharide capsule genes and 29 (64.5%) had 1 polysaccharide capsule genes 
(Table 6.11). From the mecA+ S. hominis isolates from public settings in East and West 
London 1 (10%) isolate has 15 polysaccharide capsule gene, 2 (20%) isolate have 6 
polysaccharide capsule genes and 7 (70%) isolate has 1 (10%) polysaccharide capsule 
genes. A hierarchy clustering heatmap shows no clustering based on the source of 
isolations for antibiotic resistance or virulence genes though isolates from West London 
community had similar resistance profiles with reference isolates recovered from clinical 




genes List of antibiotic classes 
Percentage 
(%) 
TEM-116 cephalosporin, monobactam, penam 2.2 
ANT(4')-Ib aminoglycoside 15.6 
qacA/B fluoroquinolone 51.1 
mphC macrolide 26.7 
lnuA lincosamide  11.1 
tet(k) Tetracycline 35.6 
blaZ Penam 48.9 
cat Phenicol 11.1 
msrA streptogramin, macrolide 33.3 
ermC streptogramin, lincosamide, macrolide 11.1 
AAC(6')-le-APH(2")-la aminoglycoside 17.8 
APH(3')-IIIa aminoglycoside 13.3 
mecA 
carbapenem, cephalosporin, penam, cephamycin, mon
obactam 51.1 
fusC fusidic acid 11.1 
dfrC diaminopyrimidine 4.4 
sat-4A nucleoside antibiotic  11.1 
fusB fusidic acid 11.1 
aad(6) aminoglycoside 2.2 
Table 6.9: Percentage of antibiotic resistance genes in 45 S. hominis included in the 
pangenome analysis 
Virulence genes Functions Percentage (%) 
atl Autolysin 86.7 
lip Lipase 97.8 
nuc Thermonuclease 91.1 
capsule Polysaccharide capsule 82.2 
capB Polyglutamic acid capsule 95.6 
capC Polyglutamic acid capsule 84.4 
gtaB Polysaccharide capsule 13.3 
capsule (Acinetobacter) capsule 13.3 
uge Capsule (Klebsiella) 8.9 
wbtE LPS 8.9 
wbtP LPS 6.7 
cylR2 Cytolysin 4.4 
polysaccharide capsule  polysaccharide capsule 93.3 
icaA Intercellular adhesion 2.2 
icaB Intercellular adhesion 2.2 
icaC Intercellular adhesion 2.2 




S. hominis ID Source Number of capsule genes 
As1 Animal 1 
As2 Animal 1 
As3 Animal 0 
BHG17 Animal 1 
K1 Animal 3 
SNUC_2444 Animal 1 
SNUC_2620 Animal 7 
SNUC_2694 Animal 7 
SNUC_3404 Animal 1 
SNUC_3870 Animal 14 
SNUC_4474 Animal 1 
SNUC_5336 Animal 14 
SNUC_5746 Animal 1 
SNUC_5852 Animal 1 
CCUG_42399 Clinical 6 
SH04_17 Clinical 1 
SH08_17 Clinical 1 
SRR5482191 Clinical 1 
SRR5482195 Clinical 0 
SRR5482196 Clinical 1 
SRR5482198 Clinical 1 
SRR5482200 Clinical 0 







372 East London Hospital 1 
385 East London Hospital 1 
386 East London Hospital 1 
387 East London Hospital 1 
H69 Environment 7 
MMP2 Environment 1 
C80 Human 7 
HUDGINS Human 1 
J11 Human 7 
NCTC_11320 Human 7 
UMB0272 Human 1 







207 West London Community 6 
208 West London Community 1 
209 West London Community 6 
479 West London Hospital 15 
620 West London Hospital 1 
623 West London Hospital 1 
Table 6.11: Number of capsule genes to isolation source in the 45 S. hominis isolates. Blue 






























































































Figure 6.5: Hierarchy clustering heatmap of antibiotic resistance and virulence genes found in 45 S. hominis isolates used for the pangenome 
analysis.(A) Hierarchy clustered heatmap of antibiotic resistance genes by Isolation source; (B) Hierarchy clustered heatmap of virulence genes by 




































































The COG family group was identified for the core and accessory genes in S. hominis 
pangenome analysis (Table 6.12). In the core genome, the highest portion of the genes 
was predicted to be the general function prediction only (12.5%) followed by amino acid 
transport and metabolism (10.0%) and translation, ribosomal structure and biogenesis 
(9.8%). In the accessory genome, the highest portion of the genes was predicted to be the 
general function prediction only (15.9%) followed by function unknown prediction only 
(13.0%) and transcription (10.7%).
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Percentage (%) of 
genes found in the 
pangenome 
Function Core Accessory 
Translation, ribosomal structure and biogenesis 9.5 2.5 
RNA processing and modification 0.0 0.0 
Transcription; 6.3 9.4 
Replication, recombination and repair 4.8 15.0 
Chromatin structure and dynamics 0.1 1.2 
Cell cycle control, cell division, chromosome 
partitioning 0.9 3.1 
Nuclear structure 0.0 0.0 
Defence mechanisms 1.2 2.2 
Signal transduction mechanisms 3.2 8.5 
Cell wall/membrane/envelope biogenesis 3.4 0.1 
Cell motility 0.2 0.0 
Cytoskeleton 0.0 0.0 
Extracellular structures 0.0 0.0 
Intracellular trafficking, secretion, and vesicular 
transport 1.2 0.9 
Posttranslational modification, protein turnover, 
chaperones 3.7 1.6 
Energy production and conversion 7.4 2.8 
Carbohydrate transport and metabolism 5.8 8.0 
Amino acid transport and metabolism 9.5 6.6 
Nucleotide transport and metabolism 4.6 1.7 
Coenzyme transport and metabolism 6.2 2.4 
Lipid transport and metabolism 2.7 2.3 
Inorganic ion transport and metabolism 6.6 5.7 
Secondary metabolites biosynthesis, transport 
and catabolism 1.5 1.6 
General function prediction only  11.8 13.6 
Function unknown 9.7 10.7 
Table 6.12: COG family group of genes in the core and accessory genome of S. hominis 
isolates 
 291 
The COG family group was identified for the unique genes in mecA+ S. hominis isolates 
from public settings in East and West London (Table 6.13). 334 genes were identified as 
being unique to public setting isolates from East and West London. The highest portion 
of the unique genes belonged to replication, recombination and repair (19.4%); general 
function prediction only (16.3%) and function unknown (13.4%).
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Function 
Percentage (%) of genes in the 
pangenome unique to S. hominis 
isolates from East and West London 
Translation, ribosomal structure and 
biogenesis  1.7 
Transcription  13.2 
Replication, recombination and repair  19.4 
Cell cycle control, cell division, 
chromosome partitioning  0.5 
Defense mechanisms  6.7 
Signal transduction mechanisms  1.3 
Cell wall/membrane/envelope biogenesis  8.2 
Posttranslational modification, protein 
turnover, chaperones  0.6 
Carbohydrate transport and metabolism  4.7 
Amino acid transport and metabolism  6.5 
Nucleotide transport and metabolism  0.9 
Coenzyme transport and metabolism  0.9 
Lipid transport and metabolism  0.7 
Inorganic ion transport and metabolism  5.0 
General function prediction only  16.3 
Function unknown  13.4 
Table 6.13: Unique genes of COG family in 10 mecA+ S. hominis isolates recovered from 
public setting in East and West London 
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Comparative analysis of the accessory genome in mecA+ S. hominis isolates from public 
settings in East and West London showed that the East London mecA+ isolates had 320 
genes that were not found in West London isolates, whereas isolates recovered from West 
London had 517 genes that were not found in mecA+ East London isolates. Only 1 gene 
was ubiquitous in mecA+ East London isolates that was not found in mecA+ West London 
isolates. This was the arsC gene that encodes for arsenate reductase (glutaredoxin), 
whereas there were no genes that were ubiquitous to mecA+ West London isolates but not 
present in East London isolates. General Public setting isolates were predicted to have 
311 unique genes not identified in mecA+ isolates in public areas in hospitals, whereas 
mecA+ isolates recovered from public areas in hospital had 625 unique genes not found 
in public areas in the community. 6 genes were ubiquitous to isolates recovered from 
general public settings, but these were not found in isolates recovered from public areas 
in hospitals, whereas 3 genes were ubiquitous to mecA+ isolates from public areas from 
the hospital, which were not present in isolates from general public settings. The known 
function of unique ubiquitous genes in mecA+ isolates recovered from public areas from 
the community was bacteriophage integrase; spore coat protein and 
recombinase/resolvase. Whereas, the known function of the ubiquitous genes unique to 
isolates recovered from mecA+ isolates from public areas in hospitals was oligopeptide; 
ABC superfamily, ATP binding cassette transporter and membrane protein. There was no 
difference in the COG function of the genes that were found in mecA+ isolates recovered 
from East and West London. There was a higher proportion of unique genes of COG 
function in mecA+ isolates recovered from general public settings than in the mecA+ 
isolates recovered from public areas in hospitals that had a function for transcription (12.6% 
and 8.0% respectively (P=0.0255)); replication, recombination and repair (21.9% and 
15.6% respectively (P=0.0411)) defense mechanisms (12.6% and 3.5%) respectively 
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(P=<0.0001)) and translation, ribosomal structure and biogenesis (3.9% and 1.3% 
respectively  (P=0.0104)) (Table  6.14). There was a higher proportion of unique genes 
of the COG function in mecA+ isolates recovered from public areas in hospitals compared 
with mecA+ isolates recovered from general public settings with the function of inorganic 
ion transport and metabolism 11.9% and 3.4% respectively  (P=<0.0001); energy 
production and conversion 3.3% and 0.9% respectively (P=0.0265); amino acid transport 
and metabolism 6.1% and 2.6% respectively (P=0.0216) (Table 6.15). 
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Percentage (%) of unique 
genes in the pangenome from 
East and West London 
COG Function East London West London 
Translation, ribosomal structure and biogenesis 1.3 1.2 
RNA processing and modification 0.0 0.0 
Transcription 8.0 8.3 
Replication, recombination and repair 15.6 17.5 
Chromatin structure and dynamics 0.0 0.0 
Cell cycle control, cell division, chromosome 
partitioning 0.8 0.3 
Nuclear structure 0.0 0.0 
Defence mechanisms 3.4 3.6 
Signal transduction mechanisms 2.0 3.1 
Cell wall/membrane/envelope biogenesis;  10.7 10.8 
Cell motility 0.3 0.6 
Cytoskeleton 0.0 0.0 
Extracellular structures 0.0 0.0 
Intracellular trafficking, secretion, and vesicular 
transport 1.0 0.6 
Posttranslational modification, protein turnover, 
chaperones 0.9 1.0 
Energy production and conversion  3.3 1.9 
Carbohydrate transport and metabolism 7.5 8.1 
Amino acid transport and metabolism 6.1 6.3 
Nucleotide transport and metabolism 0.6 1.2 
Coenzyme transport and metabolism 1.5 0.7 
Lipid transport and metabolism 1.4 1.9 
Inorganic ion transport and metabolism 11.9 9.1 
Secondary metabolites biosynthesis, transport and 
catabolism 2.1 3.3 
General function prediction only  10.4 10.4 
Function unknown 11.1 10.2 
Table 6.14: Difference in COG function of the unique genes in mecA+ S. hominis 
isolates recovered from different environmental sites in East and West London. *= The area 





Percentage (%) of unique genes in 
the pangenome from London 
public settings in the Community 
and public areas in Hospital  
COG function Community Hospital 
Translation, ribosomal structure and biogenesis 3.9 1.3 
RNA processing and modification 0.0 0.0 
Transcription 12.6* 8.0 
Replication, recombination and repair 21.0* 15.6 
Chromatin structure and dynamics 0.0 0.0 
Cell cycle control, cell division, chromosome 
partitioning 2.2 0.8 
Nuclear structure 0.0 0.0 
Defence mechanisms 12.6* 3.4 
Signal transduction mechanisms 1.3 2.0 
Cell wall/membrane/envelope biogenesis;  7.2 10.7 
Cell motility 0.0 0.3 
Cytoskeleton 0.0 0.0 
Extracellular structures 0.0 0.0 
Intracellular trafficking, secretion, and 
vesicular transport 0.0 1.0 
Posttranslational modification, protein 
turnover, chaperones 0.0 0.9 
Energy production and conversion  0.9 3.3* 
Carbohydrate transport and metabolism 8.7 7.5 
Amino acid transport and metabolism 2.6 6.1* 
Nucleotide transport and metabolism 0.9 0.6 
Coenzyme transport and metabolism 1.8 1.5 
Lipid transport and metabolism 0.7 1.4 
Inorganic ion transport and metabolism 3.4 11.9* 
Secondary metabolites biosynthesis, transport 
and catabolism 0.7 2.1 
General function prediction only  12.5 10.4 
Function unknown 7.0 11.1 
Table 6.15: Difference in COG function the unique genes in mecA+ S. hominis isolates 
recovered from different environmental sites in public settings in the community and public 
areas in hospitals.*= The area where there was significantly higher (p=<0.05) percentage 




6.4.1 S. hominis: Virulence genes and HGT  
Similar to S. haemolyticus, S. hominis had a smaller pool of virulence genes compared to 
S. epidermidis. There are only a few studies that looked at  S. hominis virulence genes 
(Calkins et al., 2016; Saiping Jiang et al., 2012; Szczuka et al., 2018). Among the mecA+ 
isolates recovered from public areas in East and West London, Bacillus capsule genes, 
capB and capC were found in 95.6% and 84.4% respectively of all isolates used in the 
pangenome analyses including the mecA+ from public settings and the isolates from the 
ENA database. These virulence genes are normally found in Bacillus, but the 
polyglutamic acid capsule has not been reported before in S. hominis (Kocianova et al., 
2005). The genes capB and capC were not identified as being horizontally transferred 
from another organism into mecA+ isolates recovered from East and West London 
(Calkins et al., 2016). These genes, therefore, may have originated from S. hominis or 
have been transferred from another staphylococcal species as the HGTector pipeline can 
only distinguish genes transferred from bacteria from a different genus (Zhu et al., 2014). 
On the other hand, the polysaccharide capsule genes that were associated with S. hominis 
and other staphylococci were predicted to be horizontally transferred (Flahaut et al., 2008; 
O’Riordan and Lee, 2004). 3 of the mecA+ isolates from public settings (207, 209 and 
479) that were predicted to have multiple polysaccharide capsule genes that have been 
horizontally transferred from another genus (Flahaut et al., 2008; O’Riordan and Lee, 
2004). For the mecA+ S. haemolyticus isolates recovered from public settings, the 
predicted donor genus for these capsule genes was Listeria and Nosocomiicoccus. Isolates 
from ENA database and mecA+ S. hominis from this study either have 1, 6, 7, 14 or 15 
genes responsible for encoding for polysaccharide capsule. These finding were similar to 
the S. haemolyticus pangenome analyses in this study. However, there were some 
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exceptions, for example, S. hominis isolates had a higher number of polysaccharide 
capsule genes in isolates recovered from livestock (SNUC_3870 and SNUC_5336) than 
in clinical samples and one of the isolates in this study recovered from West London 
hospital (479) had 15 capsule genes. This would indicate that the polysaccharide capsule 
has evolved in isolates from livestock rather than in humans for S. hominis. Expect that 
these genes in S. hominis require multiple polysaccharide genes to produce virulence 
factors as it has been shown for S. aureus and S. haemolyticus to code for different 
functions (for example chain length determination; putative tyrosine protein kinase, 
putative phosphotyrosine-protein phosphatase, putative 4,6-dehydratase, glycolysis 
transferase and aminotransferase) in the production of the polysaccharide capsule 
(Flahaut et al., 2008; Kuipers et al., 2016) Additionally, a gene was found which encodes 
for capsules in Acinetobacter spp. and Klebsiella spp. (uge gene). Uge gene has been 
identified as being important in Klebsiella pneumoniae capsule production whereas the 
Acinetobacter capsule gene is shown to be one of the genes responsible for immune 
invasion in Acinetobacter baumannii (Regué et al., 2004; Singh et al., 2019). These 
virulence determents from Klebsiella pneumoniae and Acinetobacter baumannii may not 
be encoded in S. hominis, but these findings indicate that other virulence genes could 
potentially horizontally transfer from these species making S. hominis a more virulent 
variant.  
Interestingly, an isolate recovered from the East London hospital (385) was identified to 
possess the genes responsible for icaA, icaB and icaC gene but not icaD. These genes 
were not present in any other mecA+ S. hominis isolates from public settings in East and 
West London or from the S. hominis isolates from the ENA database. This contradicts 
studies that found the icaADBC operon was typically found in S. hominis isolates from 
clinical isolates recovered from blood (Soroush et al., 2017; Szczuka et al., 2015). The 
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small collection of WGS S. hominis available from the ENA database might have biased 
this data for non-biofilm producing S. hominis. It would be expected to see biofilm 
encoding genes in high abundance in clinical isolates as it is an important virulence factor 
as well as the mecA+ isolates from high-frequency touched surfaces as the adaption gives 
the organism a better chance to survive on abiotic surfaces (Khelissa et al., 2017). It is 
possible there may be another mechanism that is not known that can also produce biofilm 
similar to that found in S. haemolyticus isolates (Fredheim et al., 2009). IcaA gene found 
in the mecA+ isolate recovered from East London was predicted to be horizontally 
transferred but not the icaB or icaC gene. The predicted donor for icaA was Macrococcus 
caseolyticus the same donor predicted in mecA+ S. epidermidis isolates from general 
public settings. Additionally, these genes were predicted to be located within a genomic 
island region. This could indicate that biofilm producing genes can be found within a 
mobile genetic cassette in this S. hominis isolate and been transferred from another 
species. 
Similar to S. haemolyticus isolates, genes were identified that were responsible for 
lipopolysaccharide production for host immune invasion in Francisella (wbtE and wbtP) 
and the gene that is involved in cytolysin production in Enterococcus (cylR2). These 
genes were found in 8.9%, 6.7% and 4.4% of mecA+ isolates recovered from public 
settings and S. hominis isolate from the ENA database, respectively. WbtE and cylR2 
genes in mecA+ S. hominis isolates recovered from public setting were identified to be 
horizontally transferred from Amphibacillus sediminis NBRC 103570 and Clostridium 
spp. W14A respectively. Cytolysin has been previously reported in Clostridium species 
and lipopolysaccharide in Amphibacillus species (Antunes et al., 2016; Heuck et al., 
2010). In mecA+ S. haemolyticus isolates recovered from public settings the predicted 
donor for cylR2 (Virgibacillus spp. SK37 and Streptococcus spp. HMSC10A01) were 
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different than in mecA+ S. hominis isolates from public settings which suggest that this 
gene in S. haemolyticus and S. hominis may have different origins. As both of these genes 
were found within an operon with other genes that were responsible for encoding for 
cytolysin and lipopolysaccharide production, it is expected that the cylR2 gene alone will 
encode for cytolysin or that the wbtE and wbtP would encode for lipopolysaccharide 
production. These findings suggest that virulence genes may horizontally transfer to S. 
hominis from a different genus making it more virulent (Coburn et al., 2004; Twine et al., 
2012).  
6.4.2 S. hominis: Antibiotic resistance genes and HGT 
In the previous chapters, it was identified that many of the antibiotic resistance genes 
were carried on plasmids in mecA+ isolates recovered from public settings in East and 
West London. This was also observed in the mecA+ S. hominis isolates recovered from 
public settings.  In one of the isolates (207), 10 out of 12 antibiotic resistance genes were 
encoded on a single plasmid. This shows that S. hominis isolates recovered from public 
settings acquire genes via plasmid conjugation or transformation. The uptake of plasmids 
is a common method of horizontal gene transfer in bacteria which gives them the ability 
to quickly obtain multiple antibiotic resistance genes from a single plasmid or multiple 
plasmids making the bacterium multidrug resistance (Millan, 2018). Interestingly, the 
blaZ was identified to be donated from another organism which was not predicted in 
mecA+ S. epidermidis and S. hominis isolates from public settings from East or West 
London. The predicted donor was Propinobacterium namnetense though it most likely 
from an ancestor of the predicted donor species (Zhu et al., 2014). This suggests that the 
blaZ gene in S. hominis was transferred from another genus other than staphylococci. It 
was determined that antibiotic resistance genes were found within the host genome in 3 
of the mecA+ S. hominis isolates recovered from public settings (isolate 208, 209 and 387). 
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Antibiotic resistance genes found in different genomic island regions were the blaZ, fusC, 
msrA, APH (3')-IIIa and sat4A. Interestingly, all these genes were identified to be 
horizontally transferred from another donor except for APH (3')-IIIa. This indicates that 
these genes have been transferred from a different genus of bacteria either via plasmid 
which has then been integrated into the host genome or via transposons or mobile 
cassettes. The APH(3’)-IIIa gene was most likely transferred from another S. hominis 
isolate or other staphylococci isolate as HGTtector pipeline can only detect horizontal 
gene transfer from bacteria of a different genus to the one that was being analysed (Zhu 
et al., 2014).  
Pangenome analyses showed that antibiotic resistance genes TEM-116 and aad(6) were 
identified from a single isolate (As1 and MMP2, respectively). Although there is lack of 
data on antibiotic resistance gene abundance in S. hominis, studies have shown that these 
genes are rarely found in S. epidermidis based on the Comprehensive Antibiotic 
Resistance Database (Jia et al., 2017). Interestingly, these genes were identified in isolates 
recovered from ancient permafrost (MMP2) for aad(6) and mosquitoes bodies (As3) for 
TEM-116, which encode for aminoglycoside resistance and broad-spectrum beta-
lactamase, respectively. Finding the TEM-116 in isolate recovered from ancient 
permafrost would suggest that TEM-116 evolved before the antibiotic resistance genes 
were mass-produced and commonly used. This gene protects against fungi that produce 
beta-lactam antibiotics as a defence mechanism (Gao et al., 2017). Additionally, dfrC 
gene, which encodes resistance for the diaminopyrimidine antibiotics was only found in 
isolates recovered from clinical samples (blood). These data were similar to findings from 
this study in S. haemolyticus analyses. However, in S. epidermidis isolates recovered from 
different sources that possess the dfrC gene was relatively higher (94.4%). This suggests 
 302 
that dfrC gene originated from S. epidermidis and has horizontally been transferred to S. 
hominis and S. haemolyticus isolates in hospitals.  
Pangenome analyses of S. hominis isolates showed that these isolates possessed less mecA 
and blaZ (51.11%, 48.9%) compared to that of S. epidermidis (65.6% and 80% 
respectively) and S. haemolyticus (78.3% and 72.3% respectively) isolates analysed in 
previous chapters. This may be due to that S. hominis is not as frequently isolated as S. 
epidermidis and S. haemolyticus in hospitals. In addition, there are fewer studies reporting 
cases of S. hominis infections (Chaves et al., 2005; Spanu et al., 2003). Therefore, S. 
hominis isolates may not have been in frequent contact with beta-lactam antibiotics to 
gain or maintain mecA and blaZ antibiotic resistance genes.  
6.4.3 HGT of mecA+ S. hominis isolates recovered from East and West London 
The HGT derived genome of the mecA+ S. hominis recovered from public settings in East 
and West (7.8% to 9.5%) was similar to mecA+ S. epidermidis (8.6% to 10.1%) and mecA+ 
S. haemolyticus (8.9% to 13.5%) recovered from the same places. Interestingly, in mecA+ 
S. hominis isolates the genus that donated the most genes was Salinicoccus, whereas in S. 
haemolyticus and S. epidermidis this was predicted to be the third most common donor 
genus. The Salinicoccus genus can live in high pH environments and is not associated 
with humans, animals or other environments (Coburn et al., 2004; Twine et al., 2012). 
Salincicoccus and Staphylococcus share a common ancestor and belong to the same 
Staphylococcaceae family. 
Intact phages were identified in 2 of the 10 S. hominis isolates recovered from public 
settings (isolate 207 and 209). The other isolates were identified to have phages that were 
considered incomplete. This would suggest that an intact phage insertion sequence 
integrated recently into the host and that integrated genes from the phage have not been 
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deleted due to them not conferring adaption for survival and/or a metabolic burden 
(Ramisetty and Sudhakari, 2019). The gene which was identified to be intact was 
Staphylococcus phage StB12. This has previously been identified in mecA+ S. epidermidis 
and mecA+ S. haemolyticus isolates recovered from public settings and been also reported 
in S. hominis and S. capitis (Deghorain et al., 2012). This shows that S. hominis can 
acquire virulence genes from other staphylococci. Therefore, it is possible for S. hominis 
to horizontally transfer the S. aureus staphylokinases, superantigens, Panton-Valentine 
leukocidin virulent genes which are found to be transferred to another S. aureus isolates 
via phages (Goerke et al., 2009). Incomplete phages that show homology to phages 
associated with Bacillus, Synechococcus, Prochlorococcus and Lactobacillus. Due to 
incomplete phage sequence in other S. epidermidis and S. haemolyticus these phage 
sequences are phages that only infect staphylococci that have not been characterised yet. 
6.4.4 Phylogenetic and Pangenomic analysis of S. hominis isolates 
Similar to S. epidermidis and S. haemolyticus SNP core phylogenetic analysis, the mecA+ 
S. hominis isolates recovered from public settings in East and West London were 
genetically similar to isolates obtained from the ENA database that have previously been 
isolated from other sources. Although there was no mecA+ S. hominis isolates from this 
study that were genetically related to isolates to those obtained from the ENA database 
that were recovered from clinical samples (blood) or livestock  (cows), however they 
were related to isolates recovered from healthy human skin (Hudgins and ZBW5), air 
samples from residential areas (H69), from mosquitos’ bodies (As1, As2 and As3), 
ancient permafrost (MMP2) and Kefir seeds (KR) (Hughes et al., 2016; Rivera-Perez et 
al., 2016). This suggests that mosquitoes could be possible vectors for transmitting S. 
hominis while feeding on their host and that genetically these mecA+ S. hominis isolates 
recovered from general public settings have has not evolved much since ancient times 
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(Hughes et al., 2016). Mosquitos are vectors for viruses, protozoa and parasites that can 
spread and cause disease in humans and animals but currently, it is unreported if they can 
transfer and initiate bacterial infections (Huntington et al., 2016). Additionally, it is 
possible that mosquitoes could transfer livestock-associated S. hominis to humans. From 
this study, it was deduced that the isolates recovered from mosquitos is same genetic 
lineages of isolates originate from humans as they were found within the same subclade 
of isolate ZBW5 which was recovered from healthy human skin. Additionally, the 
findings that the mecA+ S. hominis isolates (385) in this study belonged to same genetic 
lineage as the isolate recovered from an air sample in a residential area (H69) suggests 
that S. hominis can be transmitted through the air from humans to high frequency touched 
surfaces or vice versa (Lymperopoulou et al., 2017). S. hominis isolates recovered from 
clinical samples from the ENA database were found together in the same subclades of the 
core phylogenetic tree (Figure 6.2) and clustered together by their accessory genome from 
the t-SNE analyse (Figure 6.3) and pangenome analyses (Figure 6.4). 8 out of 10 S. 
hominis livestock isolates (SNUC 2444, SNUC 5746, SNUC 3403, SNUC 5852, SNUC 
4474, SNUC 2620, SNUC 5336 and SNUC 3870) were found in the same cluster by their 
core and accessory genomes. This would suggest that S. hominis recovered from clinical 
isolates and the majority of livestock isolates has evolved separately from other sources 
and have not spread to different niches. In addition, these results suggest that S. hominis 
recovered from clinical samples are nosocomial isolates (Chaves et al., 2005). This is 
further supported for S. hominis by the fact that these clinically associated isolates share 
22 genes which were unique to them only. This included a gene which encodes for 
cadmium and copper resistance. Previous studies have shown the importance of cadmium 
resistance in Helicobacter pylori and Listeria monocytogenes virulence Copper resistance 
is also important for S. aureus survival within macrophages (Purves et al., 2018; Stähler 
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et al., 2006). Currently, it is unknown whether these genes can benefit to the virulence of 
S. hominis. Although from virulence gene profiles (Figure 6.5B) of 83 S. hominis isolates 
from public settings, ENA database animals’ isolates, ENA database isolates from healthy 
humans and ENA database isolates from the natural environment had the same virulence 
genes found in the ENA database isolates recovered from clinical samples. This suggests 
that in S. hominis, there may be other virulent factors that have not been characterised 
before. S. hominis isolates from public areas in hospitals were found within the same 
cluster in their accessory genome. This would indicate that these species in these areas 
have a similar pool of genes that can be horizontally transferred due to the similarities in 
the bacterial populations in that geographical area or environment required to survive in 
these niches (Segerman, 2012).  
As with the pangenome analysis of S. epidermidis and S. haemolyticus isolates from 
previous chapters S. hominis was also shown to be an open genome in which it seems 
there is an unlimited number of genes as part of the species gene pool (Figure 6.4). This 
suggests that S. hominis can be found in different environments within mixed microbial 
communities in which they can exchange genetic material to increase their gene pool 
(Bosi et al., 2015). In a similar manner to mecA+ S. epidermidis and mecA+ S. 
haemolyticus isolates from public settings had a high percentage of unique genes in the 
mecA+ S. hominis isolates recovered from public settings that belonged to replication, 
recombination and repair (19.43%), and the COG group. Although this was less than what 
was found in mecA+ S. epidermidis (24.41%) and mecA+ S. haemolyticus (34.25%) 
isolates from public settings. This may indicate fewer novel genes for these functions in 
S. hominis recovered from public settings. Additionally, there was a higher proportion of 
genes unique to mecA+ S. hominis isolates recovered form general public settings that 
code for replication, recombination and repair (20.97%) COG group compared to mecA+ 
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isolates (15.6%) recovered from public areas in hospitals. This was similar to that 
observed in this study for mecA+ S. haemolyticus isolates recovered from general public 
settings and public areas in hospitals. This would indicate that these bacterial species from 
general public settings are exposed to environmental factors such as to UV light, ionizing 
radiation and genotoxic chemicals which can cause DNA damage compared to those in 
hospitals (Žgur-Bertok, 2013). Additionally, mecA+ S. hominis isolates recovered from 
public areas in the community had a higher abundance of unique genes that encode for 
transcription, defense mechanisms and translation, ribosomal structure and biogenesis. 
Whereas mecA+ isolate in public areas in hospitals had a higher abundance of unique 
genes which encode for inorganic ion transport and metabolism, energy production and 
conversion, amino acid transport and metabolism. Interestingly some of these results 
contradict findings in mecA+ S. haemolyticus isolates in public settings as hospital isolates 
had significantly more genes for defense mechanisms. This could be due to the fact that 
S. hominis isolates were recovered from public settings in West London where mecA+ S. 
haemolyticus was recovered from public settings in East London. If there were sequences 
of isolates of S. hominis isolates from public areas in East London or S. haemolyticus 
isolates from public areas in West London, then it is possible to determine whether one 
area in the community would have a higher abundance of unique genes for defense 
mechanisms. Interestingly, one of the genes identified to be ubiquitous in mecA+ S. 
hominis isolates from public areas in the community was a spore coat protein. This is 
interesting, as staphylococci are non-spore forming bacteria; therefore, it is expect that 
this gene was not responsible for spore-coating formation in S. hominis (Pruitt et al., 
2007). It is possible that they have high homology to Bacillus spore coat protein but may 




In this chapter, public setting mecA+ S. hominis isolates from East and West London were 
genetically compared to S. hominis isolates from different sources from the ENA database. 
From the phylogenetic analysis, the genetic relatedness of S. hominis isolates from public 
settings was determined to that of other isolates from the ENA database  which has not 
previously done before. Additionally, the antibiotic resistance genes, virulent genes, 
mobile elements and the pangenome were also analysed. From these analyses, there were 
novel findings. These findings were: 
1. S. hominis has an array of virulence genes which have not been fully characterised 
including the capsule genes. Some of the isolates had a different number of genes 
that encode for the capsule gene. 
2. MecA+ S. hominis recovered from the public settings were related to isolates 
obtained from the ENA database recovered from mosquitos, healthy human skin, 
plants and air samples from residential areas. This shows that public setting 
isolates may have come from different sources and may have been transmitted via 
mosquitos or through the air.  
3. S. hominis recovered from clinical samples belong to a separate genetic lineage 
and have different accessory genome to that of other isolates which shows these 
isolates are most likely nosocomial and have not spread into different niches. 
4. The majority S. hominis recovered from livestock were shown to belong to same 
genetic lineages and have evolved separately to that of S. hominis isolates from 
different sources and have not spread into different niches based on their 
accessory genome. 
5. Similar to mecA+ S. haemolyticus isolates, the  mecA+ S. hominis recovered from 
general public settings had more unique genes that had a function for replication, 
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recombination and repair compared to mecA+ isolates recovered from hospitals, 
indicating that they experience more DNA damage in general public settings than 
in public areas in hospitals.  
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Chapter 7: Concluding remarks 
7.1 Introduction 
Antimicrobial resistance (AMR) is a public health concern. Currently, 700,000 people 
die worldwide from bacterial infections that no longer respond to antibiotics (O'Neill, 
2016). By 2050 it is predicted that the death toll will increase to 10 million as during the 
post-antibiotic era where simple bacterial infections will no longer be treatable (Bragg et 
al., 2018; O'Neill, 2016). Therefore, studies looking at the abundance of antibiotic 
resistant bacteria in different environments and ecological niches and studying their 
genetic features/lineages and the transmission of AMR genes between humans, livestock 
and the environment are very important to aid in understanding the evolution of multidrug 
resistant bacteria (MDR) and the factors driving antibiotic resistance and developing 
disease.  
 This is particularly important for staphylococci, as these bacteria are capable of 
colonising different human body sites (e.g. skin and nostrils) and have the potential to 
cause infections (Becker et al., 2014). Previous studies have shown that MDR 
staphylococci have been isolated from clinical samples, people from the community and 
livestock and wildlife animals, and have been linked to causing infectious diseases 
(Argudín et al., 2015b; Naimi, 2003; Stefani and Varaldo, 2003; Weese, 2010). However, 
there is a limited number of studies on the abundance of MDR staphylococci in public 
settings, and little is known about their clonal lineages/genetic variations and the potential 
risk they pose to public health (Argudín et al., 2015b; Chen et al., 2017; Conceição et al., 
2013; Green et al., 2010; Lutz et al., 2014, 2014; Seng et al., 2017b; Xu et al., 2015). 
Therefore, in this study, it was set out to determine the levels of MDR staphylococci 
recovered from high frequency touched surfaces in public settings in East and West 
London and from public areas in the community and public areas in hospitals. This study 
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aimed to identify the MDR mecA+ isolates and determine their genetic lineages and 
variations they evolved by using whole genome sequencing (WGS) analysis. Using the 
“One health” approach, WGS data in this study was compared to known isolates obtained 
from the ENA database that were previously recovered and examined by others, including 
those from clinical samples, agriculture and companion animals, plants and other 
environmental isolates to determine if isolates from public settings are a public health 
risk.  
7.2 Findings that link MDR staphylococci recovered from public settings as a 
potential public health risk and implications 
• A total of 600 samples were collected in this study. A large portion of them 
(46.8%) were MDR staphylococci. These isolates belonged to 11 different species 
and were resistant to a broad range of antibiotics, which coincides with previous 
studies (Seng et al., 2017b; Xu et al., 2015).  These results show that high 
frequency touched surfaces in public settings are reservoirs for MDR 
staphylococci, which have the potential to spread to people from different 
communities.  
• The most commonly found antibiotic staphylococcal isolates were resistant to was 
penicillin (80.42%), fusidic acid (72.4%), erythromycin (54.5%), amoxicillin 
(27.8%); tetracycline (26.3%); oxacillin (24.9%); cefoxitin (22.4%); mupirocin 
(14.6%); gentamycin (9.6%); cefepime (7.1%) and chloramphenicol (5.0%). 
These results show that if these isolates cause an infection, they may be unable to 
be treated due to their resistance to commonly used antibiotics. 
• There was a significantly higher proportion (P=0.0458) of MDR resistance 
staphylococci from public areas in hospitals (49.5%) than in general public 
settings (40.7%)  due to there being a higher usage of antibiotics in these areas 
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(Cantón and Morosini, 2011).  This indicates that isolates recovered from hospital 
settings would be harder to treat with antibiotics compared to isolates from public 
settings. 
• There was a significantly higher proportion (P=0.0002) of MDR resistant 
staphylococci from public areas in East London (56.7%) compared to West 
London (50.0%). This may be linked to East London having a higher population 
density (9.7x103 km2; 2017 estimate) compared to West London (8.9x103 km2; 
2017 estimate) (Park, 2017; Bruinsma et al., 2003).This shows that people who 
live in areas of high population density are at higher risk to be infected by MDR 
staphylococci.  
MecA+ S. epidermidis, S. haemolyticus and S. hominis from public settings had 
intact phage sequences in their genome that is known to infect other 
Staphylococcus species from other species including S. aureus. This suggest it is 
possible for CoNS in public environment to horizontally receive virulence genes 
(staphylokinases, superantigens, Panton-Valentine leucocidin)  in S. aureus that 
is found to be transferred to other S. aureus isolates via phages which could make 
these CoNS isolates more virulent and a significant risk to public health (Goerke 
et al., 2009).  
• Some of the S. epidermidis and S. haemolyticus mecA+ isolates in this study 
belonged to the same genetic lineages as the isolates obtained from the ENA 
database that were recovered from clinical blood, eye and urine samples which 
have not been previously reported.  Additionally, mecA+ S. epidermidis and S. 
haemolyticus shared similar virulent gene profiles and other accessory genes to 
that of known clinical isolates from the ENA database. These findings show that 
isolates recovered from high-frequency touched surfaces have the potential to 
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cause infection, which could be untreatable due to being MDR and hence pose a 
public health risk. 
• MecA+ S. epidermidis, S. haemolyticus and S. hominis isolates from public 
settings shared the same or similar antibiotic resistance and virulence gene 
profiles to that of isolates from the ENA database recovered from clinical samples. 
This implies that the mecA+ isolates from public settings may be able to cause 
infections in similar manner to that of clinical isolates which may be hard to treat 
as they have resistance to antibiotics which are mainly used in hospitals. 
7.3 Genetic variations identified in staphylococci recovered from public settings 
Apart from attempting to understand the levels of MDR staphylococci recovered from 
high-frequency touched surfaces and the potential health risk they pose. Additionally,  
genetic variations were identified that have previously not been described. 
• In this study, it was identified that the isolates recovered from public settings had 
a large array of SCCmec types many of which had not been reported due to them 
having additional or novel ccr complex elements which have only previously been 
identified in clinical and community-associated isolates (Chen et al., 2017b). This 
shows there may be many genetic variations that have been undiscovered in 
staphylococci as they may only be present in isolates from public settings.  
• MecA+ S. epidermidis, S. haemolyticus and S. hominis isolates in this study were 
genetically diverse, as shown in phylogenetic and pangenome studies. Apart from 
some of the mecA+ S. epidermidis and S. haemolyticus isolates from public 
settings being phylogenetically related to clinical isolates the other mecA+ isolates, 
they were also genetically related to isolates from the ENA database that were 
recovered from healthy humans, livestock, plants and other environmental isolates. 
Additionally, mecA+ S. haemolyticus isolate was genetically related to the ENA 
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database isolates recovered from companion animals. For mecA+ S. hominis they 
were genetically not related to isolate from the ENA database recovered from 
livestock but were genetically similar to isolate’s recovered from healthy humans, 
mosquitos, air samples in residential areas and environmental isolates. This shows 
that Staphylococcus can be spread into public settings either via human contact, 
food, animal born vectors or through the air. 
• MecA+ S. epidermidis, S. haemolyticus or S. hominis recovered from public 
settings in this study were clustered with isolates recovered from many different 
sources (the accessory genome phylogenetic analyses and pangenome). These 
results show that isolates recovered from public settings in this study are likely to 
be related to isolates that were recovered from different environments. This 
suggests that high-frequency touched surfaces in public settings carry different 
species of MDR staphylococci belonging to different lineages, potentially capable 
of transferring genes between different species from different sources.  
• Using pangenome analyses, it was identified that there were unique genes in S. 
epidermidis, S. haemolyticus and S. hominis that were only found in the mecA+ 
isolates recovered from the public settings; however, there were no genes 
identified which would have been detected in all samples or genes responsible for 
adaptation for survival in these environments.  
• Compared to isolates from the ENA database recovered from a different source, 
isolates recovered from public settings in this study possessed unique gene 
encoding for replication, recombination and repair. This suggests that 
staphylococci in public settings may be exposed to different environmental factors 
(UV light, ionising radiation and genotoxic chemicals), which could cause DNA 
damage ( Žgur-Bertok, 2013).   
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7.4 Limitations of this study 
To avoid sampling bias, up to 10 colonies of different morphology were randomly chosen 
for each swab taken. This was not always possible as some would have less than 10 on 
the plate with many of them being similar in their colony morphology; therefore, some 
colonies picked that were recovered from the same swabs could have had clonal identities.  
Due to cost and time restrictions, it was limited to only do WGS analyses of mecA+ 
isolates. If it was possible to WGS on all the MDR staphylococci, then it would be 
possible to identify isolates recovered from the same swab were clones as well as better 
understand the proportion of the isolates that pose a public health risk. 
During this study there were limiting factors, due to time and resources, to only looking 
at the antibiotic resistance phenotype; therefore it was not possible to determine the 
virulence phenotype of the isolates recovered in this study. Therefore, the virulence gene 
profiles of the isolates from public settings in comparison with other isolates recovered 
from different sources are only a prediction of their virulence ability as it is possible that 
these genes are not expressed (Kwong et al., 2015). 
The main limitation of the WGS analyses in this study was the lack of WGS data for 
coagulase-negative staphylococcal species recovered from other sources available in the 
ENA database which would allow us to conduct a sophisticated comparison of isolates. 
There were data available for isolates recovered from clinical samples and animals, but 
there was a limited number of isolates recovered from plants and other environmental 
sources. Additionally, for S. hominis genome comparison studies, there were only 40 
accessible isolates in total that were WGS. This is most likely due to them not being as 
commonly found as S. epidermidis and S. haemolyticus to cause infections in humans and 
animals. For S. warneri and S. cohnii there were only 3 mecA+ isolates that were whole 
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genome sequenced; therefore, it was not possible to have a good comparison with other 
isolates from different sources 
7.5 Future work 
This research has built on previous studies of staphylococci from public settings (beaches, 
buses, hotels, restrooms and built-up areas) by incorporating WGS; but still requires 
further research to expand understanding of MDR staphylococci from public settings 
(Conceição et al., 2013; Lutz et al., 2014; Mkrtchyan et al., 2013; Seng et al., 2017b; Xu 
et al., 2015).  For the samples collected, this research is a snapshot of a single day, 
whereas in future studies, the same area can be sampled multiple times in a day or over 
different seasons. This will help to determine if weather; changes in the influx of people 
to these areas and time points before and after surface disinfectant might be driving 
factors in the proportion of MDR staphylococci found in public setting areas; what 
species are present; the difference in antibiotic resistance phenotype and genotype profile 
and if there is a difference in their genetic lineages. 
Along with WGS analyses and antibiotic resistance analyses, further studies could look 
at these isolates virulence ability by performing phenotyping assay or to use RNA 
sequencing to determine if the predicted virulence genes are expressed. This will help to 
better understand how serious the risk is these isolates pose to public health. 
7.6 Final Statement 
This thesis has helped build on the knowledge of previous studies on MDR staphylococci 
recovered from public settings and incorporated WGS analysis to determine their genetic 
variations and lineages. The growing threat of AMR bacteria to public health is concern 
internationally and the research has shown that isolates recovered from public settings 
are a public health risk which, in the case of developing a disease, could be untreatable 
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with currently available antibiotics.  These high-frequency touched surfaces in public 
settings are reservoirs for different lineages of staphylococci that were phylogenetically 
related with isolates recovered from clinical infections cases, healthy humans, livestock 
and companion animals and in their accessory genome possessed genes that have 
transferred across from many bacterial isolates originated in different ecological niches. 
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Accession No. Isolate No. Species Area isolated 
ERS2999996 1 Staphylococcus haemolyticus East London Community 
ERS2999997  27 Staphylococcus sciuri East London Community 
ERS2999998 33 Staphylococcus sciuri East London Community 
ERS2999999 59 Staphylococcus sciuri East London Community 
ERS3000000 74 Staphylococcus sciuri East London Community 
ERS3000001 75 Staphylococcus sciuri East London Community 
ERS3000002 93 Staphylococcus haemolyticus East London Community 
ERS3000003 99 Staphylococcus haemolyticus East London Community 
ERS3000004 105 Staphylococcus haemolyticus East London Community 
ERS3000005 109 Staphylococcus sciuri East London Community 
ERS3000006 207 Staphylococcus hominis West London Community 
ERS3000007 208 Staphylococcus hominis West London Community 
ERS3000008 209 Staphylococcus hominis West London Community 
ERS3000009 211 Staphylococcus cohnii West London Community 
ERS3000010 321 Staphylococcus epidermidis East London Hospital 
ERS3000011 327 Staphylococcus epidermidis East London Hospital 
ERS3000012 329 Staphylococcus epidermidis East London Hospital 
ERS3000013 343 Staphylococcus cohnii East London Hospital 
ERS3000014 349 Staphylococcus cohnii East London Hospital 
ERS3000015 355 Staphylococcus epidermidis East London Hospital 
ERS3000016 361 Staphylococcus haemolyticus East London Hospital 
ERS3000017  372 Staphylococcus hominis East London Hospital 
ERS3000018 373 Staphylococcus haemolyticus East London Hospital 
ERS3000019 385 Staphylococcus hominis East London Hospital 
ERS3000020 386 Staphylococcus hominis East London Hospital 
ERS3000021 387 Staphylococcus hominis East London Hospital 
ERS3000022 407 Staphylococcus epidermidis East London Hospital 
ERS3000023 435 Staphylococcus epidermidis West London Hospital 
ERS3000024 436 Staphylococcus haemolyticus West London Hospital 
ERS3000025 445 Staphylococcus haemolyticus West London Hospital 
ERS3000026 465 Staphylococcus epidermidis West London Hospital 
ERS3000027 475 Staphylococcus epidermidis West London Hospital 
ERS3000028 479 Staphylococcus hominis West London Hospital 
ERS3000029 492 Staphylococcus haemolyticus West London Hospital 
ERS3000030 506 Staphylococcus haemolyticus West London Hospital 
ERS3000031 538 Staphylococcus haemolyticus West London Hospital 
ERS3000032 620 Staphylococcus hominis West London Hospital 
ERS3000033 623 Staphylococcus hominis West London Hospital 
ERS3000034 631 Staphylococcus epidermidis West London Hospital 
ERS3000035 664 Staphylococcus epidermidis West London Hospital 
ERS3000036 673 Staphylococcus epidermidis West London Hospital 
ERS3000037 699 Staphylococcus warneri West London Hospital 
ERS3000038 700 Staphylococcus warneri West London Hospital 
ERS3000039 702 Staphylococcus warneri West London Hospital 
ERS3000040 711 Staphylococcus epidermidis West London Hospital 
 370 
ERS3000041 712 Staphylococcus epidermidis West London Hospital 
ERS3000042 713 Staphylococcus epidermidis West London Hospital 
ERS3000043 715 Staphylococcus epidermidis West London Hospital 
ERS3000044 716 Staphylococcus epidermidis West London Hospital 
Table 9.1: Summary of the Whole Genome Sequenced isolates 
 
